0001445305-11-003423.txt : 20111114 0001445305-11-003423.hdr.sgml : 20111111 20111114172214 ACCESSION NUMBER: 0001445305-11-003423 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20110930 FILED AS OF DATE: 20111114 DATE AS OF CHANGE: 20111114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: American Caresource Holdings, Inc. CENTRAL INDEX KEY: 0001316645 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 200428568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33094 FILM NUMBER: 111204584 BUSINESS ADDRESS: STREET 1: 5429 LYNDON B. JOHNSON FREEWAY STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75240 BUSINESS PHONE: 972-308-6830 MAIL ADDRESS: STREET 1: 5429 LYNDON B. JOHNSON FREEWAY STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75240 FORMER COMPANY: FORMER CONFORMED NAME: American Caresouce Holdings, Inc. DATE OF NAME CHANGE: 20050204 10-Q 1 anci2011q3.htm FORM 10-Q ANCI 2011 Q3
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
 
For the quarterly period ended September 30, 2011
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number 1-33094
 
AMERICAN CARESOURCE HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
 
 
DELAWARE
 
20-0428568
 
 
(State or other jurisdiction of
 
(I.R.S. employer
 
 
incorporation or organization)
 
identification no.)
 
 
 
 
 
 
 
 
5429 LYNDON B. JOHNSON FREEWAY
 
 
 
 
SUITE 850
 
 
 
 
DALLAS, TEXAS
 
 
 
 
75240
 
 
 
 
(Address of principal executive offices)
 
 
 
 
(Zip code)
 
 
 
(972) 308-6830
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes xNo o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “accelerated filer”,” large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer o
Non-accelerated filer o
Accelerated filer  o (do not check if a smaller reporting company)
Smaller Reporting Company x
 
Indicated by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.)  Yes o No x
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:  The number of shares of common stock of registrant outstanding on November 7, 2011 was 17,072,848.

TABLE OF CONTENTS
AMERICAN CARESOURCE HOLDINGS, INC.
FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2011




PART I.
FINANCIAL INFORMATION

ITEM 1.
Financial Statements

AMERICAN CARESOURCE HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(amounts in thousands, except per share data)

 
Three months ended
September 30,
 
Nine months ended
September 30,
 
2011
 
2010
 
2011
 
2010
Net revenues
$
11,496

 
$
14,763

 
$
35,881

 
$
45,092

Cost of revenues:
 
 
 
 
 
 
 
Provider payments
9,091

 
11,069

 
27,715

 
33,171

Administrative fees
616

 
799

 
1,791

 
2,552

Claims administration and provider development
1,008

 
1,189

 
3,261

 
3,597

Total cost of revenues
10,715

 
13,057

 
32,767

 
39,320

 
 
 
 
 
 
 
 
Contribution margin
781

 
1,706

 
3,114

 
5,772

 
 

 
 

 
 
 
 
Selling, general and administrative expenses
1,778

 
1,446

 
4,943

 
4,722

Goodwill impairment charge
4,361

 

 
4,361

 

Depreciation and amortization
204

 
197

 
585

 
571

Total operating expenses
6,343

 
1,643

 
9,889

 
5,293

 
 
 
 
 
 
 
 
Operating income (loss)
(5,562
)
 
63

 
(6,775
)
 
479

 
 

 
 

 
 
 
 
Other Income
8

 
24

 
32

 
85

 
 

 
 
 
 
 
 
Income (loss) before income taxes
(5,554
)
 
87

 
(6,743
)
 
564

Income tax provision
969

 
43

 
647

 
220

Net income (loss)
$
(6,523
)
 
$
44

 
$
(7,390
)
 
$
344

Earnings (loss) per common share:
 

 
 

 
 
 
 
Basic
$
(0.38
)
 
$
0.00

 
$
(0.44
)
 
$
0.02

Diluted
$
(0.38
)
 
$
0.00

 
$
(0.44
)
 
$
0.02

 
 
 
 

 
 
 
 
Basic weighted average common shares outstanding
17,011

 
16,631

 
16,978

 
16,413

Diluted weighted average common shares outstanding
17,011

 
17,124

 
16,978

 
17,169


See accompanying notes.


1


AMERICAN CARESOURCE HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(amounts in thousands except per share amounts)

 
September 30, 2011 (Unaudited)
 
December 31, 2010
 
 
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
11,061

 
$
14,512

Accounts receivable, net
3,780

 
5,510

Prepaid expenses and other current assets
553

 
532

Deferred income taxes
6

 
237

Total current assets
15,400

 
20,791

 
 

 
 

Property and equipment, net
1,906

 
1,824

 
 
 
 

Other assets:
 
 
 

Deferred income taxes
226

 
609

Other non-current assets
78

 
340

Intangible assets, net
928

 
1,025

Goodwill

 
4,361

 
$
18,538

 
$
28,950

 
 
 
 
LIABILITIES AND SHAREHOLDERS' EQUITY
 

 
 

Current liabilities:
 

 
 

Due to service providers
$
3,056

 
$
6,718

Accounts payable and accrued liabilities
1,503

 
1,446

Total current liabilities
4,559

 
8,164

 
 

 
 

Commitments and contingencies


 


 
 
 
 

Shareholders' equity:
 
 
 

Preferred stock, $0.01 par value; 10,000 shares authorized, none issued

 

Common stock, $0.01 par value; 40,000 shares authorized; 17,072 and 16,922 shares issued and outstanding in 2011 and 2010, respectively
171

 
169

Additional paid-in capital
22,183

 
21,602

Accumulated deficit
(8,375
)
 
(985
)
Total shareholders' equity
13,979

 
20,786

 
$
18,538

 
$
28,950


See accompanying notes.


2


AMERICAN CARESOURCE HOLDINGS, INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
(Unaudited)
(amounts in thousands)

 
 
 
 
 
Additional
 
 
 
Total
 
Common Stock
 
Paid-in
 
Accumulated
 
Stockholders'
 
Shares
 
Amount
 
Capital
 
Deficit
 
Equity
Balance at December 31, 2010
16,922

 
$
169

 
$
21,602

 
$
(985
)
 
$
20,786

Net loss

 

 

 
(7,390
)
 
(7,390
)
Stock-based compensation expense

 

 
632

 

 
632

Issuance of common stock upon conversion of equity incentive awards, net of tax withholdings
150

 
2

 
(51
)
 

 
(49
)
Balance at September 30, 2011
17,072

 
$
171

 
$
22,183

 
$
(8,375
)
 
$
13,979


See accompanying notes.



3


AMERICAN CARESOURCE HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(amounts in thousands)

 
Nine months ended September 30,
 
2011
 
2010
Cash flows from operating activities:
 
 
 
Net income (loss)
$
(7,390
)
 
$
344

Adjustments to reconcile net income (loss) to net cash provided (used) by operations:
 
 
 
Stock-based compensation expense
632

 
606

Depreciation and amortization
585

 
571

Goodwill impairment charge
4,361

 

Unrealized gain on warrant derivative

 
(18
)
Amortization of long-term client agreement
187

 
187

Client administration fee expense related to warrants
67

 
150

Deferred income taxes
615

 
193

Changes in operating assets and liabilities:
 
 
 
Accounts receivable
1,730

 
1,072

Prepaid expenses and other assets
(81
)
 
22

Accounts payable and accrued liabilities
76

 
(287
)
Due to service providers
(3,662
)
 
(2,313
)
Net cash provided by (used) in operating activities
(2,880
)
 
527

 
 

 
 

Cash flows from investing activities:
 

 
 

Investment in software development costs
(513
)
 
(283
)
Additions to property and equipment
(58
)
 
(282
)
Net cash (used) in investing activities
(571
)
 
(565
)
 
 

 
 

Cash flows from financing activities:
 
 
 
Proceeds from exercise of equity incentive awards

 
157

Net cash provided by financing activities

 
157

 
 
 
 
Net increase (decrease) in cash and cash equivalents
(3,451
)
 
119

Cash and cash equivalents at beginning of period
14,512

 
11,868

 
 

 
 

Cash and cash equivalents at end of period
$
11,061

 
$
11,987

 
 

 
 

Supplemental cash flow information:
 
 
 
Cash paid for taxes
$
65

 
$
134

 
 
 
 
Supplemental non-cash financing activity:
 
 
 
Income tax withholdings on conversion of equity incentives
$
37

 
$
19


See accompanying notes.



4


AMERICAN CARESOURCE HOLDINGS, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(tables in thousands, except per share data)

1. Description of Business and Basis of Presentation

American CareSource Holdings, Inc. (“ACS,” “Company,”  the “Registrant,” “we,” “us,” or “our”) is an ancillary services company that offers cost effective access to a comprehensive national network of ancillary healthcare service providers.  The Company sells its services to a number of healthcare companies including preferred provider organizations ("PPOs"), third party administrators (“TPAs”), insurance companies, large self-funded organizations, various employee groups and other middle-market organizations.  The Company offers payors this solution by:
 
lowering its payors’ ancillary care costs throughout our network of high quality, cost effective providers that the Company has under contract at more favorable terms than they could generally obtain on their own;

providing payors with a comprehensive network of ancillary healthcare services providers that is tailored to each payor’s specific needs and is available to each payor’s covered persons for covered services;

providing payors with claims management, reporting and processing and payment services;

performing network/needs analysis to assess the benefits to payors of adding additional/different service providers to the payor -specific provider networks; and

credentialing network service providers for inclusion in the payor -specific provider networks.  

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), interim reporting requirements of Form 10-Q and Rule 8-03 of Regulation S-X of the rules and regulations of the Securities and Exchange Commission (“SEC”).  Consequently, financial information and disclosures normally included in financial statements prepared annually in accordance with GAAP have been condensed or omitted.  Balance sheet amounts are as of September 30, 2011 and December 31, 2010 and operating results are for the three and nine months ended September 30, 2011 and 2010, and include all normal and recurring adjustments we consider necessary for the fair, summarized presentation of our financial position and operating results.  As these are condensed financial statements, readers of this report should, therefore, refer to the consolidated financial statements and the notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010, filed with the SEC on March 18, 2011.

The Company uses the “management approach” for reporting information about segments in annual and interim financial statements.  The management approach is based on the way the chief operating decision-maker organizes segments within a company for making operating decisions and assessing performance.  Reportable segments are based on products and services, geography, legal structure, management structure and any other manner in which management disaggregates a company.  Based on the “management approach” model, the Company has determined that its business is comprised of a single operating segment.
 
Our interim results of operations are not necessarily indicative of results of operations that will be realized for the full fiscal year.

Certain prior year amounts have been reclassified within the condensed consolidated financial statements to conform to the current year presentation.

2. Revenue Recognition

The Company recognizes revenue on the services that it provides, which includes (i) providing payor clients with a comprehensive network of ancillary healthcare providers, (ii) providing claims management, reporting, processing and payment services, (iii) providing network/need analysis to assess the benefits to payor clients of adding what additional/different service providers to the client-specific provider networks and (iv) providing credentialing of network services providers for inclusion in the client payor-specific provider networks.  Revenue is recognized when services are delivered, which occurs after processed claims are billed to the client payors and collections are reasonably assured.  The Company estimates revenues and costs of revenues using average historical collection rates and average historical margins earned on claims.  Periodically, revenues are adjusted to reflect actual cash collections so that revenues recognized accurately reflect cash collected.


5


The Company determines whether it is acting as a principal or agent in the fulfillment of the services rendered.  After careful evaluation of the key gross and net revenue recognition indicators, the Company acknowledges that while the determination of gross versus net reporting is highly judgmental in nature, the Company has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.

Following are the key indicators that support the Company’s conclusion that it acts as a principal when settling claims for service providers through its contracted service provider network:

The Company is the primary obligor in the arrangement.  The Company has assessed its role as primary obligor as a strong indicator of gross reporting.  The Company believes that it is the primary obligor in its transactions because it is responsible for providing the services desired by its client payors.  The Company has distinct, separately negotiated contractual relationships with its client payors and with the ancillary health care providers in its networks.  The Company does not negotiate “on behalf of” its client payors and does not hold itself out as the agent of the client payors when negotiating the terms of the Company’s ancillary healthcare service provider agreements.  The Company’s agreements contractually prohibit client payors and service providers to enter into direct contractual relationships with one another.  The client payors have no control over the terms of the Company’s agreements with the service providers.  In executing transactions, the Company assumes key performance-related risks.  The client payors hold the Company responsible for fulfillment, as the provider, of all of the services the client payors are entitled to under their contracts; client payors do not look to the service providers for fulfillment.  In addition, the Company bears the pricing/margin risk as the principal in the transactions.  Because the contracts with the client payors and service providers are separately negotiated, the Company has complete discretion in negotiating both the prices it charges its client payors and the financial terms of its agreements with the service providers.  Since the Company’s profit is the spread between the amounts received from the client payors and the amount paid to the service providers, it bears significant pricing/margin risk.  There is no guaranteed mark-up payable to the Company on the amount the Company has contracted.  Thus, the Company bears the risk that amounts paid to the service provider will be greater than the amounts received from the client payors, resulting in a loss or negative claim.

The Company has latitude in establishing pricing.  As stated above, the Company has complete latitude in negotiating the price to be paid to the Company by each client payor and the price to be paid to each contracted service provider.  This type of pricing latitude indicates that the Company has the risks and rewards normally attributed to a principal in the transactions.

The Company changes the product or performs part of the services.  The Company provides the benefits associated with the relationships it builds with the client payors and the services providers.  While the parties could deal with each other directly, the client payors would not have the benefit of the Company’s experience and expertise in assembling a comprehensive network of service providers, in claims management, reporting and processing and payment services, in performing network/needs analysis to assess the benefits to client payors of adding additional/different service providers to the client payor-specific provider networks, and in credentialing network service providers.

The Company has complete discretion in supplier selection.  One of the key factors considered by client payors who engage the Company is to have the Company undertake the responsibility for identifying, qualifying, contracting with and managing the relationships with the ancillary healthcare service providers.  As part of the contractual arrangement between the Company and its client payors, the payors identify their obligations to their respective covered persons and then work with the Company to determine the types of ancillary healthcare services required in order for the payors to meet their obligations.  The Company may select the providers and contract with them to provide services at its discretion.

The Company is involved in the determination of product or service specifications.  The Company works with its client payors to determine the types of ancillary healthcare services required in order for the payors to meet their obligations to their respective covered persons.  In some respects, the Company is customizing the product through its efforts and ability to assemble a comprehensive network of providers for its payors that is tailored to each payor’s specific needs.  In addition, as part of its claims processing and payment services, the Company works with the client payors, on the one hand, and the providers, on the other, to set claims review, management and payment specifications.

The supplier (and not the Company) has credit risk.  The Company believes it has some level of credit risk, but that risk is mitigated because the Company does not remit payment to providers unless and until it has received payment from the relevant client payors following the Company’s processing of a claim.

The amount that the Company earns is not fixed.  The Company does not earn a fixed amount per transaction nor does it realize a per-person per-month charge for its services.
     

6


The Company has evaluated the other indicators of gross and net revenue recognition, including whether or not the Company has general inventory risk.  The Company does not have any general inventory risk, as its business is not related to the manufacture, purchase or delivery of goods and it does not purchase in advance any of the services to be provided by the ancillary healthcare service providers.  While the absence of this risk would be one indicator in support of net revenue reporting, as described in detail above, the Company has carefully evaluated all of the key gross and net revenue recognition indicators and has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.

If the Company were to report its revenues net of provider payments rather than on a gross reporting basis, for the three and nine months ended September 30, 2011, its net revenues would have been approximately $2.4 million and $8.2 million, respectively. For the three and nine months ended September 30, 2010, its net revenues would have been approximately $3.7 million and $11.9 million, respectively.
 
The Company records a provision for refunds on a periodic basis. Refunds are paid to payors for overpayments on claims, claims paid in error, and claims paid for non-covered services. In some instances, we will recoup payments made to the ancillary service provider if the claim has been fully resolved. The evaluation is performed periodically and is based on historical data. We present revenue net of the provision for refunds on the consolidated statement of operations.

During the three and nine months ended September 30, 2011 and 2010, two of the Company’s clients comprised a significant portion of the Company’s revenues.  The following is a summary of the approximate amounts of the Company’s revenue and accounts receivable contributed by each of those clients as of the dates and for the periods presented (amounts in thousands):

 
 
 
Periods ended September 30, 2011
 
 
 
Periods ended September 30, 2010
 
As of
September 30, 2011
 
Three months
 
Nine months
 
As of
September 30, 2010
 
Three months
 
Nine months
 
Accounts Receivable
 
Net Revenue
 
% of Total Revenue
 
Net Revenue
 
% of Total Revenue
 
Accounts Receivable
 
Net Revenue
 
% of Total Revenue
 
Net Revenue
 
% of Total Revenue
Client A
$
1,627

 
$
3,964

 
34
 %
 
$
12,142

 
34
 %
 
$
2,747

 
$
6,708

 
45
%
 
$
22,265

 
49
 %
Client B
756

 
2,535

 
22

 
7,794

 
22

 
1,789

 
3,889

 
26

 
13,189

 
29

All Others
1,556

 
5,130

 
45

 
16,382

 
45

 
2,013

 
4,226

 
29

 
9,818

 
22

Allowance for Uncollectable Receivables/Provision for refunds
(159
)
 
(133
)
 
(1
)
 
(437
)
 
(1
)
 
(204
)
 
(60
)
 

 
(180
)
 

 
$
3,780

 
$
11,496

 
100
 %
 
$
35,881

 
100
 %
 
$
6,345

 
$
14,763

 
100
%
 
45,092

 
100
 %



7


3. Earnings (Loss) Per Share

The following table details the reconciliation of basic earnings (loss) per share to diluted earnings (loss) per share (amounts in thousands except per share amounts):
 
Three months ended
September 30,
 
Nine months ended September 30,
 
2011
 
2010
 
2011
 
2010
Numerator:
 
 
 
 
 
 
 
Net income (loss) for basic earnings per share
$
(6,523
)
 
$
44

 
$
(7,390
)
 
$
344

Less:
 
 
 
 
 
 
 
Change in fair value of warrant derivative liability

 
2

 

 
18

Net loss for diluted earnings per share
$
(6,523
)
 
$
42

 
$
(7,390
)
 
$
326

 
 
 
 
 
 
 
 
Denominator:
 

 
 

 
 
 
 
Weighted-average basic and diluted common shares outstanding
17,011

 
16,631

 
16,978

 
16,413

Assumed conversion of dilutive securities:
 

 
 

 
 
 
 
  Stock options

 
239

 

 
282

  Stock warrants

 
254

 

 
474

  Restricted stock units

 

 

 

Potentially dilutive common shares

 
493

 

 
756

 
 
 
 
 
 
 
 
Denominator for diluted earnings per share -- Adjusted weighted average shares
17,011

 
17,124

 
16,978

 
17,169

 
 
 
 
 
 
 
 
Earnings (loss) per common share:
 
 
 
 
 
 
 
Basic
$
(0.38
)
 
$
0.00

 
$
(0.44
)
 
$
0.02

Diluted
$
(0.38
)
 
$
0.00

 
$
(0.44
)
 
$
0.02


For purposes of this calculation, outstanding stock options, stock warrants, and unvested restricted stock units are considered common stock equivalents using the treasury stock method, and are the only such equivalents outstanding.  For the nine months ended September 30, 2011, options to purchase approximately 2.4 million shares of common stock, warrants to purchase 475,000 shares of common stock and approximately 41,000 unvested restricted stock units were excluded from the calculation as their impact would be anti-dilutive.


4. Software Development Costs

The Company capitalizes costs associated with internally developed software, developed for internal use only, during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. Costs of significant upgrades and enhancements that result in additional functionality also are capitalized, whereas costs incurred for maintenance and minor upgrades and enhancements are expensed as incurred. Capitalized costs include external direct costs of materials and services utilized in developing or obtaining internal-use software and payroll and payroll-related expenses for employees who are directly associated with and devote time to the internal-use software projects. Capitalization of such costs begins when the preliminary project stage is complete and ceases no later than the point at which the project is substantially complete and ready for its intended purpose. Capitalized costs are amortized using the straight-line method over the useful life of the software, which is typically five years.
During the three and nine months ended September 30, 2011, the Company capitalized $160,000 and $513,000, respectively. During the three and nine months ended September 30, 2010, the Company capitalized approximately $101,000 and $283,000, respectively.


8


5. Income Taxes

Income tax provision (benefit) for the nine months ended September 30 differed from the U.S. federal income tax rate of 34% approximately in the amounts indicated as a result of the following:
 
 
2011
 
2010
Computed “expected” tax provision (benefit) at statutory rates
 
$
(2,293
)
 
$
192

Change in valuation allowance
 
2,906

 

Permanent differences
 
(19
)
 
(507
)
Shortfall from restricted stock units conversion
 
42

 

Warrant deduction
 

 
511

State taxes
 
14

 
37

Other
 
(3
)
 
(13
)
Total income tax provision
 
$
647

 
$
220


At September 30, 2011 the Company determined a valuation allowance against its federal deferred tax assets was necessary. A valuation allowance of approximately $2.9 million was recorded in the third quarter of 2011, which is included in the income tax provision for the three and nine months ended September 30, 2011. Due to the nature and timing of the deferred tax liabilities, the valuation allowance was established against the net deferred tax assets except for the Texas margin tax carryforward of approximately $232,000.
Differences between financial accounting principles and tax laws cause differences between the bases of certain assets and liabilities for financial reporting purposes and tax purposes. The tax effects of these differences, to the extent they are temporary, are recorded as deferred tax assets and liabilities and consisted of the following components:
 
 
2011
 
2010
Deferred tax assets:
 
 
 
 
Operating loss carryforward
 
$
1,038

 
$
101

Accounts receivable allowance
 
56

 
69

Warrants
 
202

 
179

Texas tax credit carryforward
 
232

 
238

Stock option compensation
 
1,251

 
1,140

Goodwill
 
873

 

Accrued expenses
 
246

 
203

Alternative Minimum Tax credit carryforwards
 
16

 
16

Total deferred tax assets
 
3,914

 
1,946

Deferred tax liabilities:
 
 
 
 
Goodwill
 

 
(563
)
Property and equipment
 
(713
)
 
(496
)
Prepaid expense
 
(63
)
 
(41
)
Total deferred tax liabilities
 
(776
)
 
(1,100
)
Valuation allowance
 
(2,906
)
 

Net Deferred Tax Assets
 
$
232

 
$
846


The Company was notified during the nine months ended September 30, 2011 of an examination by tax authorities for its U.S. federal return for the year ended 2009. The examination began in April 2011 and is currently in process.



9


6. Warrants
    
The Company entered into an agreement as of February 25, 2011, whereby the Company agreed to issue warrants to purchase 250,000 shares of common stock with an exercise price of $1.67. The warrants vest in increments pursuant to the achievement of defined, agreed upon revenue targets generated by new clients within a five year term. The agreement also obligates the Company to issue warrants to purchase up to an additional 500,000 shares of common stock (issued in 250,000 increments) pursuant to the achievement of additional defined agreed upon revenue targets.

During the three and nine months ended September 30, 2011, we recognized compensation costs of approximately $11,000 and $25,000, respectively, associated with the warrant. The cost has been adjusted for the probability that the revenue targets will be reached. That probability will be re-evaluated and updated based on current market conditions, on a quarterly basis, and compensation costs will be adjusted accordingly.

7. Severance Charge

On July 25, 2011, the Board of Directors accepted the resignation of David S. Boone from his positions with the Company, including his positions as President, Chief Executive Officer and director.

In connection with his resignation, Mr. Boone entered into a severance agreement and general release with the Company, effective July 25, 2011. Under the agreement, Mr. Boone will receive, in addition to any base compensation owed and earned but unused vacation pay, severance payments over a six month period that in the aggregate equal six months' worth of his annual base compensation, and has the right to continue participation in the Company-sponsored group health insurance plan in accordance with COBRA. In addition, the terms of his vested but unexercised stock options were extended to, and expire on, October 10, 2011. During the three months ended September 30, 2011, the company recorded a severance charge of approximately $263,000 in connection with the severance agreement. The charge is included in selling, general and administrative expenses on the condensed consolidated statement of operations. In addition, in September 2011, Mr. Boone executed a cashless exercise of 209,000 options, which resulted in 84,000 shares of common stock being issued to Mr. Boone.

8. Goodwill Impairment

As of September 30, 2011 and prior to our December 31 annual impairment test, the Company concluded that impairment indicators existed based upon, among other things, the decline in market capitalization, revenue declines of the Company's two most significant client accounts and operating results for the nine months ended September 30, 2011, which required the performance of an interim impairment test. As a result, the Company performed the generally recognized threshold goodwill impairment test (step 1) which indicated that the fair value of the Company (single reporting unit), based primarily on the trading value of the Company's common stock plus an estimated control premium, was less than the book value of its net assets. Therefore, the required next analysis of the assessment was performed (step 2), in which the implied fair value of the Company's goodwill was compared to the book value of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination, that is, the estimated fair value of the Company is allocated to all of those assets and liabilities (including both recognized and unrecognized intangible assets) as if the Company had been acquired in a business combination and the estimated fair value was the purchase price paid. If the carrying amount of goodwill is greater than the implied fair value of goodwill, an impairment loss is recognized in the amount of the excess and is charged to operations.
As a result of our preliminary interim impairment assessment, the Company recognized an estimated non-cash goodwill impairment charge of $4.4 million as of September 30, 2011, representing the entire balance of goodwill. In addition, at this interim date, the Company also reviewed the carrying value of the other identifiable intangible assets, which is limited to our ancillary provider network, to determine if impairment exists. Based on this analysis, the Company concluded that no impairment of the ancillary provider network existed as of September 30, 2011. A deferred tax benefit of $1.5 million was recognized as of September 30, 2011 as a result of the total amount of estimated impairment charges, but a valuation allowance was immediately provided.
The impairment was primarily the result of our continued declining total revenues as a result of declines in revenue and claims volume from our two most significant clients and the expectation of significantly diminishing revenue from at least one of these clients. The impairment did not impact our operations or cash flows. Due to the complexity of the process, the Company will not fully complete the measurement of the implied fair value of goodwill and other intangible assets under step 2 of the test until the fourth quarter of 2011 and, accordingly, the goodwill impairment charge included in the condensed consolidated statement of operations for the three and nine months ended September 30, 2011 represents an estimate. Any adjustments to these amounts, which could be material, resulting from the completion of step 2 will be recognized during the fourth quarter of 2011.


10


FORWARD-LOOKING STATEMENTS

This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements can be identified by forward-looking words such as “may,” “will,” “expect,” “intend”, “anticipate,” “believe,” “estimate” and “continue” or similar words and discuss the Company’s plans, objectives and expectations for future operations, including its services, contain projections of the Company’s future operating results or financial condition, and discuss its expectations with respect to the growth in health care costs in the United States, the demand for ancillary benefits management services, and the Company’s competitive advantages, or contain other “forward-looking” information.

Such forward-looking statements are based on current information, assumptions and belief of management, and are not guarantees of future performance.  Substantial risks and uncertainties could cause actual results to differ materially from those indicated by such forward-looking statements, including, but not limited to, the Company’s inability to attract or maintain providers or clients or achieve its financial results, changes in national health care policy, federal or state regulation, and/or rates of reimbursement including without limitation the impact of the Patient Protection and Affordable Care Act, Health Care and Educational Affordability Reconciliation Act and medical loss ratio regulations, general economic conditions (including the economic downturns and increases in unemployment), lower than anticipated demand for ancillary services, shifts from higher margin services to services with lower profit margins, pricing, market acceptance/preference, the Company’s ability to integrate with its clients, consolidation in the industry that are impacting the Company’s key clients and the resulting transition plans, changes in the business decisions by significant clients, increased competition, implementation and performance difficulties, and other risk factors detailed from time to time in the Company’s periodic filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2010 and the quarterly reports on Form 10-Q filed for each of the subsequent quarters.

Do not place undue reliance on these forward-looking statements, which speak only as of the date this document was prepared.  All forward-looking statements included herein are expressly qualified in their entirety by the cautionary statements contained or referred to in this section.  Except to the extent required by applicable securities laws and regulations, the Company undertakes no obligation to update or revise these forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events.

ITEM 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations

GENERAL
 
Management’s discussion and analysis provides a review of the Company’s operating results for the three and nine months ended September 30, 2011 and its financial condition at September 30, 2011.  The focus of this review is on the underlying business reasons for significant changes and trends affecting the net revenues, operating results and financial condition of the Company.  This review should be read in conjunction with the accompanying unaudited consolidated financial statements and the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2010.


11


OVERVIEW

American CareSource Holdings, Inc. (“ACS,” “Company,”  the “Registrant,” “we,” “us,” or “our”) works to help employers control healthcare costs by offering cost effective access to a comprehensive national network of ancillary healthcare service providers.  The Company sells its services to a number of healthcare companies including preferred provider organizations ("PPOs"), third party administrators (“TPAs”), insurance companies, large self-funded organizations and various employee groups.  The Company offers payors this solution by:
 
lowering its payors’ ancillary care costs throughout its network of high quality, cost effective providers that the Company has under contract at more favorable terms than they could generally obtain on their own;

providing payors with a comprehensive network of ancillary healthcare services providers that is tailored to each payor’s specific needs and is available to each payor’s members for covered services;

providing payors with claims management, reporting and processing and payment services;

performing network/needs analysis to assess the benefits to payors of adding additional/different service providers to the payor -specific provider networks; and

credentialing network service providers for inclusion in the payor -specific provider networks.
  
The Company’s business model, illustrating the relationships among the persons involved, directly or indirectly, in the Company’s business and its generation of revenue and expenses, is depicted below:

Payors route healthcare claims to us after service has been performed by participant providers in our network.  We process those claims and charge the payor according to its contractual rate for the services according to our contract with the payor.  In processing the claim, we are paid directly by the payor or the insurer for the service.  We then pay the provider of service according to its independently-negotiated contractual rate.  We assume the risk of generating positive margin, the difference between the payment we receive for the service and the amount we are obligated to pay the provider of service.

12



The Company recognizes revenues for ancillary healthcare services when services by providers have been authorized and performed, the claim has been billed to the payor and collections from payors are reasonably assured.  Cost of revenues for ancillary healthcare services consist of amounts due to providers for providing ancillary health care services, client administration fees paid to our client payors to reimburse them for routing the claims to us for processing, and the Company’s related direct labor and overhead of processing billings, collections and payments. The Company is not liable for costs incurred by independent contract service providers until payment is received by it from the payors. The Company recognizes actual or estimated liabilities to independent contract service providers as the related revenues are recognized.

The Company is seeking growth in the number of client payors and service provider relationships it secures by focusing on providing in-network services for its payors and aggressively pursuing additional TPAs, self-insured employers and other direct payors as its primary sales targets. The Company believes this strategy should increase the volume of claims the Company can process in addition to the expansion in the number of lives that are eligible to receive ancillary health care benefits.  No assurances can be given that the Company can expand its service provider or payor relationships, nor that any such expansion will result in an improvement in the results of operations of the Company.
 
In addition, under the Minimum Loss Ratio regulations ("MLR") included in the Affordable Care Act, it is possible that a portion of the fees our existing and prospective payors are contractually required to pay us and that do not qualify as 'incurred claims' may not be included as expenditures for activities that improve health care quality. Such a determination may make it more difficult for us to retain existing clients and/or add new clients, because our clients' or prospective clients' MLR may otherwise not meet the specified targets. This may reduce our net revenues and profit margins. See "Proposed health care reforms could materially adversely affect our revenues, financial position and our results of operations" under "Item 1.A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2010.

The Company has experienced declining revenue over the last two years and three consecutive quarters of operating losses primarily as a result of the decline in claims volume from its two largest clients. We have been unable to identify new client relationships to replace the declining revenue streams and we expect revenue from the clients to continue to decline.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES
 
Management’s discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements.  These condensed consolidated financial statements have been prepared following the requirements of accounting principles generally accepted in the United States (“GAAP”) for interim periods and require us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, provider cost recognition, the resulting contribution margins, amortization and potential impairment of intangible assets and goodwill and stock-based compensation expense.  As these are condensed consolidated financial statements, you should also read expanded information about our critical accounting policies and estimates provided in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the heading “Critical Accounting Policies,” included in our Annual Report on Form 10-K for the year ended December 31, 2010.  There have been no material changes to our critical accounting policies and estimates from the information provided in our Form 10-K for the year ended December 31, 2010.

ANALYSIS OF RESULTS OF OPERATIONS

Net Revenues

The Company’s net revenues are generated from ancillary healthcare service claims.  Revenue is recognized when we bill our client payors for services performed and collection is reasonably assured. The Company estimates revenues using average historical collection rates.  When estimating collectibility, we assess the impact of items such as non-covered benefits, denied claims, deductibles and co-payments. Periodically, revenues are adjusted to reflect actual cash collections so that revenues recognized accurately reflect cash collected. There are no assurances that actual cash collections will meet or exceed estimated cash collections.

The following table sets forth a comparison of our net revenues for the following periods presented ended September 30:
 
 
Third Quarter
 
Nine Months
 
 
 
 
 
 
Change
 
 
 
 
 
Change
($ in thousands)
 
2011
 
2010
 
$
 
%
 
2011
 
2010
 
$
 
%
Net Revenues
 
$
11,496

 
$
14,763

 
(3,267
)
 
(22
)%
 
$
35,881

 
$
45,092

 
$
(9,211
)
 
(20
)%

13



In addition, the following table sets forth a comparison of processed and billed claims for the following periods presented ended September 30:

 
 
Third Quarter
 
Nine Months
 
 
 
 
 
 
Change
 
 
 
 
 
Change
(in thousands)
 
2011
 
2010
 
Claims
 
%
 
2011
 
2010
 
Claims
 
%
Processed
 
73

 
111

 
(38
)
 
(34
)%
 
240

 
316

 
(76
)
 
(24
)%
Billed
 
61

 
76

 
(15
)
 
(20
)
 
196

 
247

 
(51
)
 
(21
)

The decrease in net revenue for the three and nine months ended September 30, 2011 as compared to the same periods in 2010 was due to the overall decline in claims volume. The decline was primarily the result of the following factors:

Loss of a significant employer group by our largest client. Claims from the group generated revenue of approximately $2.5 million in the third quarter of 2010 and $7.2 million for the nine months ended September 30, 2010. Claims from the group generated approximately $35,000 and $535,000 during the three and nine months ended September 30, 2011, respectively;
The ongoing transition status of our other key account related to a business combination resulting in declining revenues as it transitions its payors and employer groups to network alternatives; we expect revenue from the account to be significantly impacted in 2012 by the completion of the transition;
Stronger presence of larger carriers in the market, which resulted in loss of market share;
The change in patient and specialty mix and benefit plan design changes, which has resulted in the increase in non-covered benefits; and
The extended sales cycle as we focus our sales efforts more heavily on the TPA and direct payor market. For the nine months ended September 30, 2010, we added 11 new client accounts as compared to 3 during the nine months ended September 30, 2011.
    
The decline in net revenue was mitigated by $1.1 million and $5.2 million of incremental revenue generated in the three and nine months ended September 30, 2011, respectively, from 13 new clients implemented in 2010. We have only implemented three new clients in 2011.
 
Despite the growth from our new clients, we continue to see revenue attrition in our two most significant client accounts, both of which are PPOs. Our second largest client continues to transition its payors and employer groups to alternative network options as a result of a business combination. While the Company has an enforceable contract in effect through May 2012, our client continues its transition, negatively impacting the claims volume and revenue generated from the account. We anticipate the transition will continue throughout 2012 and will be complete by December 31, 2012, significantly impacting the claims and revenue generated from the account during 2012 and thereafter.
    
The following table details the change in client accounts for the periods ended September 30:
 
Net Revenue
 
Billed Claims Volume
 
Third Quarter
 
Change
 
Third Quarter
 
Change
(in thousands)
2011
 
2010
 
$
 
%
 
2011
 
2010
 
Claims
 
%
Client A
$
3,964

 
$
6,708

 
$
(2,744
)
 
(41
)%
 
18

 
29

 
(11
)
 
(38
)%
Client B
2,535

 
3,889

 
(1,354
)
 
(35
)
 
10

 
19

 
(9
)
 
(47
)
Other clients
1,972

 
2,475

 
(503
)
 
(20
)
 
15

 
20

 
(5
)
 
(25
)
Clients implemented in 2010
2,868

 
1,751

 
1,117

 
64

 
16

 
8

 
8

 
100

Clients implemented in 2011
290

 

 
290

 
nm

 
2

 

 
2

 
nm

Total
11,629

 
14,823

 
(3,194
)
 
(22
)%
 
61

 
76

 
(15
)
 
(20
)%
Provision for refunds
(133
)
 
(60
)
 
(73
)
 
nm

 

 

 

 
nm

Net Revenue
$
11,496

 
$
14,763

 
$
(3,267
)
 
(22
)%
 
61

 
76

 
(15
)
 
(20
)%

The following table details the change in client accounts for the periods ended September 30:

14


 
Net Revenue
 
Billed Claims Volume
 
Nine Months
 
Change
 
Nine Months
 
Change
(in thousands)
2011
 
2010
 
$
 
%
 
2011
 
2010
 
Claims
 
%
Client A
$
12,142

 
$
22,265

 
$
(10,123
)
 
(45
)%
 
58

 
95

 
(37
)
 
(39
)%
Client B
7,794

 
13,189

 
(5,395
)
 
(41
)
 
34

 
75

 
(41
)
 
(55
)
Other clients
7,339

 
6,673

 
666

 
10

 
54

 
63

 
(9
)
 
(14
)
Clients implemented in 2010
8,401

 
3,145

 
5,256

 
167

 
46

 
14

 
32

 
228

Clients implemented in 2011
642

 

 
642

 
nm

 
4

 

 
4

 
nm

Total
36,318

 
45,272

 
(8,954
)
 
(20
)%
 
196

 
247

 
(51
)
 
(21
)%
Provision for refunds
(437
)
 
(180
)
 
(257
)
 
(143
)
 

 

 

 
nm

Net Revenue
$
35,881

 
$
45,092

 
$
(9,211
)
 
(20
)%
 
196

 
247

 
(51
)
 
(21
)%

The Company is seeking growth by aggressively pursuing middle-market insurance companies, TPAs and direct payors. The Company continues to derive a significant amount of its revenues from its traditional PPO relationships, but we have shifted our focus and now aggressively target TPAs and direct payors. A portion of our target market is Employee Retirement Income Security Act ("ERISA")-based health plans that seek cost-effective healthcare benefits for its members and present an opportunity for the Company to influence plan design and provide incentives.

The following table details the change in revenue generated from different client groups for the periods ended September 30:
 
Third Quarter
 
2011
 
2010
 
Change
($ in thousands)
Count
 
Revenue
 
% of revenue
 
Count
 
Revenue
 
% of revenue
 
$
 
%
PPOs
11

 
$
6,782

 
58.3
%
 
11

 
$
10,458

 
70.6
%
 
$
(3,676
)
 
(35
)%
TPAs
23

 
3,505

 
30.1

 
17

 
2,645

 
17.8

 
860

 
33

Direct/Insurance Companies
3

 
1,342

 
11.5

 
3

 
1,720

 
11.6

 
(378
)
 
(22
)
Total
 
 
$
11,629

 
100.0
%
 
 
 
$
14,823

 
100.0
%
 
$
(3,194
)
 
(22
)%

The following table details the change in revenue generated from different client groups for the periods ended September 30:


 
Nine Months
 
2011
 
2010
 
Change
($ in thousands)
Count
 
Revenue
 
% of revenue
 
Count
 
Revenue
 
% of revenue
 
$
 
%
PPOs
11

 
$
20,243

 
55.7
%
 
11

 
$
34,237

 
75.6
%
 
$
(13,994
)
 
(41
)%
TPAs
23

 
11,476

 
31.6

 
17

 
6,816

 
15.1

 
4,660

 
68

Direct/Insurance Companies
3

 
4,599

 
12.7

 
3

 
4,219

 
9.3

 
380

 
9

Total
 
 
$
36,318

 
100.0
%
 
 
 
$
45,272

 
100.0
%
 
$
(8,954
)
 
(20
)%

Cost of Revenues

Cost of revenues is comprised of payments to our providers, administrative fees paid to our clients for converting claims to electronic data interchange and routing them to both the Company for processing and to their payors for payment, and the fixed costs of our claims administration and ancillary service provider development organizations.  Payments to providers is the largest component of our cost of revenues and it consists of our payments for ancillary care services in accordance with contracts negotiated separately with providers for specific ancillary services.

The following tables set forth a comparison of the components of our cost of revenues, for the periods presented ended September 30:

15


 
 
Third Quarter
 
 
 
 
 
 
 
 
 
 
Change
($ in thousands)
 
2011
 
% of net revenue
 
2010
 
% of net revenue
 
$
 
%
Provider payments
 
$
9,091

 
79.1
%
 
$
11,069

 
75.0
%
 
$
(1,978
)
 
(18
)%
Administrative fees
 
616

 
5.4

 
799

 
5.4

 
(183
)
 
(23
)
Claims administration and provider development
 
1,008

 
8.7

 
1,189

 
8.0

 
(181
)
 
(15
)
Total cost of revenues
 
$
10,715

 
93.2
%
 
$
13,057

 
88.4
%
 
$
(2,342
)
 
(18
)%


 
 
Nine Months
 
 
 
 
 
 
 
 
 
 
Change
($ in thousands)
 
2011
 
% of net revenue
 
2010
 
% of net revenue
 
$
 
%
Provider payments
 
$
27,715

 
77.2
%
 
$
33,171

 
73.5
%
 
$
(5,456
)
 
(16
)%
Administrative fees
 
1,791

 
5.0

 
2,552

 
5.7

 
(761
)
 
(30
)
Claims administration and provider development
 
3,261

 
9.1

 
3,597

 
8.0

 
(336
)
 
(9
)
Total cost of revenues
 
$
32,767

 
91.3
%
 
$
39,320

 
87.2
%
 
$
(6,553
)
 
(17
)%

Provider payments.  The 18% and 16% decrease in provider payments for the third quarter and nine months ended September 30, 2011, respectively, is consistent with the decline in revenue, primarily related to our two significant clients. The increase in provider payments as a percentage of net revenues compared to the same prior year periods is primarily due to the following:

A shift in mix from clients that generate higher margins, relative to other clients, primarily as a result of (1) the loss a large payor group by our largest client which carried advantageous pricing relative to our other clients and (2) more competitive pricing associated with our TPAs and direct payor clients relative to other clients; and

A shift in mix from higher margin categories, such as diagnostic imaging services, to lower margin categories, such as dialysis services. In addition, margins on dialysis services claims declined as a result of a shift to service providers with which we have less advantageous pricing resulting in pressure on contribution margin.

Administrative fees. Administrative fees paid to clients as a percent of net revenues was 5.4% for the three months ended September 30, 2011 and 2010. Administrative fees paid to clients during the nine months ended September 30, 2011 decreased to 5.0% compared to 5.7% in the same prior year period. The decrease is due to a change in mix from clients with higher administrative fees to clients with lower administrative fees, primarily clients implemented in 2010.

Claims administration and provider development. Our claims administration organization consists of our operations and information technology groups.  Our operations group is responsible for all aspects of the claims management and processing including billing, quality assurance and collections efforts. In addition, our operations group is responsible for credentialing contracted ancillary service providers.  Our information technology group is responsible for maintaining and enhancing the technological capabilities and applications of the claims management process.  Our provider development group is responsible for developing our network of ancillary healthcare service providers, which includes contracting with providers to be included in the network and maintaining a relationship with existing providers, all for the purpose of enhancing our ancillary service provider network offering to our client payors. The following table sets forth a comparison of the groups related to claims administration and provider development for the periods presented ended September 30:
 
 
Third Quarter
 
Nine Months
 
 
 
 
 
 
Change
 
 
 
 
 
Change
($ in thousands)
 
2011
 
2010
 
$
 
%
 
2011
 
2010
 
$
 
%
Claims administration
 
$
710

 
$
750

 
$
(40
)
 
(5
)%
 
$
2,293

 
$
2,146

 
$
147

 
7
 %
Provider development
 
298

 
439

 
(141
)
 
(32
)
 
968

 
1,451

 
(483
)
 
(33
)
Total cost of revenues
 
$
1,008

 
$
1,189

 
$
(181
)
 
(15
)%
 
$
3,261

 
$
3,597

 
$
(336
)
 
(9
)%

The decrease in claims administration and provider development costs are primarily due to changes in headcount. Effective January 1, 2011, the Company strategically realigned personnel within departments based on responsibilities and functionality in order to achieve a more productive alignment. As a result, five positions were realigned out of the provider development group;

16


three were allocated to the finance group (classified as selling, general and administrative expenses) and two to the operations group. The following table details the change in average headcount in the groups related to claims administration and provider development for the periods presented ended September 30:
Headcount (average)
 
2011
 
2010
Operations
 
21

 
22

Information technology
 
14

 
14

Total claims administration
 
35

 
36

 
 
 
 
 
Provider development
 
9

 
12


In addition, claims administration costs increased during the nine months ended September 30, 2011 compared to the prior year period due to the timing and status of certain internal software development projects. During the nine months ended September 30, 2010, we incurred higher project development costs compared to the current year period, primarily related to our internal repricing and billing system. A significant portion of the project was completed as of June 30, 2011.

Contribution Margin

Contribution margin is calculated by dividing the difference between net revenues and total costs of revenues by net revenues. The following table sets forth a comparison of contribution margin percentage for the periods ended September 30:
 
 
Third Quarter
 
Nine Months
 
 
2011
 
2010
 
Percent
Change
 
2011
 
2010
 
Percent
Change
Contribution margin
 
6.8
%
 
11.6
%
 
(4.8
)%
 
8.7
%
 
12.8
%
 
(4.1
)%

The factors driving the overall decline in contribution margin percentage was discussed in the cost of revenue section. Our contribution margin percentage fluctuates over time due to changes in the prices we charge our client payors as compared to the financial terms of our provider agreements, changes in costs of claims administration and provider development, and changes in the mix of services we provide.  There can be no assurances that we will be able to maintain contribution margin at current levels, either in absolute or in percentage terms.

Selling, General and Administrative Expenses

Selling, general and administrative (“SG&A”) expenses consist primarily of salaries and related benefits, travel costs, sales commissions, sales materials, other marketing related expenses, costs of corporate operations, finance and accounting, human resources and other general operating expenses of the Company. The following table sets forth a comparison of our SG&A expenses for the periods presented ending September 30:
 
 
Third Quarter
 
Nine Months
 
 
 
 
 
 
Change
 
 
 
 
 
Change
($ in thousands)
 
2011
 
2010
 
$
%
 
2011
 
2010
 
$
%
Selling, general and administrative expenses
 
$
1,778

 
$
1,446

 
$
332

23
%
 
$
4,943

 
$
4,722

 
$
221

5
%
Percentage of total net revenues
 
15.5
%
 
9.8
%
 
 
 
 
13.8
%
 
10.5
%
 
 
 

SG&A expenses as a percentage of total net revenues increased during the three and nine months ended September 30, 2011 compared to the same prior year periods, due primarily to the decline in net revenues compared to the same prior year periods.

The 23% increase in SG&A expenses during the three months ended September 30, 2011 as compared to the same prior year period is primarily the result of a severance charge of approximately $263,000 related to the resignation of our former Chief Executive Officer. Excluding the severance charge, SG&A increased 5% in the third quarter of 2011 compared to the same prior year period. During the three months ended September 30, 2011, we incurred approximately $66,000 of consulting costs related to the analysis of various strategic initiatives related to our mix of services, development of new services and programs, and sales and marketing efforts. The analysis will continue in the fourth quarter of 2011.

SG&A expenses for the nine months ended September 30, 2010 included a severance charge of approximately $143,000 related to the departure of our former Chief Financial Officer. Excluding that severance charge and the severance charge during

17


2011, SG&A expenses increased approximately $101,000, or 2%, in the nine months ended September 30, 2011 compared to the same prior year period. During the nine months ended September 30, 2011, we incurred approximately $71,000 of consulting costs related to the analysis of various strategic initiatives related to our mix of services, development of new services and programs, and sales and marketing efforts. The analysis will continue in the fourth quarter of 2011.

Goodwill Impairment Charge

As of September 30, 2011 and prior to our December 31 annual impairment test, the Company concluded that impairment indicators existed based upon, among other things, the decline in market capitalization, revenue declines of the Company's two most significant client accounts and operating results for the nine months ended September 30, 2011, which required the performance of an interim impairment test. As a result, the Company performed the generally recognized threshold goodwill impairment test (step 1) which indicated that the fair value of the Company (single reporting unit), based primarily on the trading value of the Company's common stock plus an estimated control premium, was less than the book value of its net assets. Therefore, the required next analysis of the assessment was performed (step 2), in which the implied fair value of the Company's goodwill was compared to the book value of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination, that is, the estimated fair value of the Company is allocated to all of those assets and liabilities (including both recognized and unrecognized intangible assets) as if the Company had been acquired in a business combination and the estimated fair value was the purchase price paid. If the carrying amount of goodwill is greater than the implied fair value of goodwill, an impairment loss is recognized in the amount of the excess and is charged to operations.
As a result of our preliminary interim impairment assessment, the Company recognized an estimated non-cash goodwill impairment charge of $4.4 million as of September 30, 2011, representing the entire balance of goodwill. In addition, at this interim date, the Company also reviewed the carrying value of the other identifiable intangible assets, which is limited to our ancillary provider network, to determine if impairment exists. Based on this analysis, the Company concluded that no impairment of the ancillary provider network existed as of September 30, 2011. A deferred tax benefit of $1.5 million was recognized as of September 30, 2011 as a result of the total amount of estimated impairment charges, but a valuation allowance was immediately provided.
The impairment was primarily the result of our continued declining total revenues as a result of declines in revenue and claims volume from our two most significant clients and the expectation of significantly diminishing revenue from at least one of these clients. The impairment did not impact our operations or cash flows. Due to the complexity of the process, the Company will not fully complete the measurement of the implied fair value of goodwill and other intangible assets under step 2 of the test until the fourth quarter of 2011 and, accordingly, the goodwill impairment charge included in the condensed consolidated statement of operations for the three and nine months ended September 30, 2011 represents an estimate. Any adjustments to these amounts, which could be material, resulting from the completion of step 2 will be recognized during the fourth quarter of 2011.


Depreciation and Amortization

The following table sets forth a comparison of depreciation and amortization for the periods presented ended September 30:
 
 
Third Quarter
 
Nine Months
 
 
 
 
 
 
Change
 
 
 
 
 
Change
($ in thousands)
 
2011
 
2010
 
$
%
 
2011
 
2010
 
$
%
Depreciation
 
$
172

 
$
165

 
$
7

4
%
 
$
489

 
$
475

 
$
14

3
%
Amortization
 
32

 
32

 


 
96

 
96

 


Total Depreciation and Amortization
 
$
204

 
$
197

 
$
7

4
%
 
$
585

 
$
571

 
$
14

2
%


Income Tax Provision

For the three months ended September 30, 2011 and 2010, we recorded an income tax provision of $969,000 and $43,000, respectively. During the nine months ended September 30, 2011 and 2010, we recorded an income tax provision of $647,000 and $220,000, respectively. At September 30, 2011 we determined a valuation allowance against our federal deferred tax assets was necessary. The valuation allowance does not impact our ability to utilize our net operating loss carryforwards to offset taxable earnings in the future. As a result, we recorded a non-cash charge of $2.9 million during the third quarter of 2011, which is included in the income tax provision for the three and nine months ended September 30, 2011. Our remaining deferred tax assets of approximately $232,000 at September 30, 2011 are related primarily to our tax obligations in the state of Texas.

18


FINANCIAL CONDITION AND LIQUIDITY
 
As of September 30, 2011 the Company had working capital of $10.8 million compared to $12.6 million at December 31, 2010.  Our cash and cash equivalents balance decreased to $11.1 million as of September 30, 2011 compared to $14.5 million at December 31, 2010.  The decrease in cash during the nine months ended September 30, 2011 is primarily related to the timing of payments to providers and receipts from payors as of September 30, 2011 compared to December 31, 2010, as well as the decline in claims volume and resulting revenue and losses during the nine months ended September 30, 2011.

For the nine months ended September 30, 2011, operating activities used net cash of approximately $2.9 million, the primary components of which were a net loss of approximately $7.4 million, adjusted for non-cash items including: goodwill impairment charge of $4.4 million, share-based compensation expense of approximately $632,000, depreciation and amortization of approximately $585,000, amortization of warrant costs of approximately $67,000, amortization of the costs associated with the amendment to the contract with one of our significant clients of approximately $187,000, and a decrease in deferred taxes of approximately $615,000, as well as, a net cash outflow from net operating assets and liabilities of approximately $1.9 million.  The net cash outflow from net operating assets and liabilities was due primarily to a decline in revenue during the nine months ended September 30, 2011 and the timing of payments to providers and receipts from payors as of September 30, 2011 compared to December 31, 2010.
 
Investing activities during the nine months ended September 30, 2011 were comprised mainly of investments in software development of approximately $513,000.  The software development costs relate primarily to enhancements of our internal repricing and billing system.

The Company had no net cash provided by financing activities during the three and nine months ended September 30, 2011.

We believe our current cash balance of $11.1 million as of September 30, 2011 and expected future cash flows from operations will be sufficient to meet our anticipated cash needs for working capital, capital expenditures and other activities through at least the next twelve months.  While we are generating negative cash flow, we are in the process of reducing our cash expenditures both from operating and investing activities. If operating cash flows are not sufficient to meet our needs, we believe that credit or access to capital through issuance of equity would be available to us. However, as a result of the tightening in the credit markets, low level of liquidity in many financial markets and extreme volatility in fixed income, credit, currency and equity markets, there cannot be assurances that, if necessary, we would be successful in obtaining sufficient capital financing on commercially reasonable terms or at all.  We do not have any lines of credit, credit facilities or outstanding bank indebtedness as of September 30, 2011.


INFLATION
 
Inflation did not have a significant impact on the Company’s costs during the quarters ended September 30, 2011 and September 30, 2010, respectively.  The Company continues to monitor the impact of inflation in order to minimize its effects through pricing strategies, productivity improvements and cost reductions.

OFF-BALANCE SHEET ARRANGEMENTS
 
The Company does not have any off-balance sheet arrangements as of September 30, 2011 or 2010 or for the periods then ended.

ITEM 3.
Quantitative and Qualitative Disclosures About Market Risk

Not applicable.



19


ITEM 4.
Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures.  Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2011.  Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are effective to ensure that information required to the disclosed by us  in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
 
Changes in Internal Controls Over Financial Reporting.  Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has concluded that there were no changes in the Company’s internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) since the last fiscal quarter that have materially affected the Company’s internal controls over financial reporting or are reasonably likely to materially affect internal controls over financial reporting. 


20


PART II.
OTHER INFORMATION

ITEM 1A.    Risk Factors

The Company has experienced declining revenue over the last two years primarily as a result of the decline in business from its two largest clients. Our second largest client continues to transition related to a business combination. While the Company has an enforceable contract in effect through May 2012, our client continues to migrate its payors and employee groups to network alternatives, negatively impacting the claims volume from our client. We anticipate the transition to continue through 2012 and be complete by December 31, 2012. Although we continue to seek new clients and to expand our product offerings, we expect that our revenues will continue to decline over the next several quarters while we explore various options to offset revenue declines and return to a certain level of profitability.

In addition to the other information set forth in this report, one should carefully consider the discussion of various risks and uncertainties contained in Part I, “Item 1A.  Risk Factors” in our 2010 Annual Report on Form 10-K.  We believe those risk factors are the most relevant to our business and could cause our results to differ materially from the forward-looking statements made by us.  

ITEM 5.
Other Information

As previously reported, on September 21, 2011, the Company received a letter from The Nasdaq Stock Market stating that for 30 consecutive business days immediately preceding the date of the letter the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share (“Minimum Bid Price Requirement”) as required by Nasdaq Listing Rule 5550(a)(2).
The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market. Under the Nasdaq Listing Rules, if during the 180 calendar days following the date of the notification, the closing bid price of the Company’s stock is at or above $1.00 for a minimum of 10 consecutive business days (subject to extension in the discretion of Nasdaq staff), the Company will regain compliance with the Minimum Bid Price Requirement.
If the Company does not achieve compliance with the Minimum Bid Price Requirement within the required period, it will be afforded an additional 180 day compliance period, provided that on the 180th day of the first compliance period it meets the continued listing requirements for market value of publicly held shares and all other applicable standards for initial listing on the Nasdaq Capital Market (except for the Minimum Bid Price Requirement) and notifies Nasdaq of its intent to cure this deficiency. If it appears to Nasdaq staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, its common stock will be subject to delisting.
The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider implementing available options to regain compliance with the Minimum Bid Price Requirement under the Nasdaq Listing Rules.

ITEM 6.
Exhibits
Exhibit 31.1
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32.1
Certifications Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 101
The following financial statements and footnotes from the American Caresource Holdings, Inc. Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 formatted in Extensible Business Reporting Language (XBRL): (i) Consolidated Statements of Operations; (ii) Consolidated Balance Sheets; (iii) Consolidated Statement of Stockholders' Equity; (iv) Consolidated Statements of Cash Flows; and (v) the Notes to Unaudited Consolidated Financial Statements, tagged as blocks of text.*





*Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections

21



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
 
AMERICAN CARESOURCE HOLDINGS, INC. 
 
 
 
 
Date:
November 14, 2011
By:
/s/ Kenneth S. George
 
 
 
Kenneth S. George
 
 
 
Chairman of the Board of Directors and Chief Executive Officer (Principal Executive Officer)


Date:
November 14, 2011
By:
/s/ Matthew D. Thompson
 
 
 
Matthew D. Thompson
 
 
 
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
 
 
 
 


22
EX-31.1 2 anciexh2011q3311.htm CHIEF EXECUTIVE OFFICER CERTIFICATION ANCI EXH 2011 Q3 31.1


Exhibit 31.1
CERTIFICATION
 
I, Kenneth S. George, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of American CareSource Holdings, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation, and
d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a)
all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Dated:
November 14, 2011
 
By: /s/ Kenneth S. George
 
 
 
Kenneth S. George
 
 
 
Chief Executive Officer



EX-31.2 3 anciexh2011q3312.htm CHIEF FINANCIAL OFFICER CERTIFICATION ANCI EXH 2011 Q3 31.2


Exhibit 31.2
CERTIFICATION
 
I, Matthew D. Thompson, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of American CareSource Holdings, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation, and
d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a)
all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Dated:
November 14, 2011
 
By: /s/ Matthew D. Thompson
 
 
 
Matthew D. Thompson
 
 
 
Chief Financial Officer




EX-32.1 4 anciexh2011q3321.htm CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TO SECTION 9 ANCI EXH 2011 Q3 32.1


Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
Kenneth S. George, Chairman of the Board of Directors and Chief Executive Officer of  American CareSource Holdings, Inc., (the “Company”) and Matthew D. Thompson, Chief Financial Officer of the Company, each certify pursuant to section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

1.
The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2011, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:
November 14, 2011
 
By: /s/ Kenneth S. George
 
 
 
Kenneth S. George
 
 
 
Chief Executive Officer
 
 
 
 
Dated:
November 14, 2011
 
By: /s/ Matthew D. Thompson
 
 
 
Matthew D. Thompson
 
 
 
Chief Financial Officer
 
A signed original of this written statement required by Section 906 has been provided to American CareSource Holdings, Inc. and will be retained by American CareSource Holdings, Inc. and furnished to the Securities and Exchange Commission upon request.



EX-101.INS 5 anci-20110930.xml XBRL INSTANCE DOCUMENT 0001316645 2010-07-01 2010-09-30 0001316645 2010-01-01 2010-09-30 0001316645 2011-07-01 2011-09-30 0001316645 2011-01-01 2011-09-30 0001316645 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-09-30 0001316645 us-gaap:CommonStockMember 2011-01-01 2011-09-30 0001316645 us-gaap:RetainedEarningsMember 2011-01-01 2011-09-30 0001316645 2009-12-31 0001316645 2010-09-30 0001316645 2010-12-31 0001316645 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0001316645 us-gaap:CommonStockMember 2010-12-31 0001316645 us-gaap:RetainedEarningsMember 2010-12-31 0001316645 2011-09-30 0001316645 2011-11-07 0001316645 us-gaap:AdditionalPaidInCapitalMember 2011-09-30 0001316645 us-gaap:CommonStockMember 2011-09-30 0001316645 us-gaap:RetainedEarningsMember 2011-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares 1503000 1446000 3780000 5510000 21602000 22183000 150000 67000 19000 0 632000 0 632000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill Impairment</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:5px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of September&#160;30, 2011 and prior to our December 31 annual impairment test, the Company concluded that impairment indicators existed based upon, among other things, the decline in market capitalization, revenue declines of the Company's two most significant client accounts and operating results for the nine months ended September 30, 2011, which required the performance of an interim impairment test. As a result, the Company performed the generally recognized threshold goodwill impairment test (step 1) which indicated that the fair value of the Company (single reporting unit), based primarily on the trading value of the Company's common stock plus an estimated control premium, was less than the book value of its net assets. Therefore, the required next analysis of the assessment was performed (step 2), in which the implied fair value of the Company's goodwill was compared to the book value of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination, that is, the estimated fair value of the Company is allocated to all of those assets and liabilities (including both recognized and unrecognized intangible assets) as if the Company had been acquired in a business combination and the estimated fair value was the purchase price paid. If the carrying amount of goodwill is greater than the implied fair value of goodwill, an impairment loss is recognized in the amount of the excess and is charged to operations. </font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of our preliminary interim impairment assessment, the Company recognized an estimated non-cash goodwill impairment charge of $4.4 million as of September 30, 2011, representing the entire balance of goodwill. In addition, at this interim date, the Company also reviewed the carrying value of the other identifiable intangible assets, which is limited to our ancillary provider network, to determine if impairment exists. Based on this analysis, the Company concluded that no impairment of the ancillary provider network existed as of September 30, 2011. A deferred tax benefit of $1.5 million was recognized as of September 30, 2011 as a result of the total amount of estimated impairment charges, but a valuation allowance was immediately provided. </font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impairment was primarily the result of our continued declining total revenues as a result of declines in revenue and claims volume from our two most significant clients and the expectation of significantly diminishing revenue from at least one of these clients. The impairment did not impact our operations or cash flows. Due to the complexity of the process, the Company will not fully complete the measurement of the implied fair value of goodwill and other intangible assets under step 2 of the test until the fourth quarter of 2011 and, accordingly, the goodwill impairment charge included in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2011 represents an estimate. Any adjustments to these amounts, which could be material, resulting from the completion of step 2 will be recognized during the fourth quarter of 2011.</font></div></div> 18538000 28950000 15400000 20791000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of Business and Basis of Presentation </font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American CareSource Holdings, Inc. (&#8220;ACS,&#8221; &#8220;Company,&#8221;&#160;&#160;the &#8220;Registrant,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) is an ancillary services company that offers cost effective access to a comprehensive national network of ancillary healthcare service providers.&#160;&#160;The Company sells its services to a number of healthcare companies including preferred provider organizations ("PPOs"), third party administrators (&#8220;TPAs&#8221;), insurance companies, large self-funded organizations, various employee groups and other middle-market organizations.&#160;&#160;The Company offers payors this solution by:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">lowering its payors&#8217; ancillary care costs throughout our network of high quality, cost effective providers that the Company has under contract at more favorable terms than they could generally obtain on their own;</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">providing payors with a comprehensive network of ancillary healthcare services providers that is tailored to each payor&#8217;s specific needs and is available to each payor&#8217;s covered persons for covered services;</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">providing payors with claims management, reporting and processing and payment services;</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">performing network/needs analysis to assess the benefits to payors of adding additional/different service providers to the payor -specific provider networks; and</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">credentialing network service providers for inclusion in the payor -specific provider networks.&#160;&#160;</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;), interim reporting requirements of Form 10-Q and Rule 8-03 of Regulation S-X of the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).&#160;&#160;Consequently, financial information and disclosures normally included in financial statements prepared annually in accordance with GAAP have been condensed or omitted.&#160;&#160;Balance sheet amounts are as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2011</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2010</font><font style="font-family:inherit;font-size:10pt;"> and operating results are for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2011</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2010</font><font style="font-family:inherit;font-size:10pt;">, and include all normal and recurring adjustments we consider necessary for the fair, summarized presentation of our financial position and operating results.&#160;&#160;As these are condensed financial statements, readers of this report should, therefore, refer to the consolidated financial statements and the notes included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2010</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;18, 2011</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses the &#8220;management approach&#8221; for reporting information about segments in annual and interim financial statements.&#160;&#160;The management approach is based on the way the chief operating decision-maker organizes segments within a company for making operating decisions and assessing performance.&#160;&#160;Reportable segments are based on products and services, geography, legal structure, management structure and any other manner in which management disaggregates a company.&#160;&#160;Based on the &#8220;management approach&#8221; model, the Company has determined that its business is comprised of a single operating segment.</font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our interim results of operations are not necessarily indicative of results of operations that will be realized for the full fiscal year.</font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified within the condensed consolidated financial statements to conform to the current year presentation.</font></div></div> 11061000 14512000 11987000 11868000 119000 -3451000 0.01 0.01 40000000 40000000 16922000 17072000 16922000 17072000 17072000 16922000 171000 169000 10715000 13057000 39320000 32767000 193000 615000 237000 6000 609000 226000 197000 585000 571000 204000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Warrants</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company entered into an agreement as of February 25, 2011, whereby the Company agreed to issue warrants to purchase 250,000 shares of common stock with an exercise price of $1.67. The warrants vest in increments pursuant to the achievement of defined, agreed upon revenue targets generated by new clients within a five year term. The agreement also obligates the Company to issue warrants to purchase up to an additional 500,000 shares of common stock (issued in 250,000 increments) pursuant to the achievement of additional defined agreed upon revenue targets.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three and nine months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2011</font><font style="font-family:inherit;font-size:10pt;">, we recognized compensation costs of approximately $11,000 and $25,000, respectively, associated with the warrant. The cost has been adjusted for the probability that the revenue targets will be reached. That probability will be re-evaluated and updated based on current market conditions, on a quarterly basis, and compensation costs will be adjusted accordingly.</font></div></div> -0.44 0.02 0.00 -0.38 -0.44 0.00 0.02 -0.38 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (Loss) Per Share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table details the reconciliation of basic earnings (loss) per share to diluted earnings (loss) per share (amounts in thousands except per share amounts):</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="61%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months ended</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nine months ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2010</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2010</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income (loss) for basic earnings per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,523</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7,390</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">344</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Change in fair value of warrant derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net loss for diluted earnings per share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7,390</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">326</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Denominator:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted-average basic and diluted common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17,011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,631</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,978</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Assumed conversion of dilutive securities:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;Stock options</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">239</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;Stock warrants</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">254</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">474</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;Restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Potentially dilutive common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">493</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">756</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Denominator for diluted earnings per share -- Adjusted weighted average shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17,011</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17,124</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,978</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17,169</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Earnings (loss) per common share:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.38</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.00</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.02</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.38</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.00</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.02</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For purposes of this calculation, outstanding stock options, stock warrants, and unvested restricted stock units are considered common stock equivalents using the treasury stock method, and are the only such equivalents outstanding.&#160;&#160;For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2011</font><font style="font-family:inherit;font-size:10pt;">, options to purchase approximately 2.4 million shares of common stock, warrants to purchase 475,000 shares of common stock and approximately 41,000 unvested restricted stock units were excluded from the calculation as their impact would be anti-dilutive.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> 4361000 0 0 4361000 0 4361000 1706000 781000 3114000 5772000 -6743000 87000 -5554000 564000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax provision (benefit) for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30</font><font style="font-family:inherit;font-size:10pt;"> differed from the U.S. federal income tax rate of 34% approximately in the amounts indicated as a result of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="75%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2010</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Computed &#8220;expected&#8221; tax provision (benefit) at statutory rates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,293</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">192</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Change in valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,906</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Permanent differences</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(507</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shortfall from restricted stock units conversion</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Warrant deduction</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">State taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total income tax provision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">647</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">220</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At September 30, 2011 the Company determined a valuation allowance against its federal deferred tax assets was necessary. A valuation allowance of approximately $2.9 million was recorded in the third quarter of 2011, which is included in the income tax provision for the three and nine months ended September 30, 2011. Due to the nature and timing of the deferred tax liabilities, the valuation allowance was established against the net deferred tax assets except for the Texas margin tax carryforward of approximately $232,000. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Differences between financial accounting principles and tax laws cause differences between the bases of certain assets and liabilities for financial reporting purposes and tax purposes. The tax effects of these differences, to the extent they are temporary, are recorded as deferred tax assets and liabilities and consisted of the following components: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="74%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2010</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred tax assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Operating loss carryforward</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,038</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">101</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts receivable allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">69</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">202</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">179</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Texas tax credit carryforward</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock option compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,251</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,140</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">873</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">246</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">203</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Alternative Minimum Tax credit carryforwards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total deferred tax assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,914</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,946</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred tax liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(563</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Property and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(713</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(496</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prepaid expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(63</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total deferred tax liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,906</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net Deferred Tax Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">232</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">846</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company was notified during the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2011</font><font style="font-family:inherit;font-size:10pt;"> of an examination by tax authorities for its U.S. federal return for the year ended 2009. The examination began in April 2011 and is currently in process</font></div></div> 43000 220000 969000 647000 65000 134000 76000 -287000 -1730000 -1072000 -22000 81000 928000 1025000 18538000 28950000 8164000 4559000 0 157000 -565000 -571000 -2880000 527000 -6523000 44000 344000 -7390000 -7390000 0 0 85000 24000 8000 32000 1643000 6343000 5293000 9889000 479000 63000 -5562000 -6775000 187000 187000 340000 78000 283000 513000 282000 58000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Severance Charge</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On July 25, 2011, the Board of Directors accepted the resignation of David S. Boone from his positions with the Company, including his positions as President, Chief Executive Officer and director. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with his resignation, Mr. Boone entered into a severance agreement and general release with the Company, effective July 25, 2011. Under the agreement, Mr. Boone will receive, in addition to any base compensation owed and earned but unused vacation pay, severance payments over a six month period that in the aggregate equal six months' worth of his annual base compensation, and has the right to continue participation in the Company-sponsored group health insurance plan in accordance with COBRA. In addition, the terms of his vested but unexercised stock options were extended to, and expire on, October 10, 2011. During the three months ended September 30, 2011, the company recorded a severance charge of approximately $263,000 in connection with the severance agreement. The charge is included in selling, general and administrative expenses on the condensed consolidated statement of operations. In addition, in September 2011, Mr. Boone executed a cashless exercise of 209,000 options, which resulted in 84,000 shares of common stock being issued to Mr. Boone. </font></div></div> 0.01 0.01 10000000 10000000 0 0 0 0 0 0 553000 532000 157000 0 1906000 1824000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Software Development Costs</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company capitalizes costs associated with internally developed software, developed for internal use only, during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. Costs of significant upgrades and enhancements that result in additional functionality also are capitalized, whereas costs incurred for maintenance and minor upgrades and enhancements are expensed as incurred. Capitalized costs include external direct costs of materials and services utilized in developing or obtaining internal-use software and payroll and payroll-related expenses for employees who are directly associated with and devote time to the internal-use software projects. Capitalization of such costs begins when the preliminary project stage is complete and ceases no later than the point at which the project is substantially complete and ready for its intended purpose. Capitalized costs are amortized using the straight-line method over the useful life of the software, which is typically five years. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2011</font><font style="font-family:inherit;font-size:10pt;">, the Company capitalized </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$160,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$513,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2010</font><font style="font-family:inherit;font-size:10pt;">, the Company capitalized approximately $101,000 and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$283,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div></div> -985000 -8375000 35881000 11496000 45092000 14763000 4722000 1778000 1446000 4943000 632000 606000 150000 2000 -51000 -49000 0 20786000 13979000 171000 21602000 -985000 22183000 -8375000 169000 0 18000 17011000 17124000 16978000 17169000 16413000 16978000 17011000 16631000 2552000 799000 616000 1791000 3261000 1189000 1008000 3597000 6718000 3056000 -3662000 -2313000 27715000 9091000 11069000 33171000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue on the services that it provides, which includes (i) providing payor clients with a comprehensive network of ancillary healthcare providers, (ii) providing claims management, reporting, processing and payment services, (iii) providing network/need analysis to assess the benefits to payor clients of adding what additional/different service providers to the client-specific provider networks and (iv) providing credentialing of network services providers for inclusion in the client payor-specific provider networks.&#160;&#160;Revenue is recognized when services are delivered, which occurs after processed claims are billed to the client payors and collections are reasonably assured.&#160;&#160;The Company estimates revenues and costs of revenues using average historical collection rates and average historical margins earned on claims.&#160;&#160;Periodically, revenues are adjusted to reflect actual cash collections so that revenues recognized accurately reflect cash collected. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines whether it is acting as a principal or agent in the fulfillment of the services rendered.&#160;&#160;After careful evaluation of the key gross and net revenue recognition indicators, the Company acknowledges that while the determination of gross versus net reporting is highly judgmental in nature, the Company has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following are the key indicators that support the Company&#8217;s conclusion that it acts as a principal when settling claims for service providers through its contracted service provider network:</font></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Company is the primary obligor in the arrangement</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;The Company has assessed its role as primary obligor as a strong indicator of gross reporting.&#160;&#160;The Company believes that it is the primary obligor in its transactions because it is responsible for providing the services desired by its client payors.&#160;&#160;The Company has distinct, separately negotiated contractual relationships with its client payors and with the ancillary health care providers in its networks.&#160;&#160;The Company does not negotiate &#8220;on behalf of&#8221; its client payors and does not hold itself out as the agent of the client payors when negotiating the terms of the Company&#8217;s ancillary healthcare service provider agreements.&#160;&#160;The Company&#8217;s agreements contractually prohibit client payors and service providers to enter into direct contractual relationships with one another.&#160;&#160;The client payors have no control over the terms of the Company&#8217;s agreements with the service providers.&#160;&#160;In executing transactions, the Company assumes key performance-related risks.&#160;&#160;The client payors hold the Company responsible for fulfillment, as the provider, of all of the services the client payors are entitled to under their contracts; client payors do not look to the service providers for fulfillment.&#160;&#160;In addition, the Company bears the pricing/margin risk as the principal in the transactions.&#160;&#160;Because the contracts with the client payors and service providers are separately negotiated, the Company has complete discretion in negotiating both the prices it charges its client payors and the financial terms of its agreements with the service providers.&#160;&#160;Since the Company&#8217;s profit is the spread between the amounts received from the client payors and the amount paid to the service providers, it bears significant pricing/margin risk.&#160;&#160;There is no guaranteed mark-up payable to the Company on the amount the Company has contracted.&#160;&#160;Thus, the Company bears the risk that amounts paid to the service provider will be greater than the amounts received from the client payors, resulting in a loss or negative claim.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Company has latitude in establishing pricing</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;As stated above, the Company has complete latitude in negotiating the price to be paid to the Company by each client payor and the price to be paid to each contracted service provider.&#160;&#160;This type of pricing latitude indicates that the Company has the risks and rewards normally attributed to a principal in the transactions.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Company changes the product or performs part of the services</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;The Company provides the benefits associated with the relationships it builds with the client payors and the services providers.&#160;&#160;While the parties could deal with each other directly, the client payors would not have the benefit of the Company&#8217;s experience and expertise in assembling a comprehensive network of service providers, in claims management, reporting and processing and payment services, in performing network/needs analysis to assess the benefits to client payors of adding additional/different service providers to the client payor-specific provider networks, and in credentialing network service providers.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Company has complete discretion in supplier selection</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;One of the key factors considered by client payors who engage the Company is to have the Company undertake the responsibility for identifying, qualifying, contracting with and managing the relationships with the ancillary healthcare service providers.&#160;&#160;As part of the contractual arrangement between the Company and its client payors, the payors identify their obligations to their respective covered persons and then work with the Company to determine the types of ancillary healthcare services required in order for the payors to meet their obligations.&#160;&#160;The Company may select the providers and contract with them to provide services at its discretion.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Company is involved in the determination of product or service specifications</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;The Company works with its client payors to determine the types of ancillary healthcare services required in order for the payors to meet their obligations to their respective covered persons.&#160;&#160;In some respects, the Company is customizing the product through its efforts and ability to assemble a comprehensive network of providers for its payors that is tailored to each payor&#8217;s specific needs.&#160;&#160;In addition, as part of its claims processing and payment services, the Company works with the client payors, on the one hand, and the providers, on the other, to set claims review, management and payment specifications.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The supplier (and not the Company) has credit risk</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;The Company believes it has some level of credit risk, but that risk is mitigated because the Company does not remit payment to providers unless and until it has received payment from the relevant client payors following the Company&#8217;s processing of a claim.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt; width:100%;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The amount that the Company earns is not fixed</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;The Company does not earn a fixed amount per transaction nor does it realize a per-person per-month charge for its services.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has evaluated the other indicators of gross and net revenue recognition, including whether or not the Company has general inventory risk.&#160;&#160;The Company does not have any general inventory risk, as its business is not related to the manufacture, purchase or delivery of goods and it does not purchase in advance any of the services to be provided by the ancillary healthcare service providers.&#160;&#160;While the absence of this risk would be one indicator in support of net revenue reporting, as described in detail above, the Company has carefully evaluated all of the key gross and net revenue recognition indicators and has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If the Company were to report its revenues net of provider payments rather than on a gross reporting basis, for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2011</font><font style="font-family:inherit;font-size:10pt;">, its net revenues would have been approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$8.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2010</font><font style="font-family:inherit;font-size:10pt;">, its net revenues would have been approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$11.9 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company records a provision for refunds on a periodic basis. Refunds are paid to payors for overpayments on claims, claims paid in error, and claims paid for non-covered services. In some instances, we will recoup payments made to the ancillary service provider if the claim has been fully resolved. The evaluation is performed periodically and is based on historical data. We present revenue net of the provision for refunds on the consolidated statement of operations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2011</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2010</font><font style="font-family:inherit;font-size:10pt;">, two of the Company&#8217;s clients comprised a significant portion of the Company&#8217;s revenues.&#160;&#160;The following is a summary of the approximate amounts of the Company&#8217;s revenue and accounts receivable contributed by each of those clients as of the dates and for the periods presented (amounts in thousands):</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.2421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="36" rowspan="1"></td></tr><tr><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Periods ended September 30, 2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Periods ended September 30, 2010</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">September 30, 2011</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nine months</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">September 30, 2010</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Three months</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nine months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts Receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">% of Total Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">% of Total Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts Receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">% of Total Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">% of Total Revenue</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Client A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,627</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12,142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,747</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Client B</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">756</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,794</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,789</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,889</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13,189</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">All Others</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,130</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,226</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,818</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Allowance for Uncollectable Receivables/Provision for refunds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(159</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(133</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(437</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(204</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(60</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(180</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,780</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,496</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35,881</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,345</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14,763</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45,092</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td></tr></table></div></div></div> false --12-31 Q3 2011 2011-09-30 10-Q 0001316645 17072848 Smaller Reporting Company American Caresource Holdings, Inc. EX-101.SCH 6 anci-20110930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1002000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002500 - Statement - Consolidated Balance Sheets Parenthetical link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statement of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Description of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Goowill Impairment link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Severance Charge link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Software Development Costs link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 anci-20110930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 anci-20110930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 anci-20110930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entities [Table] Entities [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Entity Information [Line Items] Entity Information [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Statement, Scenario [Axis] Statement, Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Statement [Line Items] Statement [Line Items] Shareholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net Accounts Receivable, Net, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Deferred income taxes Deferred Tax Assets, Net, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Other assets: Other Assets, Noncurrent [Abstract] Deferred income taxes Deferred Tax Assets, Net, Noncurrent Other non-current assets Other Assets, Noncurrent Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Total Assets Assets LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Due to service providers Due To Service Providers Due To Service Providers Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Total current liabilities Liabilities, Current Commitments and contingencies Commitments and Contingencies Preferred stock, $0.01 par value; 10,000 shares authorized, none issued Preferred Stock, Value, Issued Common stock, $0.01 par value; 40,000 shares authorized; 17,072 and 16,922 shares issued and outstanding in 2011 and 2010, respectively Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated deficit Retained Earnings (Accumulated Deficit) Total shareholders' equity Stockholders' Equity Attributable to Parent Total Liabilities and Shareholder's Equity Liabilities and Equity Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income (loss) Net Income (Loss) Attributable to Parent Adjustments to reconcile net income (loss) to net cash used by operations: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Stock-based compensation expense Share-based Compensation Depreciation and amortization Depreciation, Depletion and Amortization Goodwill impairment charge Goodwill, Impairment Loss Unrealized gain on warrant derivative Unrealized Gain (Loss) on Derivatives Amortization of long-term client agreement Other Amortization of Deferred Charges Client administration fee expense related to warrants Adjustment of Warrants Granted for Services Deferred income taxes Deferred Income Tax Expense (Benefit) Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Due to service providers Increase (Decrease) Due to service providers Increase (Decrease) Due to service providers Net cash used by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Investment in software development costs Payments for Software Additions to property and equipment Payments to Acquire Property, Plant, and Equipment Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from exercise of equity incentive awards Proceeds from Warrant Exercises Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Net decrease in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Cash paid for taxes Income Taxes Paid Supplemental non-cash financing activity: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Income tax withholdings on conversion of equity incentives Adjustments Related to Tax Withholding for Share-based Compensation Statement of Stockholders' Equity [Abstract] Statement, Equity Components [Axis] Statement, Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Retained Earnings [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance, shares Balance Net loss Stock-based compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Issuance of common stock upon conversion of restricted stock units, net of tax withholdings, shares Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Issuance of common stock upon conversion of restricted stock units, net of tax withholdings Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Balance, shares Balance Note 8. Goodwill Impairment [Abstract] Note 8. Goodwill Impairment [Abstract] Asset Impairment Charges [Text Block] Asset Impairment Charges [Text Block] Description of Business and Basis of Presentation [Abstract] Description of Business and Basis of Presentation [Abstract] Business Description and Basis of Presentation [Text Block] Business Description and Basis of Presentation [Text Block] Severance Charge [Abstract] Severance Charge [Abstract] Postemployment Benefits Disclosure [Text Block] Postemployment Benefits Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Text Block] Earnings Per Share [Text Block] Revenue Recognition [Abstract] Revenue Recognition [Text Block] Revenue Recognition [Text Block] Revenue Recognition [Text Block] Warrants [Abstract] Warrants [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Income Taxes [Abstract] Income Taxes [Abstract] Income Tax Disclosure [Text Block] Income Tax Disclosure [Text Block] Software Development Costs [Abstract] Software Development Costs [Abstract] Research, Development, and Computer Software Disclosure [Text Block] Research, Development, and Computer Software Disclosure [Text Block] Income Statement [Abstract] Net revenues Revenue, Net Cost of revenues Cost of Revenue [Abstract] Provider payments Provider Payments Healthcare Provider Payments Administrative fees Administrative fees Administrative fees - cost of revenue Claims administration and provider development Claims administration and provider development Claims administration and provider development Total cost of revenues Cost of Services Contribution margin Gross Profit Selling, general and administrative expenses Selling, General and Administrative Expense Total operating expenses Operating Expenses Operating income (loss) Operating Income (Loss) Other Income Nonoperating Income (Expense) Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income tax provision Income Tax Expense (Benefit) Net income (loss) Earnings (loss) per common share: Basic Earnings Per Share, Basic Diluted Earnings Per Share, Diluted Basic weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Diluted weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted EX-101.PRE 10 anci-20110930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 businessmodel.jpg GRAPHIC begin 644 businessmodel.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0`617AI9@``24DJ``@```````````#_ MVP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+#!D2$P\4'1H?'AT:'!P@)"XG("(L M(QP<*#7J#A(6&AXB)BI*3E)66EYB9 MFJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?H MZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+ M_\0`M1$``@$"!`0#!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1 MH;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U15 M5E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W M^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`*K7E_:Z>B/=3+&)'$<8/+.QZ*H'+'@\#GBK-< MMXC$UIXJT#5Y$D?3;5;B.X*(7\EY%4)(0.<`*ZENV_GC-`%RY\8:-:%EFGF1 MTEAB9&MI%96E8I'D%1@$J1D\7%G=:''-:A9&;4+`-<(,JZI3:1XC@6YRTDYMXV$;['D& MV:.Z:/>EP\T4@")\T3/\VS)(PVOM0?[5I%TC$VI M+.7N(R>47.3_`'6W<J07B.D[KM/F^2')! M##!3!).`1TK.$&K6'@*VFTJ_U.#R_#;)>Q^)/=7-NL4RM;LJLSQ%5?*AOD8\,.<''0\5Y/J\U_:_P#"2-9ZOJ;& MUATZZLO]+=@9';$I'/S+@+E>5&[IS6O<7FH3W?B^&SU64;;VT-F\C.\84HA= M)>+,4BGC\J5HCYL13<5.,C/53V(X->:0:AKIO M-(G*W)C)B6>S-S+O&;J0>9%)]V9"H&589$84Y&34UE?ZFVG,K7=W/9CQ+-%= MS>8Q=+3+;"&!RJ9"9(XVD]LT`>FT5Y8O]HR^)-*M+K5;]=*FU*]6'9=.A>V\ MH;-S9#$>9O"L3R-N">#76_#Z[NKWP+I4M]-)-=B(I*\IR^0Q`W=\XQUYH`Z: MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`Q1BBB@`Q1BBB@`HQ110`8HHHH`,48HHH`*3%+10`8HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBN#^*7B'6O#^E:.-!N(;>[U#5(K+S)HPX4.&['W`H`[RBO-/[$^+O_`$-F MA_\`@'_]C1_8GQ=_Z&S0_P#P#_\`L:`/2Z*\T_L3XN_]#9H?_@'_`/8T?V)\ M7?\`H;-#_P#`/_[&@#TNBO-/[$^+O_0V:'_X!_\`V-']B?%W_H;-#_\``/\` M^QH`]+HKS3^Q/B[_`-#9H?\`X!__`&-']B?%W_H;-#_\`_\`[&@#TNBO-/[$ M^+O_`$-FA_\`@'_]C1_8GQ=_Z&S0_P#P#_\`L:`/2Z*\T_L3XN_]#9H?_@'_ M`/8T?V)\7?\`H;-#_P#`/_[&@#TNBO-/[$^+O_0V:'_X!_\`V-']B?%W_H;- M#_\``/\`^QH`]+HKS3^Q/B[_`-#9H?\`X!__`&-']B?%W_H;-#_\`_\`[&@# MTNBO-/[$^+O_`$-FA_\`@'_]C1_8GQ=_Z&S0_P#P#_\`L:`/2Z*\T_L3XN_] M#9H?_@'_`/8T?V)\7?\`H;-#_P#`/_[&@#TNBO-/[$^+O_0V:'_X!_\`V-'] MB?%W_H;-#_\``/\`^QH`]+HKS3^Q/B[_`-#9H?\`X!__`&-']B?%W_H;-#_\ M`_\`[&@#TNBO-/[$^+O_`$-FA_\`@'_]C1_8GQ=_Z&S0_P#P#_\`L:`/2Z*\ MT_L3XN_]#9H?_@'_`/8T?V)\7?\`H;-#_P#`/_[&@#TNBO-/[$^+O_0V:'_X M!_\`V-']B?%W_H;-#_\``/\`^QH`]+HKS3^Q/B[_`-#9H?\`X!__`&-']B?% MW_H;-#_\`_\`[&@#TNBO-/[$^+O_`$-FA_\`@'_]C1_8GQ=_Z&S0_P#P#_\` ML:`/2Z*\T_L3XN_]#9H?_@'_`/8T?V)\7?\`H;-#_P#`/_[&@#TNBO-/[$^+ MO_0V:'_X!_\`V-']B?%W_H;-#_\``/\`^QH`]+HKS3^Q/B[_`-#9H?\`X!__ M`&-']B?%W_H;-#_\`_\`[&@#TNBO-/[$^+O_`$-FA_\`@'_]C1_8GQ=_Z&S0 M_P#P#_\`L:`/2Z*\T_L3XN_]#9H?_@'_`/8T?V)\7?\`H;-#_P#`/_[&@#TN MBO,)]*^+D%O+,WBO1"(T+$"SZX&?[M;GPLUW5?$W@&SUC6)XYKJYDEPR($`5 M7*@8''\)H`[.BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*\T^,?_'OX0_[&.U_D MU>EU\_?'[4O$FE:WI#K<(VD>N3Z4`?0-%8'@MM; ME\)V$_B*82:I/'YLP$839NY"X'<#`/OFM^@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@"MJ/_`""[O_KB_P#Z":X;X(?\DBT7ZS_^ MCY*[G4?^07=_]<7_`/037#?!#_DD6B_6?_T?)0!Z%1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`9=UJ< ML&IR6RHA584D!.:?K5/4?\`D8)O^O6'_P!#EIE`%_\` MM67_`)YI^M']JR_\\T_6J%%`%_\`M67_`)YI^M']JR_\\T_6J%%`%_\`M67_ M`)YI^M96NV5EXDMK>WU2TCFCM[F.YC![.AR/P/(([@FIJ*`+_P#:LO\`SS3] M:/[5E_YYI^M4**`+_P#:LO\`SS3]:2/597U"UMS&FV4L">?\`]`-`'34444`0W=U'96LMS-O\J)2S[(V;'?+NMY(T9E<;=V=P&!QSSBI=05WTVZ2*-I)&B8*BD98D'`YP*YG^Q-4M&5 M=,016\T4LP5W`:UN6C(XZ@JS-N..A!ZAN`#KZ*\QO[6]A:WA33=0,URTK&QG MFMG)Q&$,JHKHN`67G=G))(!(-:@TF_O;()$ERZ2V=L+"]ED5I+9UR7,@+=22 M"2NX,.#P!D`[**\BGD58A.X1&8Y(`R<`D_D.35?3K^#5=- MMM0M2QM[F)98RRX)5AD9':N0M-*OUE@EETN_:S,Y:XLYYH"S/Y>T.%0A-N?4 MY).XC(KH/"5I<'_HO86T:?K1_:LO\`SS3] M:H44`6Y]0DGMY(610)$*DCW&*R?"6GQ^$/#5IH=F[306Q^_Z]Y/\`T$T`=A1110`4444`%%%%`!1110`4444` M%8=IK4\]K'*T48+#)`S6Y7(:=_R#H/\`=H`V?[5E_P">:?K1_:LO_/-/UJA1 M0!?_`+5E_P">:?K1_:LO_/-/UJA10!?_`+5E_P">:?K1_:LO_/-/UJA10!?_ M`+5E_P">:?K1_:LO_/-/UJA10!?_`+5E_P">:?K1_:LO_/-/UJA10!K:9?/? M?:BZJODS>6-O<;%;_P!F-%5O#_\`S$?^OH?^BHZ*`*NH_P#(P3?]>L/_`*'+ M3*?J/_(P3?\`7K#_`.ARTR@`HHHH`****`"BBB@`HHHH`*2#_D-:?_O/_P"@ M&EI(/^0UI_\`O/\`^@&@#IJIZCJ=KI4,0EV.%&%!/)('XU< MK"\56EW>Z;:Q644LDBWUM*QB*!D5)59F^9#.C/G499&8#Y2AW8(S@2*,#;0!V=Q:6UV%%Q M!%,%Y`D0-C\Z9^=D<<;.Q`ZG:H)P,CGW'K7&WF@7=SJ-K+'IE MQ'ILEQ`TUB9$`BPDJR.0'P0P:(8&>4)QSD]#=VUU;>((-1AMY+J#[*ULT4;* M&C.X,&`8@$'&#SGA>#V`-*SO8+^W\^W9FCWLGS(R$,K%6!#`$8((JU?E.Y<8`P30!W<,\5PA>&174.R$J9W0\'^ZRCG&.E;M`'-ZA_P`C+<'_ M`*'+24NH?\C+$/\`U\Q?^A"J-`!1110`4444`%%%%`!1110` M54U7_D#WW_7O)_Z":MU4U7_D#WW_`%[R?^@F@#L****`"BBB@`HHHH`****` M"BBB@`KD-._Y!T'^[77UR&G?\@Z#_=H`M4444`%%%%`!1110`4444`%%%%`% MWP__`,Q'_KZ'_HJ.BCP__P`Q'_KZ'_HJ.B@"KJ/_`",$W_7K#_Z'+3*?J/\` MR,$W_7K#_P"ARTR@`HHHH`****`"BBB@`HHHH`*2#_D-:?\`[S_^@&EI(/\` MD-:?_O/_`.@&@#INE0VUY;7B.]K<13JCF-FB<,%8=0<=QZ5Y_P#%/PEXN\3V M&SP]KWV:`)B73_\`5>"7$@-C)IZ2X M/'S!B>0?;B@#W6FQQ1Q+MC147).%&!DG)KS;_A"?B-_T4UO_``51_P"-'_"$ M_$;_`**:W_@JC_QH`]+HKS3_`(0GXC?]%-;_`,%4?^-'_"$_$;_HIK?^"J/_ M`!H`]+HKS3_A"?B-_P!%-;_P51_XT?\`"$_$;_HIK?\`@JC_`,:`/2Z*\T_X M0GXC?]%-;_P51_XT?\(3\1O^BFM_X*H_\:`/2Z@M+RVO[9+BSN(KB!_NR1.' M5OH1Q7G?_"$_$;_HIK?^"J/_`!KSKX9_#SXC6>J-?07\V@6;2$R"X7)GY_YX M'^;8]J`/;-0_Y&6X_P"O.#_T.6DHOLCQ'."^_Z]Y/_030!V%% M%%`!1110`4444`%%%%`!1110`5R&G?\`(.@_W:Z^N0T[_D'0?[M`%JBBB@`H MHHH`****`"BBB@`HHHH`N^'_`/F(_P#7T/\`T5'11X?_`.8C_P!?0_\`14=% M`%74?^1@F_Z]8?\`T.6F4_4?^1@F_P"O6'_T.6F4`%%%%`!1110`4444`%%% M%`!20?\`(:T__>?_`-`-+20?\AK3_P#>?_T`T`=-1110`445S7C0ZC'I]I/I MHVNK1:4;.W::2:%1/O;RRDJRD$#&2087!&1QM M.>>`#JJ*\UNO$6KZK;WC;X[=(8]/D2.)V4B1KR6)_F&,J?*Z$=#6C_;&J7/B M5OLT:O>6UE?Q?9_-80S/'+;E#CL2'(SC(R>HH`[FBLG1-6.LPFZB*&T*)M8` MABY4%A]!D#UR&!ZH?\C+<'_H< MM)0`4444`%%%%`!1110`4444`%.T_P#Y&.#_`*])O_0XJ;3M/_Y&.#_KTF_] M#BH`Z.BBFNJNC(ZAD888,,@CWH`=17!6"M86^D6%S_I%CPRZX\87B+/.+O3(X%<))&90H"`_-AL-SC.*O'Q=>$RR+$/_7S%_P"A M"J-7O$7_`!X0_P#7S%_Z$*HT`%%%%`!1110`4444`%%%%`!535?^0/??]>\G M_H)JW535?^0/??\`7O)_Z":`.PHHHH`****`"BBB@`HHHH`****`"N0T[_D' M0?[M=?7(:=_R#H/]V@"U1110`4444`%%%%`!1110`4444`7?#_\`S$?^OH?^ MBHZ*/#__`#$?^OH?^BHZ*`*NH_\`(P3?]>L/_HL/_`*'+ M3*`"BBB@`HHHH`****`"BBB@`I(/^0UI_P#O/_Z`:6D@_P"0UI_^\_\`Z`:` M.FHHHH`*AFM8+B2&25-SPMOC.2-K8QG\B?SJ:O/S-<1^,;U!)+#!_;<:"Z:X M3:K<*HG8;B\38Z!]S` MX)Z+C(Y-6$\0ZH_B"XT'_0Q=*))(KHQ,(F"I&=A7?G?F7)Y^Z,XYH`U3X8T4 MIL_LZ';QZ]F+C\F8D>A)]:>V@V<4\MY9116^H.'VW!4MM9\;B1D9SM7([X'I M7)7'B?7=0TR>YM_LU@B?86\MX6>4>>R94G2Y!VPM('QOZG;@\T`=386::?91VZ,6VY9G(`+L22S$#C)))X]:LUQ& MB>+M7UEK`I:6Z^<8/-58W8*CP+*TF_.U<,VT(?FZ'HPKMZ`"BBB@#F]0_P"1 MEN/^O.#_`-#EI*74/^1EN/\`KS@_]#EI*`"BBB@`HHHH`****`"BBB@`IVG_ M`/(QP?\`7I-_Z'%3:=I__(QP?]>DW_H<5`'1T$`@@C(-%%`$2Q06\2HB1Q1J M>%`"@&J>H:3:ZG!M9FCW2)(TD(7+E>@;((8>Q!K+\>&$>%9#,(2/M-MM$Q`4 MGST[GVS^&:SH8+S2?$5I8IJ,-I%J<\]TUM;HA5`JQ@(NX9P=K$D`9+,1B@#J M+32;2T@\H1))^\\TLZ+]_`&[```.`!P!4LMO9O<(98H&G;E-ZJ6.WN,\\9KB M+C7-?N=,CN].N"9Q;R7%[:"--]J\;*3$`5SDC>G())`(P,YM7.NWMM=6-Q'. M+K[7;WEU;VKHBLRA0T2J0,C(^IY/7%`'6B"R:22$1VY<*"Z!5R%))&1Z$[C] M6R\27=Q'J]O(+NPL1/>R.D2Q:`.IBAC M@39%&D:_W44`4^BB@#(\1?\`'A#_`-?,7_H0JC5[Q%_QX0_]?,7_`*$*HT`% M%%%`!1110`4444`%%%%`!535?^0/??\`7O)_Z":MU4U7_D#WW_7O)_Z":`.P MHHHH`****`"BBB@`HHHH`****`"N0T[_`)!T'^[77UR&G?\`(.@_W:`+5%%% M`!1110`4444`%%%%`!1110!=\/\`_,1_Z^A_Z*CHH\/_`/,1_P"OH?\`HJ.B M@"KJ/_(P3?\`7K#_`.ARTRGZC_R,$W_7K#_Z'+3*`"BBB@`HHHH`****`"BB MB@`I(/\`D-:?_O/_`.@&EI(/^0UI_P#O/_Z`:`.FHKQ;XN>/_'/AUY;;3=&: MPTXG:NJC$Q?Z8XC^C<^E+X,^(/C-?"&FA?`VHZP/+)^WF^`,_P`Q^;E2?;KV MH`]HJD^D:9(EPDFG6CIJ>&M.U&QO;=8(K62\A\B6XAA02%/[N<GLT[-8VQ:X`$Q,2YD`Z;N.?QID>BZ5#(LD6F M6:.K%U98%!#$8)!QU(XS7!?\+#\:_P#1+M0_\#U_^(H_X6'XU_Z)=J'_`('K M_P#$4`=/!X)TFWU,WL=O;@B99HP+6)6BVA<*CA0P7YO_`,10!Z717FG_``L/QK_T2[4/_`]? M_B*GLO'GC"YO[>"?X;7UO#)*J/,UZI$:D@%B-G.!S0!T&H?\C+<'_H<'_`*'+24`%%%%`!1110`4444`%%%%`!3M/_P"1C@_Z])O_ M`$.*FT[3_P#D8X/^O2;_`-#BH`Z.BBB@!&954LS!0!DDG@5#;W=K=J3;7,,P M'4QN&Q^7TK,\2I*UG:LL336T=W$]U&B%V:('LHY.&VL0.P/7H:FIWL(87VFH M[":6"&]NX5^Y""Q!SWP6(.,[0Q)QB@#I.*./6O-[O4M>B;5BNIW#):VCS611 M%_>8EPA;Y?F)''N,'O4\#W::ZMLFIWT*W>L3"4#!S#]G)0@LIP-P0#''('I0 M!Z%BDR,]:\ZMO$VKLSF5;P6?EVDL\GV9O-B5VF68XQP04B!5=VW+=<$C9T); M@>+;N2XN+V19-,M?*:="@D(DN`3MZ`X\LGH?F&0,XH`ZVBBB@#(\1?\`'A#_ M`-?,7_H0JC5[Q%_QX0_]?,7_`*$*HT`%%%%`!1110`4444`%%%%`!535?^0/ M??\`7O)_Z":MU4U7_D#WW_7O)_Z":`.PHHHH`*@FOK2WE6*:Z@CD89"/(`2/ MH:GKEK/[+Y&KZ?K,):XN;J8NIC)-Q$S'RBG'S8CV+QT*G/K0!U-5I]1L;6=8 M+B\MXIG&5CDE56(SC@$^M M688XP(]6@O=2\1Z=:S+9VUQ/I%Y%.I!N(UWO!@`D)NR%8C(&=IXXH`[/--DD M2*-GD=411DLQP!7"+'_^ M8C_U]#_T5'10!5U'_D8)O^O6'_T.6F4_4?\`D8)O^O6'_P!#EIE`!36D1,;G M5<^IQ3JXCXG1JVD:0WEH[C6+4+N]WZ9]#0!VRLKC*L&'J#2UPES:WWAB\U'6 MEFT^RCOYK>!+-"S)G=@LN%&96!X&W'J<98A!9ZH]M?A8 MLDVXDV[QSPPXSC(Y)H`]'HKCKCQ#J2ZI8:Z%!IYL[-M2TIKMQ/"SA'5@.,$'!_ES0!Z)D9QGFBL72,W>KZM MJ+88"1;.%AT*1CYL?]M&D!_W1Z<;5`!20?\`(:T__>?_`-`-+20?\AK3_P#> M?_T`T`=))%'+&T,82*)0JJ,YX`Z5/ M6%K.M7.CZG9L\<;Z8\;M-W'`RV>,4`;M%83>(8M/L)+C M4IXB3/,L2Q`*2B,1GYFY.!GJ.H`&<9K6WC&">ZN(_L5QY*W:VL,RE-LA:!)@ M>6&,J_?V[\4`=-16':^*;*\M8+B*&XV3QI)$"%RQ=F55QN^\=K'G@`')# M^+;2Y:XM+!9S?11.SAX"5@9200_(Z,,<'N".#F@#HZ*Y[3M>GU#0+2XCC/VB M>.%1+@>6TCJI;:,Y(7+9_P!TCM5:T\17\J3VEPMO#J,-V(U;RV,<\)G\KS$& M[.1T(R=IQV89`.JHK#;Q=HRW$T!NEW1J6!W+A\,$.#GCYF4?-CKD9'-9^K^, M8AX=NKW1R9;B*!ICF/>L05RAWX(ZLK`8)SM)&0":`.LHJA9:O:ZA=7$%L6D\ MAVC>1<%0ZG#*2#P0>QP>,].:OT` M<'_HK=7VCSV6GRSI=P1B\0PPM)ET8-&AP#PQ5OR%8GB M7Q#)K?AKPK=1.T6DZI>PQZBRG;M4]8R>H!8$'Z=>>0#TA71_NNK?0YI0ZMG: MP.#C@UAZEHVE0Q->@II\D%K-&L\`"%$*\G`Z[<9'ICW-E4444`%.T__`)&.#_KTF_\`0XJ; M6/K.LWN@SK?V&BW6KSI:38M[8@-]Z+DYYQ_N@GGIW`!WM%?-FB?&CQGJ/C9I M&T:XU"*.)U&CV*LI7D?,WRLQ(]_7M7<_\+:\6_\`1*==_.3_`.,T`>M45Y+_ M`,+:\6_]$IUW\Y/_`(S1_P`+:\6_]$IUW\Y/_C-`'K5%>2_\+:\6_P#1*==_ M.3_XS1_PMKQ;_P!$IUW\Y/\`XS0!ZU1BO)?^%M>+?^B4Z[^O:@#WCQ%_P`>$/\`U\Q?^A"J-2:C=R7WAZQNI;2: MSDEFA9K>?&^,EAP<$C/XU'0`4P2QL<+(A)[`BGD`C!Z5Y/I/AZ?7=/\`%EA9 MQ6EN_P#PD=QLO6)$EMMV',8"]>WWAU/X@'K%%<-HNOZ[=#7KR:6UELM'O;NV M,*PGS9A&BE,-G`///'.:K0^*]>O(+.*U6!KS4-$.IP_NOECD!!\OKRI!QD\Y M[T`>A$@#).!2,RJ,LP`]S7G&K>([C5?A3?ZZ5BEA:TB'D31?*TFX"3H>1DX] MBIK-\;:W=:OH>O6K>5%!IMY91"(IEFW,C%LYXY/';`/KP`>M45QT/B75[SQ5 M?V%K9HUM87L-O,&95/ENF3(26!SDC``.0#W/#O!FK:YKOVB[O)[/['#HKG; MB?[)XUDN9+>[:`:<(_,BM9)%W>83C*J><5B+%K%C9VUJ1?6L4SS36XM;9YFB M9IV=(VVL%4!&4?/\G!![4`=O)>VL5[#9O,BW,RL\8ZVNL3, MMRL&K?VI%'?;C#'-L0Y'E",@;<%5&,=>^36E)>ZF=3OP\6M#27U`X:*&7S51 MK:+85_BV>;YF0O0XR`,T`=E>FUE@>WN';9*?*;8S*02,XW+RO'.D6 MVCV]Q!<0QZ?E8(67[N=VQ5'X\5R5O#J%CK\K[=5W3ZS"\C;9'1X39QJQ;:-F M/,!'&,8]`*SY;+4X-&MH(;?4BJW#&\A:*5UR+Q'0HN#_``[SE>,=><4`>H45 MR^ES:C-XEF^TO>H$:8&(VSK"8]W[IO,9MA.T#A!NY.ZNHH`*Y#3O^0=!_NUU M]'W`ED(S_LG&/UH`[JBN&N/&5VNBZ5J=LOF0:M>6 M]M"60`QJR9=N2!G<&`S@9'<5$VO>*I]?T_1U%C97-Q9SRR>:GFA6CEVJ?E;^ M)<9&>,^U`'?4A900"0">@SUKCX/$NKWGBF_L+:SC:WL+R&WFW%5/ENF6DR6S MG)&``(M:\%:K<>4@DU*\18`F&B"AE`)SUP`3QU-`'JU%%%`%W MP_\`\Q'_`*^A_P"BHZ*/#_\`S$?^OH?^BHZ*`*NH_P#(P3?]>L/_`*'+3*?J M/_(P3?\`7K#_`.ARTR@`JG?Z58ZHL:WUK'<+$P=`XR%8="/<>M7**`*MYIMC MJ-JMK>VL5Q`K*P25=P!'0\]Q67<>&T!2#33:V.GS2.]_;+:J?M.X`=O/ M/6MZB@"M=Z=9WP3[5;1R[,A2R\J",$`^A'7UI@TK3UO8+Q;.%;B"+R8I%0`H MG]T>@]JN44`1P016T7E0QK&@).U1@9)R3^))-2444`%)!_R&M/\`]Y__`$`T MM)!_R&M/_P!Y_P#T`T`=-52>P%Q?Q7+R$HD3Q-"5!5P^,YR,_P`(JW10!@KX M6BM[&WM[#4+VS>VDE:*:-E9@LC%F0[U(*\@#(R-HYXHF\*6=Q#?PRSW+Q7L\ M-Q("PR)(UC4$-C/(B3//KZUO5GZUJ']G:9)*LL$+;" M\73E1;F'^TXT:W>2,#ET+`8SR0!R1D`X!-`#]&\+P:)Y"07<[V\"`1P,%"*X M7:9!@<$@G('&23C)),K^'+>>*V$\TKRVUV;J.885LF3>5.!RI/4>P[@&LS0_ M%C2:+IQO[>YENY=*2^,JK&%G/RAE0;A\V67C`'S#GFIY?%MG+,8(5N@T5[%: MS-$8F,;M($VNI;(!)QG'(Y7/6@"8^%QY4L(U;4%AW[[>,,F+9MX?*_+EN1@! MMV!D=#45WX02]M[A)=5OC)=6HM;F;]V6E4,[*?NX!!D?&`!@XQP,:.E:[::S M+=I:;B+5_+=BR_>R01@$LI&.C`'D5IT`9%CX>M[+6)=4\Z66ZE1HV=@JEE+; ML-M`W8Q@9S@9`ZUKT44`XGC@59;G'G.."^!@9_"H+;0M)L["2QM]/MH[20DO`(QL8GK MD=*T**`*::581Q/$MK&4=#&P8;LH1@KSV]J+;2K"SE\VVM(8G"[%*J!M7.<# MT'L*N44`%%%%`!3M/_Y&.#_KTF_]#BIM.T__`)&.#_KTF_\`0XJ`-/\`L/3/ M[976!8P#450Q_:53#E3C()'7H.M:%%%`!1110`4444`%%%%`!6?::'I=AJ%U MJ%M8P1WEVVZ><)\\A]VZXXZ=*T**`,CQ%_QX0_\`7S%_Z$*HU>\1?\>$/_7S M%_Z$*HT`!`((/0U3L=*L-,:9K*UC@,SF278,;V/5CZD^M7**`*MGIME8>?\` M9+:.'[1(9IM@QYCGJQ]2?6DM=+L+&0O:VD,+E=F40#"YSM'H,\X'%6Z*`*<^ ME:?<]/KS4$_AW1KJN*TZ M*`*?]DZ=_:?]I?8H/MVP)]HV#?M'09IUCIUGID+Q65M';QNYD98Q@%CU/U-6 MJ*`"JFJ_\@>^_P"O>3_T$U;JIJO_`"![[_KWD_\`030!U[NL:%W8*H&22<`" MHK6[M[ZV2YM)XYX'Y22)@RMSC@CK7C?Q>\%?$#7FEGTS53?Z3U&EP_N60?3. M)?Q.?04>"O#GQ/C\':8ECXDLM-MEB(2TN;`&2(;CPV5SG-`'M5%>:?\`"/\` MQ:_Z'72O_!>O_P`31_PC_P`6O^AUTK_P7K_\30!Z717FG_"/_%K_`*'72O\` MP7K_`/$T?\(_\6O^AUTK_P`%Z_\`Q-`'I=%>:?\`"/\`Q:_Z'72O_!>O_P`3 M1_PC_P`6O^AUTK_P7K_\30!Z717FG_"/_%K_`*'72O\`P7K_`/$T?\(_\6O^ MAUTK_P`%Z_\`Q-`'I=3!:"-M_ M&#D*/>I-._Y!T'^[0!:J&ZM+>^MVM[J".>%NJ2*&!_`U-10!533;)(Y$%M&5 MD78X<;MR_P!TY[>W2EM=/L[$.+:VCB\S&\JO+8&!D]\#@59HH`IW&DZ==Z:- M.N+*"6R4*H@:,%`!TP.V*1-(TZ.[@NTLX5GMXO)BD"X*)_='M5VB@"G_`&3I MYU3^T_L4'V[9L^T;!OQZ9J)/#^CQ7GVQ-,M%N?,,OFB)=V\]6SCK[UHT4`%% M%%`%WP__`,Q'_KZ'_HJ.BCP__P`Q'_KZ'_HJ.B@"KJ/_`",$W_7K#_Z'+3*? MJ/\`R,$W_7K#_P"ARTR@`HHHH`.E%>']T/S2[D8L)AU.5;.?7'7G`!ZC1110`4D'_(:T__ M`'G_`/0#2TD'_(:T_P#WG_\`0#0!TU("",@@CVKQ3XOR?$]!/_92A=`P?FTO M)GV_]-/XA_P'C'6D\!W_`,48_`^E+I&DZ#-8"(^3)=2N)&&X\MAASG-`'MM5 M9K(3WUM7?[N[DO$B)38DDBLK8^7.,.QQGJ2>M5+;P- MI]I]E,-Y?*;81",^8O\`RS5E0GY<<*Y'_P!?)/-_VC\8O^@'X8_[_2?_`!=' M]I?&+_H!^&/^_P!)_P#%T`=3!X;6WDT>T5$DT_24#0322DS%@"H0J%`V@;3G M)R5''&:?=^$;&\ODO))[H7"2"1'#+D8D$NW)4Y7:?VE\8O\`H!^&/^_TG_Q=']I?&+_H!^&/^_TG_P`70!Z7 M17FG]I?&+_H!^&/^_P!)_P#%U/9:A\66O[=;W1O#:6AE43-'+(6"9&XCYNN, MT`=!J'_(RW'_`%YP?^ARTE+J'_(R7'_7G!_Z'+24`%%%%`!1110`4444`%%% M%`!3M/\`^1C@_P"O2;_T.*FT[3_^1C@_Z])O_0XJ`.CHHHH`****`"BBB@`H MHHH`****`,CQ%_QX0_\`7S%_Z$*HU>\1?\>$/_7S%_Z$*HT`%%%%`!1110`4 M444`%%%%`!535?\`D#WW_7O)_P"@FK=5-5_Y`]]_U[R?^@F@#L****`"BBB@ M`HHHH`****`"BBB@`KD-._Y!T'^[77UR&G?\@Z#_`':`+5%%%`!34ECD^XZM MCT.:<1D8/2N&\`FWLX_&$[A(HXM>NRS8QM0*A_(4`=QD<\CCK[4*RNNY2&![ M@YKR?Q!J$TGAGXA^3L@:&ZC'F1+M:0,J#YOPXXQ_.MC3=3O;'7K_`$71M/C\ MJS>UFF#,J^=Y_,LF688P.@4=01W`H`]!R,XSSZ45BZ%_I5QJ>IGG[1'_\`F(_]?0_]%1T4 M`5=1_P"1@F_Z]8?_`$.6F4_4?^1@F_Z]8?\`T.6F4`%%%%`%=+&U2\FO$@1; MF90DD@'+J.@/TR?S-06FAZ78P7$%K86\4-PQ>:-4&V1CU+#N35^B@"G!I=A; M*%AM8U4+L`QT7I@>@^E);:1IUG(DEM901-&"L>Q`-@/4+Z9]JNT4`%%%%`!2 M0?\`(:T__>?_`-`-+20?\AK3_P#>?_T`T`=-2*JHNU0`/0"EHH`**RY=<@C\ MQU@N9+>.7R7GCCRJONVD=A]*`'T52?5+87$EM$XG MN8TCD:&-EW!'8JKO;Z9;JVJPZ1IEU?2I)*ELF^1(=I<#Z$C^=`%^B MH5N`6F$BF)8WVAG93_P!!-6ZJ:K_R![[_`*]Y/_030!V%%%%`!111 M0`4444`%%%%`!1110`5R&G?\@Z#_`':Z^N0T[_D'0?[M`%JBBB@`(!!!Z&LM M?#>C+'-&NG0!)G,DJ[>)'.,LP[G@_8-=FLW2W4>;]F10=RJ3AG&>GIGIU MJO:^);FY\7)?)?/=6:>&FOTA2(1J\ADVL`IR1DH."20:W/CG5X- M(CN-L+2W6@OJJ,(_EAD&#MZ\K@XYY]^:KWWCGQ!96>J2^;9NUEI]I?K_`*.1 MN\P@,A^;ISUZT`>I45Q>H^*-7_X26?2]-LXW:WLH;K:[*OF[GPV69AA0H/(S MSU]*E\+ZMKFM:KJK37%H+#3]4N;(QB$^8ZJ%V'=G`QGGCF@#KZ2#_D-:?_O/ M_P"@&EI(/^0UI_\`O/\`^@&@#IJ*0D*"2<`!I([Y)UO#-D MI$(#'LR1N)4GCL1R2"2*BM_"UXUS82W6DP"2*ZA:=Q<^:KA$D!:0^#]2@MYA_943.R6BQX>/,?DW]@"I.`"9)4>-B#Z*#G)."2``,9]#HH`XE_#US/K$L[Z4@@DUQ M+\;S&<1_9DB8D`GG>I/N"#UXKFWL)+6\33+JRA=888?-@,T?F!1<2RHL2GU! M`.,[L;>,`GUJB@!`,#`X%+110!S>H?\`(RW'_7G!_P"ARTE+J'_(RW'_`%YP M?^ARTE`!1110`4444`%%%%`!1110`4[3_P#D8X/^O2;_`-#BIM.T_P#Y&.#_ M`*])O_0XJ`.CHHI'571D895A@CVH`6BO.O#]QJ-CX?TC5PWE0RV%O`XNIFD^ MTSR.@5PH)P0"P&2NXN-VT+FM*U\5:E<)9RM%:QQZA#)%:CRV8B[1RNUB&QM* M@L`.RM\W`R`=G17'1:]KDFI0VGFZ>!+J4UB&^ROQLA:0-_K/]G&/?KQ5;3O& M6I:G86]Q%#9QN88S,)"`-[VXER@W[B,L!MP<@'YO0`[JBO/Y/$NN7$%M'Y]G M#)(NE7/F1P,`%N)G5D(+G('E]QP,]<\`'5T5DZ9?WLVJ7MC=K#(L,,,\5S`I5'63>-N"3R#&3P>C MKTK6H`Q?$W_'E:_]?<7\ZJ5;\2_\>5K_`-?<7\ZJ4`%%%%`!1110`4444`%% M%%`!535?^0/??]>\G_H)JW535?\`D#WW_7O)_P"@F@#L****`"BBB@`HHHH` M****`"BBB@`KD-._Y!T'^[77UR&G?\@Z#_=H`M4=**",C!Z4`1K<0NP59HV) MZ`,#4E>4:3X?GU[3_%EA:1VEN3XCN-EZQ(DMMNPYC4+U[#YAU/X[6G^+[^;Q M?IVE&:VN+:ZEO(&EA!VJ80I7:3@EN<-U&3P>*`.\)`ZD"EKR2'5KP^&8[F\G M6^FD\3K"1<(#@"7:&`&,$8&.W'2NDTGQ3K.K7%W*EK&EG%,=;U,Z;%=30#^T=(FNP\4.UH9$;`QDD'\171?# MNYN+SP+IEU=7+3SS(9'9L9R6/I0!U%%%%`%WP_\`\Q'_`*^A_P"BHZ*/#_\` MS$?^OH?^BHZ*`*NH_P#(P3?]>L/_`*'+3*?J/_(P3?\`7K#_`.ARTR@"O=V% MI?!!=6TQJ*;2-.N+-K.>R@EMW(9HW0,&(Y!.>I]ZNT4`9L/ MA_2+:-HX--M8D:4S$1QA1YA&"W'0XXSZ5(-%TL36TPT^V$MJGEP/Y0S&OHOH M*O44`9_]@Z3Y,T/]G6WE3)Y6,,F<[?]W/;I4G6>GF?B1["HO!7AKXG1^#M-2R\3VFFVZQ$ M)9W.GJ9(?F/#97.:]IIKR)$NZ1U1?5C@4`>;?\([\6/^AYTS_P`%R?\`Q-'_ M``COQ8_Z'G3/_!)98G62-P&5T.0P/<&@#S?_A'?BQ_ MT/.F?^"Y/_B:GLM`^*$=_;R7GC/3IK595,T:Z>BET!&X`[>,C(KT2B@#F]0_ MY&2X_P"O.#_T.6DI=0_Y&6X_Z\X/_0Y:2@`HHHH`****`"BBB@`HHHH`*=I_ M_(QP?]>DW_H<5-IVG_\`(QP?]>DW_H<5`'1TCHLB,CJ&5A@J1D$>E+10!6&G M6(LA9"RMQ:#I!Y2[!SG[N,=>:@CTB"&^AGA8Q00J?+M(T18E.0A\+R%UC8BYMMHD.`3YZ#KSC@D?3-9]M'JFDZ]:Z>EU:6UOJ,\]P+ M>-3((D58P$0G;PQ#,?EX+G'2@#IQI&FJX<:=:!Q(90PA7.\]6Z=?>F?V/I*L M@_LVR!6,Q)^X3A.ZCC[OMTKD;GQ'KDNE0W]@475O'Y($I15#1A3U^88[9Y]J`.G_LK3"2 MO]GVF?+6,CR5^XIRJ].@(X'3BK#VT$LL+Y7+H"2&/.,].!P:`.OMK6VLXO*M;>*"/.=D2!1GZ"IJ**`,7Q-_QY6O_ M`%]Q?SJI5SQ(NZQMS_=NHC^N*IT`%%%%`!1110`4444`%%%%`!535?\`D#WW M_7O)_P"@FK=5-5_Y`]]_U[R?^@F@#L****`"BBB@`HHHH`****`"BBB@`KD- M._Y!T'^[77UR&G?\@Z#_`':`+5!`((/0T44`4['2K#36F-E:10&9S)*8UQO8 M]6/J?>H(_#NBPW2W4>E6:3I*TRR+"H8.WWF!QU-:=%`&8_AS19&D9M+M"TDP MG<^4/FD&<,?<9//O4J:-IL=W*GL=-L=,A:&PM(;:-F+LD*!06/?BK5%`!1 M110!=\/_`/,1_P"OH?\`HJ.BCP__`,Q'_KZ'_HJ.B@"KJ/\`R,$W_7K#_P"A MRTRGZC_R,$W_`%ZP_P#H&6\\QA?M5M]_&/]>A/7VS^&:Z*B@# MS'7M6O[G3-2M_P"T#=0W%S?6"V_EQD%1:NZ`87=NWA0.>>_AVF./"I'.$21=JY) M6/YLDXHQ0!Q>B/*T'C,:5=+=79NR]O*=N'8.H^\<[N]=?1B@#SFP\32VB:!91WL<=N;:UBE#J MJA%>%_F!.2Q#)C/R@=,,%$CAP9]V&!&W@=B!C' M;%>GXHQ0!A^'KV>YNM;MYKPW26EZL<$A"`F-H(I/X0`?F=QG';VK MH?\`(RW'_7G!_P"ARTE+J'_(RW'_`%YP?^ARTE`!1110`4444`%%%%`!1110 M`4[3_P#D8X/^O2;_`-#BIM.T_P#Y&.#_`*])O_0XJ`.CHKSSQ/\`$'Q+H?B" MYT[3_A]J6K6L6S9>PR,$DRH)P!&W0DCKVK(_X6OXR_Z)1K'_`'^?_P",T`>K MRPQS+MEC5UZX89%(8(FD61HT+K]UBHR/H:\I_P"%K^,O^B4:Q_W^?_XS1_PM M?QE_T2C6/^_S_P#QF@#U=88U9V6-0S_>('+?7UI#;PEE8Q1ED&%)494>U>4_ M\+7\9?\`1*-9_P"_LG_QFH_^%K>-_P#HE>J_]]2?_&J`/6HK>"`L888X]WWM MB@9^N/K4E>0_\+6\;_\`1*]5_P"^I/\`XU1_PM;QO_T2O5?^^I/_`(U0!Z\! MBBO(1\5?&QX;X5ZM@]#@?*KA M0??E2.>U`'O/B+_D'P_]?,7_`*%5&I-1NI;WP_8W4UG-9RRS0LUO-C?&=PX. M"1FHZ`"BBB@`HHHH`****`"BBB@`JIJO_('OO^O>3_T$U;JGJQQHU\?^G>3_ M`-!-`'8T444`%%%%`!1110`4444`%%%%`!7(:=_R#H/]VNOKD-._Y!T'^[0! M:HHHH`****`"BBB@`HHHH`****`+OA__`)B/_7T/_14=%'A__F(_]?0_]%1T M4`5=1_Y&";_KUA_]#EIE/U'_`)&";_KUA_\`0Y:90`4444`%%%%`!1110`44 M44`%)!_R&M/_`-Y__0#2TD'_`"&M/_WG_P#0#0!2\2^.-3T'5VLK7P;K.JQ! M%;[3:1Y0D]NG45C_`/"T=<_Z)KXE_P"_)_PKTNB@#S3_`(6CKG_1-?$O_?D_ MX4?\+1US_HFOB7_OR?\`"O2Z*`/-/^%HZY_T37Q+_P!^3_A1_P`+1US_`*)K MXE_[\G_"O2Z*`/-/^%HZY_T37Q+_`-^3_A1_PM'7/^B:^)?^_)_PKTNB@#S3 M_A:.N?\`1-?$O_?D_P"%'_"T=<_Z)KXE_P"_)_PKTNB@#S3_`(6CKG_1-?$O M_?D_X5P7P^^,OB^\U8:5=Z/-KR%S\UN@6>(9[GA2![X^M?1%4=*T73-#M/LN MEV,%I!G)6%`NX^I]3[F@#(OB3XCG)&#]C@X/;YY:*74/^1DN/^O.#_T.6DH` M****`"BBB@`HHHH`****`"G:?_R,<'_7I-_Z'%3:=I__`",<'_7I-_Z'%0!T M=%%%`!1110`4444`%%%%`!5"TT73+&^NKZVL8(KNZ;?/.J#?(?<]>W2K]%`& M1XB_X\(?^OF+_P!"%4:O>(O^/"'_`*^8O_0A5&@`HHHH`****`"BBB@`HHHH M`*IZO_R!;_\`Z]Y/_035RJ6K_P#(%O\`_KWD_P#030!V5%%%`!1110`4444` M%%%%`!1110`5R&G?\@Z#_=KKZY#3O^0=!_NT`6J***`"BBB@`HHHH`****`" MBBB@"[X?_P"8C_U]#_T5'11X?_YB/_7T/_14=%`%74?^1@F_Z]8?_0Y:93]1 M_P"1@F_Z]8?_`$.6F4`%%%%`!1110`4444`%%%%`!20?\AK3_P#>?_T`TM)! M_P`AK3_]Y_\`T`T`=-1110!R/B'6M1L-8N+>SN"72P^T6]L(/,\Z7>5"<#=@ MX`X(QG-6KSQC:V7VI'LKM[BV@DN&@C"[F2-E5V&6'`+`C.-PY&:UAID8UDZI MYLOG&`0;,C9MSGTSG/O6:?#45C=2:CIRM->?O]D-S<%83YSJ\@.%8@;EST/I MTQ@`2[\5QVU^UHFFWEP=CNDD31;'VHKL`2X/1QVZTV#QC93!@UK=1,8()XED MV9E28.4(PQ`_U3YSC&*DM_"EI!::?"LTJ?8K=X5$6`IWC#GY@3].>*0>#[`* MN)[L2);P01RK(%>,0E_+*D`[$YSUQT`Q>M='@L]*ETZ"6989#(02P)3>22 M!D>I/7-`&'HWB&66VT^6>XN+F:\MXBMNUN(B960N=A(4%0J.>?0<'_H$/_`%\Q?^A"J-7O$7_'A#_U\Q?^A"J-`!1110`4444`%%%% M`!1110`53U?G1;X?].\G_H)JY535?^0/??\`7O)_Z":`.PHHHH`****`"BBB M@`HHHH`****`"N0T[_D'0?[M=?7(:=_R#H/]V@"U1110`4444`%%%%`!1110 M`4444`7?#_\`S$?^OH?^BHZ*/#__`#$?^OH?^BHZ*`*NH_\`(P3?]>L/_HL/_`*'+3*`"BBB@`HHHH`****`"BBB@`I(/^0UI_P#O/_Z` M:6D@_P"0UI_^\_\`Z`:`.FHHHH`*CFE$$$DK`D(I8@=3@9J2B@#!TX:EJ>E: M?J*ZF\9N42>2$1Q[%1AG:IVYR,CDD]/>LS1O%;1:#H'VX///=VMJ9)MPW.\I MV@A1_M#DG`&1C/0;\.AV5N-L(F2('*Q+._EH?]EI9\?)T*\\9QS@YJV/!^C^3Y7E3 MF/[/-;;3 M@#6C<21JXQA@#P<_K3JCAACMX(X(45(HU"(BC`4`8`%24`%%%<_X;\;>'O%B M-_9&HQ2S)D26[?+*F/53SCW''O0!'J'_`",MQ_UYP?\`H M<'_H$/_7S%_P"A"J-7 MO$7_`!X0_P#7S%_Z$*HT`%%%%`!1110`4444`%%%%`!535?^0/??]>\G_H)J MW535?^0/??\`7O)_Z":`.PHHHH`****`"BBB@`HHHH`****`"N0T[_D'0?[M M=?7(:=_R#H/]V@"U1110`4444`%%%%`!1110`4444`7?#_\`S$?^OH?^BHZ* M/#__`#$?^OH?^BHZ*`*NH_\`(P3?]>L/_HL/_`*'+3*`" MBBB@`HHHH`****`"BBB@`I(/^0UI_P#O/_Z`:6D@_P"0UI_^\_\`Z`:`*7B7 MX8>'_%>KMJ>HO?BX*+&1!>-THY_[Y_.O M=Z*`.:OAM\1SCGBS@Z_[\M%+J'_(RW'_`%YP?^ARTE`!1110`4444`%%%%`! M1110`4[3_P#D8X/^O2;_`-#BIM.T_P#Y&.#_`*])O_0XJ`.CHHHH`****`"B MBB@`HHHH`****`,CQ%_QX0_]?,7_`*$*HU>\1?\`(/A_Z^8O_0JHT`%%%%`! M1110`4444`%%%%`!535?^0/??]>\G_H)JW535?\`D#WW_7O)_P"@F@#L**** M`"BBB@`HHHH`****`"BBB@`KD-._Y!T'^[77UR&G?\@Z#_=H`M4444`%%%%` M!1110`4444`%%%%`%WP__P`Q'_KZ'_HJ.BD\/_\`,1_Z^A_Z*CHH`V"H)S@9 MHVKZ#\J**`#:OH/RHVKZ#\J**`#:OH/RHVKZ#\J**`#:OH/RHVKZ#\J**`#: MOH/RHVKZ#\J**`#:OH/RHVKG.!FBB@!:***`"BBB@`HHHH`****`"BBB@`HH MHH`3:" XML 12 R3.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Balance Sheets (USD $)
In Thousands
Sep. 30, 2011
Dec. 31, 2010
Current assets:  
Cash and cash equivalents$ 11,061$ 14,512
Accounts receivable, net3,7805,510
Prepaid expenses and other current assets553532
Deferred income taxes6237
Total current assets15,40020,791
Property and equipment, net1,9061,824
Other assets:  
Deferred income taxes226609
Other non-current assets78340
Intangible assets, net9281,025
Goodwill04,361
Total Assets18,53828,950
Current liabilities:  
Due to service providers3,0566,718
Accounts payable and accrued liabilities1,5031,446
Total current liabilities4,5598,164
Commitments and contingencies  
Shareholders' equity:  
Preferred stock, $0.01 par value; 10,000 shares authorized, none issued00
Common stock, $0.01 par value; 40,000 shares authorized; 17,072 and 16,922 shares issued and outstanding in 2011 and 2010, respectively171169
Additional paid-in capital22,18321,602
Accumulated deficit(8,375)(985)
Total shareholders' equity13,97920,786
Total Liabilities and Shareholder's Equity$ 18,538$ 28,950
XML 13 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Balance Sheets Parenthetical (USD $)
In Thousands, except Per Share data
Sep. 30, 2011
Dec. 31, 2010
Shareholders' equity:  
Preferred stock, par value$ 0.01$ 0.01
Preferred stock, shares authorized10,00010,000
Preferred stock, shares issued00
Preferred stock, shares outstanding00
Common stock, par value$ 0.01$ 0.01
Common stock, shares authorized40,00040,000
Common stock, shares issued17,07216,922
Common stock, shares outstanding17,07216,922
XML 14 R1.htm IDEA: XBRL DOCUMENT v2.3.0.15
Document and Entity Information
9 Months Ended
Sep. 30, 2011
Nov. 07, 2011
Entity Information [Line Items]  
Entity Registrant NameAmerican Caresource Holdings, Inc. 
Entity Central Index Key0001316645 
Current Fiscal Year End Date--12-31 
Entity Filer CategorySmaller Reporting Company 
Document Type10-Q 
Document Period End DateSep. 30, 2011
Document Fiscal Year Focus2011 
Document Fiscal Period FocusQ3 
Amendment Flagfalse 
Entity Common Stock, Shares Outstanding 17,072,848
XML 15 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 16 R12.htm IDEA: XBRL DOCUMENT v2.3.0.15
Warrants
9 Months Ended
Sep. 30, 2011
Warrants [Abstract] 
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Warrants
    
The Company entered into an agreement as of February 25, 2011, whereby the Company agreed to issue warrants to purchase 250,000 shares of common stock with an exercise price of $1.67. The warrants vest in increments pursuant to the achievement of defined, agreed upon revenue targets generated by new clients within a five year term. The agreement also obligates the Company to issue warrants to purchase up to an additional 500,000 shares of common stock (issued in 250,000 increments) pursuant to the achievement of additional defined agreed upon revenue targets.

During the three and nine months ended September 30, 2011, we recognized compensation costs of approximately $11,000 and $25,000, respectively, associated with the warrant. The cost has been adjusted for the probability that the revenue targets will be reached. That probability will be re-evaluated and updated based on current market conditions, on a quarterly basis, and compensation costs will be adjusted accordingly.
XML 17 R8.htm IDEA: XBRL DOCUMENT v2.3.0.15
Revenue Recognition
9 Months Ended
Sep. 30, 2011
Revenue Recognition [Abstract] 
Revenue Recognition [Text Block]
Revenue Recognition

The Company recognizes revenue on the services that it provides, which includes (i) providing payor clients with a comprehensive network of ancillary healthcare providers, (ii) providing claims management, reporting, processing and payment services, (iii) providing network/need analysis to assess the benefits to payor clients of adding what additional/different service providers to the client-specific provider networks and (iv) providing credentialing of network services providers for inclusion in the client payor-specific provider networks.  Revenue is recognized when services are delivered, which occurs after processed claims are billed to the client payors and collections are reasonably assured.  The Company estimates revenues and costs of revenues using average historical collection rates and average historical margins earned on claims.  Periodically, revenues are adjusted to reflect actual cash collections so that revenues recognized accurately reflect cash collected.

The Company determines whether it is acting as a principal or agent in the fulfillment of the services rendered.  After careful evaluation of the key gross and net revenue recognition indicators, the Company acknowledges that while the determination of gross versus net reporting is highly judgmental in nature, the Company has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.

Following are the key indicators that support the Company’s conclusion that it acts as a principal when settling claims for service providers through its contracted service provider network:

The Company is the primary obligor in the arrangement.  The Company has assessed its role as primary obligor as a strong indicator of gross reporting.  The Company believes that it is the primary obligor in its transactions because it is responsible for providing the services desired by its client payors.  The Company has distinct, separately negotiated contractual relationships with its client payors and with the ancillary health care providers in its networks.  The Company does not negotiate “on behalf of” its client payors and does not hold itself out as the agent of the client payors when negotiating the terms of the Company’s ancillary healthcare service provider agreements.  The Company’s agreements contractually prohibit client payors and service providers to enter into direct contractual relationships with one another.  The client payors have no control over the terms of the Company’s agreements with the service providers.  In executing transactions, the Company assumes key performance-related risks.  The client payors hold the Company responsible for fulfillment, as the provider, of all of the services the client payors are entitled to under their contracts; client payors do not look to the service providers for fulfillment.  In addition, the Company bears the pricing/margin risk as the principal in the transactions.  Because the contracts with the client payors and service providers are separately negotiated, the Company has complete discretion in negotiating both the prices it charges its client payors and the financial terms of its agreements with the service providers.  Since the Company’s profit is the spread between the amounts received from the client payors and the amount paid to the service providers, it bears significant pricing/margin risk.  There is no guaranteed mark-up payable to the Company on the amount the Company has contracted.  Thus, the Company bears the risk that amounts paid to the service provider will be greater than the amounts received from the client payors, resulting in a loss or negative claim.

The Company has latitude in establishing pricing.  As stated above, the Company has complete latitude in negotiating the price to be paid to the Company by each client payor and the price to be paid to each contracted service provider.  This type of pricing latitude indicates that the Company has the risks and rewards normally attributed to a principal in the transactions.

The Company changes the product or performs part of the services.  The Company provides the benefits associated with the relationships it builds with the client payors and the services providers.  While the parties could deal with each other directly, the client payors would not have the benefit of the Company’s experience and expertise in assembling a comprehensive network of service providers, in claims management, reporting and processing and payment services, in performing network/needs analysis to assess the benefits to client payors of adding additional/different service providers to the client payor-specific provider networks, and in credentialing network service providers.

The Company has complete discretion in supplier selection.  One of the key factors considered by client payors who engage the Company is to have the Company undertake the responsibility for identifying, qualifying, contracting with and managing the relationships with the ancillary healthcare service providers.  As part of the contractual arrangement between the Company and its client payors, the payors identify their obligations to their respective covered persons and then work with the Company to determine the types of ancillary healthcare services required in order for the payors to meet their obligations.  The Company may select the providers and contract with them to provide services at its discretion.

The Company is involved in the determination of product or service specifications.  The Company works with its client payors to determine the types of ancillary healthcare services required in order for the payors to meet their obligations to their respective covered persons.  In some respects, the Company is customizing the product through its efforts and ability to assemble a comprehensive network of providers for its payors that is tailored to each payor’s specific needs.  In addition, as part of its claims processing and payment services, the Company works with the client payors, on the one hand, and the providers, on the other, to set claims review, management and payment specifications.

The supplier (and not the Company) has credit risk.  The Company believes it has some level of credit risk, but that risk is mitigated because the Company does not remit payment to providers unless and until it has received payment from the relevant client payors following the Company’s processing of a claim.

The amount that the Company earns is not fixed.  The Company does not earn a fixed amount per transaction nor does it realize a per-person per-month charge for its services.
     
The Company has evaluated the other indicators of gross and net revenue recognition, including whether or not the Company has general inventory risk.  The Company does not have any general inventory risk, as its business is not related to the manufacture, purchase or delivery of goods and it does not purchase in advance any of the services to be provided by the ancillary healthcare service providers.  While the absence of this risk would be one indicator in support of net revenue reporting, as described in detail above, the Company has carefully evaluated all of the key gross and net revenue recognition indicators and has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.

If the Company were to report its revenues net of provider payments rather than on a gross reporting basis, for the three and nine months ended September 30, 2011, its net revenues would have been approximately $2.4 million and $8.2 million, respectively. For the three and nine months ended September 30, 2010, its net revenues would have been approximately $3.7 million and $11.9 million, respectively.
 
The Company records a provision for refunds on a periodic basis. Refunds are paid to payors for overpayments on claims, claims paid in error, and claims paid for non-covered services. In some instances, we will recoup payments made to the ancillary service provider if the claim has been fully resolved. The evaluation is performed periodically and is based on historical data. We present revenue net of the provision for refunds on the consolidated statement of operations.

During the three and nine months ended September 30, 2011 and 2010, two of the Company’s clients comprised a significant portion of the Company’s revenues.  The following is a summary of the approximate amounts of the Company’s revenue and accounts receivable contributed by each of those clients as of the dates and for the periods presented (amounts in thousands):

 
 
 
Periods ended September 30, 2011
 
 
 
Periods ended September 30, 2010
 
As of
September 30, 2011
 
Three months
 
Nine months
 
As of
September 30, 2010
 
Three months
 
Nine months
 
Accounts Receivable
 
Net Revenue
 
% of Total Revenue
 
Net Revenue
 
% of Total Revenue
 
Accounts Receivable
 
Net Revenue
 
% of Total Revenue
 
Net Revenue
 
% of Total Revenue
Client A
$
1,627

 
$
3,964

 
34
 %
 
$
12,142

 
34
 %
 
$
2,747

 
$
6,708

 
45
%
 
$
22,265

 
49
 %
Client B
756

 
2,535

 
22

 
7,794

 
22

 
1,789

 
3,889

 
26

 
13,189

 
29

All Others
1,556

 
5,130

 
45

 
16,382

 
45

 
2,013

 
4,226

 
29

 
9,818

 
22

Allowance for Uncollectable Receivables/Provision for refunds
(159
)
 
(133
)
 
(1
)
 
(437
)
 
(1
)
 
(204
)
 
(60
)
 

 
(180
)
 

 
$
3,780

 
$
11,496

 
100
 %
 
$
35,881

 
100
 %
 
$
6,345

 
$
14,763

 
100
%
 
45,092

 
100
 %
XML 18 R14.htm IDEA: XBRL DOCUMENT v2.3.0.15
Goowill Impairment
9 Months Ended
Sep. 30, 2011
Note 8. Goodwill Impairment [Abstract] 
Asset Impairment Charges [Text Block]
Goodwill Impairment

As of September 30, 2011 and prior to our December 31 annual impairment test, the Company concluded that impairment indicators existed based upon, among other things, the decline in market capitalization, revenue declines of the Company's two most significant client accounts and operating results for the nine months ended September 30, 2011, which required the performance of an interim impairment test. As a result, the Company performed the generally recognized threshold goodwill impairment test (step 1) which indicated that the fair value of the Company (single reporting unit), based primarily on the trading value of the Company's common stock plus an estimated control premium, was less than the book value of its net assets. Therefore, the required next analysis of the assessment was performed (step 2), in which the implied fair value of the Company's goodwill was compared to the book value of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination, that is, the estimated fair value of the Company is allocated to all of those assets and liabilities (including both recognized and unrecognized intangible assets) as if the Company had been acquired in a business combination and the estimated fair value was the purchase price paid. If the carrying amount of goodwill is greater than the implied fair value of goodwill, an impairment loss is recognized in the amount of the excess and is charged to operations.
As a result of our preliminary interim impairment assessment, the Company recognized an estimated non-cash goodwill impairment charge of $4.4 million as of September 30, 2011, representing the entire balance of goodwill. In addition, at this interim date, the Company also reviewed the carrying value of the other identifiable intangible assets, which is limited to our ancillary provider network, to determine if impairment exists. Based on this analysis, the Company concluded that no impairment of the ancillary provider network existed as of September 30, 2011. A deferred tax benefit of $1.5 million was recognized as of September 30, 2011 as a result of the total amount of estimated impairment charges, but a valuation allowance was immediately provided.
The impairment was primarily the result of our continued declining total revenues as a result of declines in revenue and claims volume from our two most significant clients and the expectation of significantly diminishing revenue from at least one of these clients. The impairment did not impact our operations or cash flows. Due to the complexity of the process, the Company will not fully complete the measurement of the implied fair value of goodwill and other intangible assets under step 2 of the test until the fourth quarter of 2011 and, accordingly, the goodwill impairment charge included in the condensed consolidated statement of operations for the three and nine months ended September 30, 2011 represents an estimate. Any adjustments to these amounts, which could be material, resulting from the completion of step 2 will be recognized during the fourth quarter of 2011.
ZIP 19 0001445305-11-003423-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001445305-11-003423-xbrl.zip M4$L#!!0````(`-:*;C\>_>Q'CE<``&=?!``1`!P`86YC:2TR,#$Q,#DS,"YX M;6Q55`D``[24P4ZTE,%.=7@+``$$)0X```0Y`0``[%U9<]M(DG[?B/T/6,UL M3W>$*.$^Y","9Z]CNMMNR[/=^S0!$46RQB#`00$Z_.LWLPH%@"1(':9L*ZP7 M6P+JR,S*XZNL1.GE?TTF?P;O?U&B9L M,GG]G__Q\OJBRND9_JM<+_."G:7%E+XZ6M3UZNST].KJZB1=DHI.X7%:$58V MU92<3,OEJ:YJFNH9ZE';+R-]-QSNA)'IR;R\/(47O/%$U2:&)IM35IJZYJS- MQ+N5U1R:J\9IVT)V`)H_[FF-KR]21F3SADWF:;KJ>LQ2=L%;MR]&2,(!LPTF MVO'M4_%RV)3NH[U@-4BLH^9ZB_HK@[?6/,\[Y6^[IHR.-81AM=,_?_WE?+H@ MRW3230!KJ"@O<8`SQE^])S.%#WBVJ,CLU1&NYT0NULDURX[:U_7-BKPZ8G2Y MRH'.4S&04(=I6=3DNE9H]NHH@K[J[X:8J&L!>D7KF_99]Y1F^'Q&2:5P8L@: M)U(APC=_/WJM`C^&9MNF]?)TL[.ADF6W.#S*IZ@B4_342/5$= M6&`Y2O]NHQ,ILD$7;V*H_<39H(-\.IA:/FKE=8L(_^]#]"2EJ'T[4M2>HB)J M]U=$[5%%^"054;N_(CZZ%/_9!I-_GM6RU59P*_,OZ:L:^5G M&:UI6:3YNY1F;XHP7=$ZS7\ERPM2?845Z05-YDA\][A]D0$9UZN<3FDM:%0R M"NT8L/#JJ&7J;"_K1Z]EL[V\OSP=G:XG\W2,SF>%@L?+LCBOR^G'[T*)MOA] M5IR'*T(%F<5@7N!;X+[1EG^CM7H3>PL?!^-Y\$'A";GOHUDCS1=-BZ M=8.W;PX@C2>SV>FEL8FX#RN-IZ8;((U'U`WS&?,]+U MFV=$\1@\EWPPEP MM-'1&Y;M&+H]>S_[QWGTT)'?D8K'_8T9,GH)ZK(I1NSX6[,D55J7U::VW)FL MH:#'1QQ,%Y&B7-)B_X2WB7ASQNU!Y=L!W]O2Z\+;=%HVH.'OTIOT(B=^D<&3 MJB'9+S2]H#F$/L+"IJJPJJ-5F_=XQB]1IY*1*5VF.7MU-('?<"62=%I/S,B/ M0RVR`B]PG21VG4A+HL"-$B_TP9*#(P5IX4-QG=`LU0`S?WGZ`,(.QQ&FGG9Q M%*E!$GB:H7M^Y'B!$ZBA)3F*U4C=XL@T[<-R])Y,";W$OK^1^B&+DKB&XVFQ MER1Q;"=Z9!B:(5@(?"\(G4T6#,=51UD8H^0S:-XG=L_Q5%=/'"_Q0]TPS,#T M?2EV/W2V:+8L[<$TCT.]>Y'K^I9AZ7;LFV'H@+15PXJDB)W(MC;)U35;U=?I M':?B8:3N-5$_#K3$UDS-LKTH4E4K<:1D0\>*MDC5-==X"*G_:EB-(>_M[(^T MJB!"L9_Q7Y(E975.JDLZ)6R-\D'URD[B@S$2,(X3%Q!?.RYH3KF M7S9(OPM5!^%$V\^)[FBJ`8XE##4U4"/7-35=KS)B>TQ*X:@(&4D0QP$4"G%I;[O.KF1KGEN9)JA[5MQ$'D6\-AR MYWOF%G>:MX.[>U.ZD^4/Y0Z]Y>-<;([SG@`89+0FK2S?<3P%WJ2<%WR4_TWS MANQ8]U?:@V;E=BQ!'CFO&AF_$#H1UVPRL*)&+$/G:5@#]RB;`&*G? M+%$_8!9!?DH'`[[;^/0ZJEH9\T-,>-/<_4?-?V+%W3'=LT8@`[ MKW_(ZQ>P95)8?9.35TF\.$-UI+,;\8@6F"`Z,UUH)K6P[;`%)WB1I\I!!P`?F#!C4MIP"T<*RFXW[E2 MPE@P]P+A@Q@8'`#*$;HKR[3Z2&#_)*Q4Y)(43=>2\S@@Z6],J:]* M95DRD!>(FL[PXPP8)J=(5MINL#CKY0KS'S`Y#,J:')[.4!0P6($T`(GU`L@O MD+].C(J4WK%RM:#3!?0%%U%Q$1`%1H0QEOCM`1*6%L!)#2NTW)3CB0++D[83 MKPNU':,=<4X*H#+/;Z`M]SJ?^`OHB*!2F4MKVAA?^1%DOE*TGUHJV_60*X4C MSZ"]@/JS*'8OO,\5*Q6;Y#V$2F#..;\&[*J5]C]:WK,'4-OL'D)],(PZ^NUOJB<_.LI)5Q!%ODK`DAX1.<:`!#XAIY@RKF[&/&EOS.LN=$VY!JL. M47TR3=EBU&T*>>+,?S5/3`7(S;GNK(?1@?\']PC4XFD(*`9?'_BQ`HM/DM_`R.UR!.6'STP+*%D*0/JUCD`$%QBK*/DJ@T$G0JNV:0(H?*("3.&V]8C M(Q5,B,)LK1;%BU^_Y3D*=U65F(&OT+%>E=7'8VS2^1VTO8&D>$0'5>-Y#!$$ MT">TGG8O1"C*X4#2)^\DHP,/NU;A1%%\H'-&*NYRTVOP"06943[V7[43JUM' M-/.A7NP8$%\,M9#'MQ+SE;TM]@JUI3[`_44#BLE7J74^X"NON$(@"70)P89" MY[SC-GO*1MM&,"D%'E,[?"#"\="@,=A3P&]9"^"XZ7#QML".;2Y`!_3`)4KP MAQYPFJ=TR93+,F\@%LZJP8W-+%;0`:'P\*5;'H/ M",UHD`(==1:!$!.L@>8"2@)W$-/_W:05AD%H)/<7QQQR5ZBC^8W@8(_OI=)7 MM.$/M`6TE@F0R,J<9MSJF,PU<*WJA2KA.\)CH21[@/S(?JASZ&L(%:`Z.N0^ MA]"N%)/AN7.PL+?($90HV*VB:7[A?H$[W1-RY0*Y($,/E365#"SC M\CW9ZS7DSX,TR/[$Q$@6@]WKD"9RO<10_22.+<,R[417G>[X2TW,K>,OS;4, M=SU1PR>]$R%[#[9!>LO:)R0ZB6(M43[==W0_4 MV+,M5Y[_17JRM5ZPGIYV5[*"%H='A$TKND)U]XL,$`-E;V?OA)EQL[U'8LP' MLCS+]=W$51T[4'U=*ECL!:%E/>W$V$!2:.%2@-R/<;GATZ'D/A\UY&16G^GF M@2'!P3-I7WPCTM[IH82PD3_GEWHH_R..\,#7ORFF)\J/(GRXNJZ^\,/SX^Y7 M[84R>-5&Z^'K/N[T/Z&/'_1Z3^:`>O%@=->X5V37FX:MO8&(.'@)K`Q>_L1W M\L4`?K/^7%B@#([9RQG`:WP&,9_`S].:7A*,ZSQ'`_M_WKPB"ZQ1@S=BTPV0 M3H)XG@F3A?G8R)IP/`]3#2)XSG@#J2.4$%`T'\3#18'C! M!.704>8>@,QVK]!M-C/,6%=B93F M8\!E%6T;`"F`#HH;P"_ MS*NR6;$!-%O2+,O)I$V,KG6_57#M&J[2&Z2?[]<`3S70> ML6X[9!Q@8<%B[/TKNRZKG9S>+O0O=8P$^SG"<3LZ*6%NDE?->3'P@ZV+8KB? M6("ISQ=E([:)`[>Y`"(1]N>P'3S>],"=V^QS^GUR5.[;>'8=-Z#08EE6F/:_ M+"MN+YCMD=9))TNQ#P# M=P8@8@5[RQF=PC0DZXXFTDOH*7S,SI[3$F2+.`QFE,D;^4S2].QNGMW-L[OY MIMU-FX8'%4OG1)S$]64#HL"$9Z^[7],;GKE]-O%G$W\V\6_-Q$4U#-IJ"QM. M95QOJV@PV\(/W45MBSAKY8];IX`P@PN[.^Y. MV#P)9KAWRIZ=Q;.S>'86WX:SF`)2Q[*3-!_XBQ$#1V#/$[#X`;,\V;W5W$>F\/1A5?>5`O\H."'\ M*X3U_/S/OO]N,S\OJJYZG-J6C`H"(8(E$`0539W\SB'K^P9.J>]^5G)Z3:5.),DAL$5]/%VDQY\FZ)67<*H8$G\?A MD-Y10PAA>*"98,'*\4#.M.#EQUW18T;9-"^Q&(0I!;Y!V0VK+$:7J%L840/. MNVRM$,IUL)B]"H!=ETM:PW*,DAZTU7%L0;"&=]G68U>D+%160$2.=".4.[$^J\IQ#D-\Z(>CI?M*$8:^$#)ALPQ2D5$RO>CA76++$F\1,_^!V44+1EB;T;7)6,=NYS2^5'/9K/ M9#E8-2Q9&W.MF!Q).2KBL8'7?&,0`F^(AR^\0$Y^R\!/JONJP-OBJJQM+,JZ M._$6/AX9],77/._%;,">#'%_[P4%L0*:W``^^<*6\,C>"P-D+O_""P_(<:B, ME<\\$GN_IM5TT?.FN0!!;WNU$B]K;C^U$XY/8-,Q$]]9Y#%""I["7/3E^5A[+LJQ MIPM*9@/'AK6!"$$GR_1C7PQ#6$\@F@W_M$86!2%KT!I[;X\C')'($7'TWG\1 M-TJ_\$@\J]'-F/*/*%KB@9^LF;8.3F:-CV$K4,ZK=+4`^)N3.9=3!71/!5E8"2-J:<2W4]VG7H,N@)G3^1QP/-]*=&SO`+,#$=]=.99E1O+CK1/[ MP7=>X@@.N.Z^9Z*B*JNB?,89$-9^I=>O02O`@_J$M6R(81\Z!W:WK?VWY!?> M-M5@!RF`\'H9.JHO5N9++$+Y!HI_?XD'LM!XO!]?\[X0'#]ZQ6`OPW,#+P8Q M^BFM\E./!2&I>"F,^%B:(R2Y<>UWP`!.<_![>--?)IWFGH\81D$?=`A=[UO]?_^"[/6"[C!E"^B`_^$5#Y=ISF]WJ,/VN[3M6R)NO=0) M8),3FY;A^K'AV(85)MV]:WIDFUME\9IJK]>?WXFF0["QKXQ>"U3+T4)']\)` MUPQ7-;5`?FV@6O'6-5J::6GZUV)C]VHXNJ^'7N@9@>.%H9'$KFEVQ?6FO?WU MAN:YSE=A@_]%CIW7Y7BZZYAZ;`:VHR:!;D?RWKC8QU"<)"/K<@=VQFD[(%>WW&KD M1(X>VY:G6KYK:)%K1&:W3):V_8G.Q#"MN]C^G?C"O*O('>``)4\S$_#%9,=G M1KW'"B++#`(_BOW0MA)3M<*XNY0P]#<_Y%&N&3TK:/[J"%!H_U>TDL"]/QWM;4COTNIMQ9/H&5=S>4WI;7Y='Q"G M)K$7ZI$1Q.#_W#@&ERB6UHW5($PVA-1?A*J>X)_\N0=1G\_%AEO7UR\%U7W- MU"T'@I,>66'87HX(7.BV%C\^%^)>>+^I%Z5(7-TK*+F:J7J.[7H6N&]7=UU= MW&7G1JIF6,.@)&_1%=^3O4^1*!:MA\ZJJBB%GB2> M^<;=U,0.%-PX>XY#B)&O5RUOW8':%8LSU=WT^Q(.1AU.Z5K^>8 ML97H6N#I@%&T2`TZI?9#UQNCUE&=0U`[^/L&]Q.PX05:[%ANH#J>#41'OM<) M.`FUAPEX0,UGT+WWFT_+5+78TV,M\;PH=@V[O0L61.W%0?0P41^,[L>[,,^. M',M28R,V?/`Y@>&ZMD3#NA<87Y/O0_P9HIT?/X>:Z3MFE!B)%?J);7MQV'US M',7.X^GI_3=>`&!,R_;,1'?MT`J!.B^0,$8''+8%*1UM%YEC8/@VTO::NZLY MAF[',>`'%^^M-CV[N[G:#;;AN^W=BS16OYWMN_UV)V&6KP$Y&D1^6W-\(-%. MVNV1&7EFO'5_J:8Z_![?(6G#R>]%V+Y]FPD!WO7LT+7`JR>PEX:?!6%VZ%G; MMSAK!FQ7#TC87I0?)J&OJ99IZQ'LWO408J(4FAH:6ZMI>/SFQL/0=ML.)-83 MO!_=!6]E6([E^T8LY>;"7GB+-MVQ[RZWJ/W,%'8BY9)\2*_C:[Q4D@3M[33W M%&0Q;[ MJ);IM'9LR:-+NGM__2$IR9;OEY9M2:Z'F=AM78K%^HHLLOB5(-*9J$1G=FH5 M+E$?(JYTLK'(?KU#G-?)OD/1IB&Z6,*&+%&OJ'F.2G%=R4YC^14R>G4)-T?) M3B\KR`F.I'+'V'%5`1NV0`#M?OJHX M"M9EG<',,&T3BY7CU`5AA:A6;4[Q5&)CI\QS45XE]C9%TTF=)FJ.8KJ>8BJFB@UI-M!3!['*FH%WJWJSV-.$ M2L&79>GG@C6&%6.8L'W%_VYD.=\RFU8]3Y14G88`FFAC35=+LU8<[*HK.A>- M9;/>+5`#3=CA42S&S4Y#?KBRWCNZS9-/1U)=DQ3=%D6*[&=TS= M_"J#C/S:)LP2&G\;+1(U<\9]-B2GZL/.VO@5KT\(/315O20M7\DP(VUDIPEMV%E3D),[WAX622/9+?Q4[LA6YI!3V6O\V,Z%WB(+.T+DF21!.&-%+5@55>T><;Z[V9-_,$*XD*7W!U4>-7U3FC/V MO7(GTV>I)S]FO&U#.GF+"".(*Z1EQ-`SOKV,L:5D5<(W9X]^01'%5<7D-TM* M&;$M=;XYRG(G2K%J>F,\FO$#[4Z>S5'7TG;UY%-4]L'L&!.BH\@VE=V&Q8H< ME:M2[EP=;W?IH_:>4C7;-`-Y7Z?"HS.GW=O&(]B7+.$!2Y^ML0X&BP5TTB)+ MA23[LL<59BE).9 ML*RG@L29Y_/6TEWH^QX*^NB7.;W)LGNH)%5E+=U295?<(JEP`DFW;.\JGBPY@HH5$;N>+CJNK.MS M"]#4+18@Z:\2U0G'>;:TX[7;8B7/D%1!LSQ9ER1+TRU!-BO-FJ*U4;,[++84 MYCB)MQB"*@F286//=313UAR#7NU5)FNJRY7N]C6$UTJ[1;^F;JK4:D6-K8RK MCB$ZICNS!\?8MMV_!6.O$GB+]O<0] M(`K5!$_2:12M:C+6V1ZMI1E5%.IJAM?M*+12#+K]-4[IS)@J"'$-'3U)A!GL M4D0YBAGK/)_(\MSZ(:O6-T[+610CY:?3H]D1J`<^")!9MXQYMTP9[3?/FV&U M`$JL;;[HMDJ)Y7FO<9[2^5'*:U9,L]IEY55OS\(Y67O,0HKSC"F_[`/VO?Z> MXLS9*KO^G!FA*1Z&)DEC@@M*GLFKG:S M75>E@YUK`O$3&JA:F#E&EVM=;4U;-=\=\!7?6KOUX]2ES\=^MF157ZG:=Y@] MI50+978.Z$8P7N!QGU5V!'WNCS9:TZ/K[,ZZ0)6MT.39[;#MMIN/:W3#]@/V,_1^CEJ.O3@!W^R*H'1\*Y,)PP"0D:C?LV3 M"$LL9D>_JBUGEB*XM&,]VUZ^)%XW=D<[%/E34[K9:7;[+AKOKPINE`WJXE8= M*%@ZFT+FF#J=BAJVEK=G4\X5#XG@@J[7!EGE])FG9X-ZS_CK=G`U/+[`?V MP\!ZP/N`_8#]G'0_3.SX+,DNJH>RXIU^F*`?G&,U'E7T&FA(;_Q1E)H9AR4- MQC%FB7?ELS49\AXP-C8=HE2%F41\^@7)OH0JL!S2@-^_%H!A@!7`"F`%XQ8` M#`#6(8").N`*EJ[WLQ66I,"QP6.JWM)F3`C`\<&C@T@$6T ML6E9E9R'98S&(B5!3N\,R7'L8+#X"HNOL'@&H`!0`"BV@P)6E,%^P'Y@1^+L MK)RS3U^S./@3Q=.,SH%3"#&!_0;6<%K@PZX18%@R`%@`+``6C%P`,`!8AP"& M=6`$K*PY(\"D\3D_0E_(?U-5A? M:^70!0`#@`'`3@FP!=K`56)``&#SJ@.``D!A!(01$'::=AG-ES@C41;ZX_'+ M_&C+`N7`)<;$8S2\/_MN]V&Y:UR\!B+B]J&TPT/@%>%1-DY4>0IP"#AL(0ZO M:^@#5`&JKGETTY03U;NXTM&MZ_N"[>6T/N2(XCD5VC4EMD9Q8(E@B>U0'%@B M6&([%`>6>,V6>/6["[6R'6A$_ZLXC>ED/*+RIFA*DF*;`=W=(7/XGSQE/S^5 MK,BH8D4^UTY$0X4D^T-\O$L[?0GSV@?*OBRW]`)2(FXL81H@!9`"2#5+_'<=I^I8OY]\,Z4]YYUZ MM^=0%JOX?+9UVV.,[\2G@%^KP)_.IKR=!KGOUL#^NFIZF^!6N)?.M_&V4V%S M,)Y.A0V;V]LK6*>X^&`*3@Z58)(##@@<$#B@2ZWY]&624UO:^3GS M:0O77E_[7&O7.(S(794XCX4W[VL-9:0KX>CE\FT]4%[^IS"BSBU[)^L-'P;P MX@1-\V0:IR1%\0AECV&*J.T%^=C/PC@:H#C/TLR/&,)0400MGK)?TD'YM2K5 M/$#T*I1'/P@GMTG6UDY#C`,GH'>'U)C)<)9%SZ\@?^7A#W],&YJB/&4OS!X) MRA+BIWGR4EXT(=EC/"Q>QA[&+HFC,?TY#QX7'E&3_+[FRF>?6-O9W6BEMP[4 M9+G$6N*0]]>0!''"-?B.646A[(CV]FO?Q1^$J,ZRQQ01:A7#LXG_E4PS,GD@ MR5R%DC!`>!T1SS&M&E26A;*8&67PZ*<$^=-I$C^'$S\CM)/QO8SH@\;AK&X# ML]JZ%0UF!KGP&"1KRH"V;\-=A3DMO$H6^?6[#/J)VC$BS\$X9WTQ2N()-ZH: MAI"?LC^%"0HG4S_(T%.K?K\R\]Y>O?=]Z?O MJA,S7TCRE2G\&[4J:TRU]O'O?T/HE^JR?\3Q\(EV)W,)S/#^(*,/-Y^H10F_ MRS>(6B'MC''ZX>9.ND'A\,.-1]5WAP555$T!2[8IN=B2!$\3'4MW/,,V+5MP M;GC/\$?EZ?#FHRRI(NW)N7#56_>41?Q=VBR+*[FR8-FFH[@N_4>11;60Q3$M M[$C+LNPMQ2=J*F$RH8[LUSA-%V1RN'ZD?W]S-HKE&HKG6KKMVIZ$%0/KAFGH MLFN:FF$)DB7L(=:B`$<)*6X7TG%%39!EV=$](+3**$U)<]\U_)JG[ MG"4^#8+"R$]>/M&92/HYCEB#DIC.!Z+OGVC3V!A]J.8]"UL6[6`5,PNUF%%J ME>8=S<7+C;Q3-5E::.4)&W,YK6V#M"5+AJW+EJ=KDJ=@W?,\<09ISU.65:9K M_=?7-H>C6EAED'$<739DRU2I\@I]J73*(*XXG#M%4>3^JVR']U&IT!_QQ-^\_'F&\(%_+2AMWSW$ MXV'QH$(WB&NWNP%.FY9L2HUF_C.BX>J/,&4AYNT#B0@=9=]R_F$6@,*BQF&+ M&DA:W8\^JAG#<#3B:UNSM8!_WG^]1R,RI&YGC,)Y]U%A"%N(D.0W2VL/8<1O M]"=QSA8RJ"F%@<^9HE/DLY6(?)P5RW6$=OAX'#]1Y[2=A>(8?-7N6=B88)0D M=1MGW^L/C>*$^O.%A7I.8S)[,%_710$9C\MK/MS0F)1]3Z=^4'T_W-\]A M/$\)VW";_4E\OS'N\=D+_2S/XN2%SZP/J:/2%?6WSD(! M;K#(.!S+!1<$+@A@[86NK/_QQ7J9FL;53 M/PI6E[`A;GQUW+BK-LVKD]W/ZVSPP!`:JSK?%Z\">+A:/%11N8@;LY:^H`*6 M>389S1>23/R(T/O*?5(Z]L)*39N\4*-*O*![NA6;*Q,':Q,`.@#=/J!3!`U0 MUP#JKCY:__H8)]F(QN=%'M6&TU=!'%%5L*T@"%@@8-EA4G)CBX5]B5,`#%<+ M!HC>(7H_V&C^51RM1D,RS(.LP5&W1=KKK@?J2Q!Q`M?4^]T]`!@`;&^`*6!"(9^R84K;S`!^$%1!69._%Q@@7^^)```Q7"P:IL;7POH`!0NM-MO); M1G^"V7Z+G$U?9ONWD*,/^^"`N?-B3@30P39X`YKZ%F>+I"&SLX\0?S3FGK;C M[R25_>:'F<7MAYE[<,ZH`4+W4^BK:9^ORLVE/NTL\'=Z^[E\L`B>"SP7>*XS M>"Z,SUA'_AH\5Z,U+):,2EW"*?O>.ETTW)Z3$BJ:&:JS`!85#3BU'N,D\:,7 M-"0922:T'4/DKSL\BOSO?ABE&6(IJ171WY",2,)X`-FLW4]3PHH%^"F*2$#2 MU$]>[A$RUSXM'BW1`?Z$[XU9V0/VC(11&3*:Q)(H,'L,DR'Z*_<3*BB[GS5A M@)X>P^`1A8Q`L*Q/4%Z_+IZ8,4=FCPDAO"`"XW9.>Q7O*?6"V8/"7ULUJS MQS`%/_AEW9B`#@:T>ZI^8(^H=3+OD/EK$S*-D^*M5>F9ZIW5'^[1M\?"/@E] MO,9EE<]IT7J>&% M/Y9Y-EGAD&G,SK"E[XZWE&V,5!UGX2P`5PCIYUE<_:&8<_._M)&H4^X(CV7O MB3K/U,".K"UV*^8$_0!OXKY1)]!U@ME=Q.R`KO/56G16I]';^>=A)_W,*#^C M$KN@N-8H"RSN&BSN]<&%V/$1HBRS%'U'8U[/L+;T!K.^]@9C[3">QK;P3M?B MQD].#`1);ZK9?=E(`P\`'N!Z/(#0V'I(7_!_P@"\Z_,KL]B\XYO!)/S!]W(: MIS.&P`B2VN?'QAMC/^[]J7'`%>!J_\3ATQ.5]@57L*Q24C`!%\,%'$['_`H6 M@/`0T`!H**-KK;%AMB]H@.AZ\[E+GCK,V!!?/V55Q>(I_PT$COI0:+4;Y+J&%Q0?T.,`59@"P_P`'BH M\"#*C9TL[PL>(.C>:"__B./A4S@>0QC0(I_3ES!`UTY/R=87'P7``F!!N8ZV M30)Z-=:;09#D9(C(,XNPH;8`A!.[%_+DQA+0^N)'``W7BP:AL?EL7]``H?7F MX7:W&QN*(4IH(DI88&M8I4SL2Q0A-I=`2\!E^W#9$<*Q4QUK@]3JV;+\D\90V_X67HR%_Y>%T0J@^8?;<'N?4ETV> M6PWJ54.1>$#=F5$G&Z=GU+L&U$'<_B4A4S^<95-#H'(!K[0CO:%KSJFY.&9? MS?3910'2`&D;IP&-<08`TF`/^*#TJ]I.,(0X;7)Q?0EQ-`U"'%A8`-2=%W7B M0!0:(UZY:MQ=?<[V__GCG/.?-5]I&J1#EOGAPY8@I.FSV@8YZPVVVM6)S?V1ODV=NOJ M:E\[#+6Q0HX[-;O39K=I^`2*;#-#_-&Z/(/%77[8`>\(WA&\8[>\H][<<4CP MCOM.RG_.6-W9M=?7/M?:-0XC::71L6:Z<-+P7*19X]QPK=9T2A.4)BEZ)_W7^_1 MB%!WX8]10K(\B?AOK$-?J+66RL&"8-PCQ,Q@X<'D.WU5&"%SFH1CW@:>)QZF M*,AI3!AEXQ?V\S2)`Y+N"`O+S[_\G*=WWWU_^NY3%,030J-*)TR#<9SF"?E& MU6J-X^#/CW__&T*_K%SI%IEG%HG(B!&*T7?1._X@HP\W#I5.^%VZ0;17PHD_ M3C_<'V9UA.B*6)4O'@B)J6+1$Q74LW?$,Q7%46;]!>106C\K3 MXM?6VK23IOR(,!M@7)^C[91\&Z.L@BYGC;'(. MYG&@2'3,A2QI12F)Y]=O-2G2,EL74Y*=<["3`(DM4>177=7555]7EZ;;5KY_ M>ZHE&3JZ6#.,2/`D*IC;G"HGNM&55MF^"%+T)3@#Y*L(>D)7R$3,2-21,L.E MC]1IV0K*D9%]0=\1E=GZ*XKZJ9@4Y;=TFZ$:M%@1S!3%W$8<38A2=T;((D.9 M8%C2S#6>1'4%.4Y-IF!100JX=*))P4117(YX/*KR[$MYV[YW:U?`]7> M0G2P:IC>H9(19+R/A%++.>*>(N,ZR02B,3>]4W*]!.6K2'K"%I$"#P>.FC`K M"--*<-S9HJ):]R55^!4$78_G7\LT'^MW?RG6X<=DMDF)=7O&_IE8'TZLY]Q0 MA2V*,G!,O36*.-_(9`V$3%F,I(GJ"74:T!5$0/_-#CMY[`31)@0J<=`8N4!M M(X(W+/I,!%@1^HOH4!EV7"!HJ_YJM_O%#$+N*OSOIEP_#E)!T%9J&0,+GGJ! M-*#?FI6QR)$L3,&P$#]7PBDX%X(_-OA>.1A_F/X(*ZH,UD+IUGX@[*99X*HT M1]^9PH(=0KM]_F!\QVS!8;!9@Q7& MR@5GB'4>M?@L8RY+63C7@_"!;;MQ=?]QM?A60AIH'W^KBNF'>83\;SX!>S>3 M=?GMK%B+$\V%P!Q[3(GG((!7AF@B7%1@S]E*O0/ZY:"N)LRI?(P81#EV,.S* M1:LI@AB=.D>1D!!09L)@_CRJO%R:%<3Z83%$688)$DJ\)VBB5)2CON,2O*=+MLDC< MT"4B22^"4\A9;+@RSGG-:"<2^*T]<;Q"+Y%I#[:KR73"\C"'@,]"M$XAR@B0 MDB'4!8B2ZTQ-G+QH+KU$HB8%_=NBVJN(PR0'11'68H6"-Y`QS@XBY'#DS`,-0D03F*'NS&GU(G,%&"=R";D M)>(=]G["0NCN@V`\(*\T`3?8A@K8NCPSOC:R@0,/+S\LYG5\=V+,E3#!,16Q MA877:>*CT:UD!*+WXY'$&XIDIM,RL>;C62*X/LS=>%FNQ[,3XL48O9418\N" M`*_ND.X4!ZX_,ZD7BK>8+UJ/V%RS32>'3F=I)&;".R>1-,)I0:)K6=/(3!;1 MJUZ8<`C'!7`/LRHQ&A\=#9"V$AV$0GB+5<#O.O.(A+TNUJ-IGJ&,.BL%DD0) MX:7BKF/."';=X>M MAQ`J(0;/!0-P6$1IM#:M;X;U.TOF()=[ODIGCQ^*[IB^38(7B*11:QA-;FF@ MK6T"WBR($/3:Z$[%93!I'*0!$KP/)39(I[IU&W&?N5D(L*\_?,<`*L<%MMPQ MHS23U'E/<3N"EA"><5-*Z;,`GA_[I(S*J@`+L5'$2")"&RD*F-PBV-V/5U^'SV\6('=13B@+HZL2.]\NY$$K0C/0N+\F$_.X!==E(@:RID/D`D) M;JU2+1WJ?*"/=9@L--@M`B'KNN?9` M&([QE%L(&FS3@G\56AHD+6J#I*"#U%GFR_&9&']=F`DD(JNB[=WX<3:>K\U\ M&MKVC8.C?,J$H8X$J21/\9+S'=$$CC?;&2>*[(5^&MG5)#JA#,\0Y3+2&#AR MD@1806Q72>%SZHRKZPBTJ"!37,X6]<>W)2+5GOJF@_(\90AI!X(1*;R2$FQ? MV(`@\.&1."DQ8G_Z2Z^(<+>`[-?R`1SL+\7WT:?%P_APO?:Q&L0KU1?6OWYO M[OME,9NV57+?8`F<3XI1XWO/KI3\(Y=Q,G6],L[]PWR5BL/;^>B_-K/'$>%- M&>--73UH%^/5-!4C>I@>D_5B58W&DTDJ?IS6[Z^*"N1NZ@C35>-OY73T^3U\ M#L9U=+=:/(SNRVJT7%0U:U*-OI?K^_J3VT+4FU$YW^Z[]JX<5Z./Z?9I$&_` M@,KB;A1^%)--_<6CMW=WY:18U86*TRVV]WGYY__3TN%KVES]N0_SY,OF,,Q) MT[42D[9VU'\S^ONJU3M`*-)9PG*^7HS&HZIS`^.OJZ+FV&J]?07/V52LSE)Q MQ![;*.[NTB-!W\]L\_WH-Y"SJ6_M;KD+H"XH6-4U,D6RL-%X2]N-$J#YX^C+ MN.9''E*.N+7>[P"X;H\\7LWAQR^;-:P>FPI^_#:>--IZCNXNH_1M\A7+U/\R>-Z7@^ M3^]G"&]J=/J)EVPA29.6F'*^26C2^8-RV4#=/G4[DN^J)4RI1=)).FNP M'-T7XQD\LIS#>M7(,FMJ@&%V+U;3^J5:'>[6?C+O1Q^>AK!Q#*#@AZJ%G/;. MNB$K?A2K29G&K4K$[VBQW,Y\,(D1V&A3B[Q>-/(4/Y8P>T?IMKB&JRZN7R]7B!X05 MZP),Z\]$T!N(#M(8]"T]W72/#;^O*ZFW-X11:!Q9;?9P^0SF[->;SL:3K./I M0SDOJ_6J^>[DHN5(%O,M[C1YT\!-DK)FY72\KD=QRTLGT%N&#=[OZ02>^30> MS5CLS,?:;=8C,1E7][,"TN%63>FN\`%="[_5US-;-Q*-%*LO MJ4#>HM;\I&;WMUK^4B1-E56UJ97[]/`33CDO&']Q=-4+RE;;-*_>;O@X7MVN M:D9_FKJ.%!^+U>?[?KB_)[,CN[%9B-Y+&AUET0GI%#(-`Z`"$E'TBG3:)_SI M+^@]PCOBO`C7563I)8"[L@@EJ`N,6*(C=<8QAD(K"U="O)4L]065:28==A-UJ$-\'^H9F>0W`+'8S6@GJ'F0=#P5K9%C=1SPKJ6]PG`#<@ MS@9[S$`HH]PCRE3PSD;X7R/:6CFFC+\>V-O-&OSTO`YCAR#6`!-IJ1#W.&H9 ML*.J'5Z.M1B.>`?)9;"/687&@F"L4*184FT\]O,%S:G#@=A2 MH?'>`N-SRA0-B]%B6!*YB8$*37ED[3C&P'*NA=.^[SJ%YW(!CAF"8D$$J:/4 M`1$4F#.XXVG3,:%,@-[^YAD"+"9%,:TB9,'_&*\@>ER';=`UF-CGO*Y#@7\$ M"PI6)]HL3CV&Y`/6I'65KN$6:,B&)(E@R)46-VL542'.L M/G00X/VD76IK,\3"E54L50IKZA2-P6)B?B@M1XR,'"3FU8D.2W]8/K37 M]`'3Y8\WYZMVC[I/FA(MN"`Y,!CVT;BJ%I.RSJ[K!+],?-5\/)L]PCRK=93R M[JW:;G9>JP]<;R\>;5+R/)\]WNR>GQ\OE[-R2Q=-=_0-PWZ+:4 M07WHNF843J!^EX!4._M9=^77S6K+&4T6TYJ'*.?PB-ELVWYS#CEZ4^_\?C1J M;#%E](G,*^\`'R#:++^NQM.B:EB:^7WB/AJVJV:U&FI@EUJ#$;G;S"?-C^E, M"7BKQ:B&U"E@FIB%(AV%VLI4-IN)S<@^C)-(\X9E@:<^E'-X]3"0\:HC4::) M+FYO]G[DGI[X]*!Z*!,!56NO(8VW[X+LB0=:E8"Y?DY5K+Z5$WCH9ETVMRD[ MA255`Z[%EU156K,>>Q61;K,LLE-7=M[@3WJ#9?4KR_+FM#?W9',(_I8]?;H#:)Q*HM-ZOEHBKV*;<> M[F;/'U[;5.UD3%1;\DOODH\:/120*4\;LC:]"P-UMYF-9N5=38+5'^CF?`,: M@*X?EZFK"X"\2Z1=:J=07;#1\'MPCO[MVWTT]&W2[K\;?QR5ZF:7MM_UG&\F MX9]!IL3T7D=)2>5OAIQC>C7D-VF)6S:[3[-'\)__GC6O,6NNI:Q#LZ:WRX,1 MKG9A4P]D[WCB"%=4G4.)\4_1)@Y?TH"'86AF1=YKIQ-$8R]N3"3SJC)FA7/5:&_0` M#$9WN'S9!18H99)Y):E"L2L/%D[RD%>`8J;%]:"=JE&4*``PXB5AP49I@\'= M`02*LP)UQI$F5T5WN!K.66&)MUYK[8F4')"UT(CU67T?9K)7^GT<6K.E_=B>T;RG',B)Q`@N!H;$#IF(CBOFV@Q7UT,>\` MQ9CXB?HX9EJ46NH](P`<,Q6,96V3#64)4EFI+M.]TSAGB9)VLRRDQ/6:VE47 M#6T[$PDX#J>""#9([D$-71T_PC[S,J*W5[$?Q5E(3\U?8BA3L$H[`NL>TU1SI#R1<-4[PW^/D;)613AKY&&"J&4X3J8=I20R,V:O&2` MCLCW^QB?\XX,(Q@KPXDUDE/L)81"B+5CY://SQ]Q_/L;'Y:B6>VSP8H"OUU8A,`S)':$T8@E1MI)$/$TQGJ<$9HZ^BEV^W(?I#6/D`U(!P$,#M9;$5PW,6%QRULV M#'.QO\U714/V_A7&/9VROIU[6.>^U4G:X)HES3!!FE-+G+;@#B5ZZLZ<^O0= M66Y/(+D,]JG#G4(3K%V`B1&UQJJA?+89(_=["H&>#?(@Z/^H]S.+J4E'(KX6 MOVR2_F_O?#E+APR.5Y:>XE$02YURA7!4*!>L5K$]`PP&)/&^RE(LX9;/I!D( M\+K2'6-72*",VW2B(#!*)(_(D99VC9KNEP[W2K9^JG2G8GI"M$."8VQ"-,%A M33IZ%-:NO27Z0O>HL)^MOJ,=5)Q*98$X"!LYQ+>(\:X!C>=Q7\$V:+#GTEY# MP.Q3$-N7D\$M([V%&)A*#%AD2_TK"Q&BO,1KOKYD MQSRFBH['$*4A!E8&31AO.SU+AS3==Z0#"T$OEBSU;/W/YWQO+,YHN!0,T1PY M2$@P=MRG,_ZM8I3->VH1SINDY,#S!X,[G/M**Z1,NQ;(65B%7&R_ZD$XY%#& MCDNMKP?L:'ORU*K98F4PHE1Q8F(;]BL+9IXEY0*+JP([WB(-W`?,,!4]"YZG MWN.N:UVD\D&#I!N_$)R;C2Q=S,I]L6J*O=VN&A+4L,BM8&"%\AZ5

?FR+=]LIJ$#GI9#0".Q(5=T@:QBA^^A8$MN=;>"3> MT<#>YP_&=W1)=Q!7:2D]L5A2@T7M%AMNTAF9L1_IE-O+\?6_F.(TWI=XQPAF M;4CZFI,`(;)F<>>+6ZC/JV"H$#NKW8LP72S#"5N&!!J'U++:0N0AJ(7Q[WJF M:S"2O!LWW4:_9\G0OM:V(AK<+LU'YQP$Z58)'&4R$MP%?C%O1T7^K[TC[6U; M.7XOT/]`"'U`'D#;(JG3>0F@$PU:O",O1=&/E+2R65.DP,..^^L[LQ=)B3KL M4+(DSX<$DDSNSL[.O3.S[;;5S,!=G?Z%D&VYWV((GD.GXS2`P49`%'W5'[HY M[#J=-4KHUO-Z\D>@VIK;T*V/!KSUKM-H#[K.<-C25G*SUUXO\++JK6YE8&UU MFP?])MCP8PO0X#2:#?!0&CKKHF.O0>8X*E*_"S*9S?.53<.[@`=A7U"7U6J/ ML,DYR*$6D'E[V.BU>ZHN:V@U[?.NRY*H,7*XNS_",&;);NQ"6:4\_WL8Q%M+R9RJH8(8E-&+LP^)0;(P;0*_B)HJM0Q)9868)% M5/(&3'Q05O2(XBVY$CY:83@)R$W`>',AUW^.L:0DQ*(>;,*">)C(#B?XB`QR!6F"F-)EWY`P23JG#YXCX7E1PQ) MPG-]7N0TUYC4FY7-(VKA8(OB7+\A,:M8QY:YKW/7@>M/BA]Y7RE)-3-1DJ2G MYY51S(=-CD0Q&1)*.)VFV)ALCO5'-V8XA:V<,NW(!1+R0 M#[L3H%C%EF+3A-,73_5-88XR@-[QK9CL:!HD`%:%429Z@4HD$RQQ6"QFL.=/@3A M$[#OG=(5P/4^X\^H%>OIQ#3`,W$:RYFD]$8\W,,^`97^-YW=X2H!![!T>#G% MBK_\G/>\0%7U\Y(*"G[RHFFZP&BADD4+8&_>K@O8$_$F^X6%L5AUMB8Q2)PN M$1P)9H8%">,UL M92RILI+$SYD4J"Y+E/5]%*9W]X*Z`.[(G?*>;RL/*L5Y>Q@"Z;P.O9T?(H]$ MW*G*?%_6Q'ZJU6O\>[QTI^K['HZ%L;+AP(2SY!X^P[(U>$FD/\W4H.(Y3FLU M(PJ?8-[@4\VJH>92GS7DR2PWP/X/W^0F+@$!)%6"REEN31(N=T+R`C=$%1O[ M;)[C.GB';,.`$;G#WFG+?-&.&N#2`D=J4M.6%3%YL4B+>PFA'U)PH#E)&9 M,U(P0,`/]+!/Q.19R,J\";\7?F8>]KN8)MC`=>E*>S5@=V$B>BLHZ9N*AK2B MR>:]MY0NYMJDW);1[4%7W4RCZ&BQ,HL)G&+Z8)H9L)2N,0&FK%5_GFDR!H%NQJM:OF]1DJ<^] MIM)T']6=V"@.KE_+;YG/VU3<>Q,LW%S#0*F3S)L4BQ;%NA?(5A+`3JHNX!$8 M=2/$Q;GO70Q&B!Z]P))9ZXG=*,Q6F6M!N[**4BB^!++=*]^N'-^M6-7@UJ(: M13-HR2+@O`5:M;H[2>3%6\AT99E(5_G!5WDZYUF8BNK4*DP>YO#]-9>CQ%./ M>&MI+Y&^?*J:0'N1WKOXX\I+LY#3OA^&#\K_7R>'%2`W(;;8`CF3A6ZDI1\: M+C?"0^=Z?A,F]7B9L$+*:O.2E7/!PIU)OO_TL#W0)KZ!=^>9 M-HJ7V$L&-BAY8K*QC;L(4YQ5-@>?B1[UY0C-GC>P\]]&\C$1%8(*\AV42JAA M$T-%/.H%DN(N=;'5'88+X;6'JW2)`'%+696^Q(8ITW@3$7.J MY6I=X6K;XD6K]0D#"X(5^__LB6E3MI(2C93`//'1$@G1Y;D3?;*Y`[7=-2XW MN&^XB_%*8[)@.Z_XH^0OD;]$_M(+_"4426A/)=B"#;B*`CY.3A M7*5>+)KHSPQW$CZ6AOJD\LO#N&KV9+QEF<1<'FSNTRF_;'6=2KS'LL_:DQO-4.V`[8<6M)LDD3=) MY9&`N\MF(8%,`ID$\GD*9##<@SNF/;%9"NXO!E^$)QCSRV16/;+CQ+)4%D#Q M;'RU"::X>RKOHJ,)GGK^;*N+5'`PM_L9_]:'3/QB'9XKG/K8>A,C_#@%E]\\ M'*";=9IE,13^&H^_8#@@MZQM`0#L#AK!,+(5*O^:X'4M:"/',5M,^.'"ELR' M,CP)<"3*-!5 M6(VS8SSZ#A-]\C:[$*1:;:B?>=PS<1^8NH)1!%L]WG6;IV5Q63=_YDEK>-N< M^JR\#9Y3III),%8L@[U3O-HX3Y+&BY$T56RF<"M M7LF")Q6*9W))="*;)>,04GND]LY([6U0!:0(1E\U.;9YW8AH:$Z_G\`E@5>10/%)Q.[4AQ M;V[W*:B;J7:Q>=RWW.E!)N7[7W(T)`^Y\.3]'L8R<_%4[=2J9]`1-W%U,?;- M%:!$[-%C3V;.W2V"5"!XTH*D!<]("Y+.XXI$>W8?>')Y6#CU^%GXA"#VO(2? M?!Q'J>GL."_A`'#-X&,A,[\W.0/'Y'=FB\H*/'8'.;T`V7K'`YV37`+(6EY8 MQ!9>H@599N6#Q$\#?L$SHB,%Y\A74.B#>/66/I#'"]@?,66AJ'[G.FEZ2[J% M$O6HE.FHGN0HR='SE*,ZD6CEW!BKS&*1G002P_O.9L>1H5K2(0`@6OC4.AT+ M$XVRPV@\PA8OH%P5C>SP_)I%5\)FYQ_YS3TJ%.ZOQ75E=QF:9T9\OX]&I[%LJS4Q962P*:T6='.:;A>L)$_(J1O2F M874AN)O;LOC6:9>';O&7\H&X!X54.,&B4%3:GM+N(@M7GG:!*D@QC,SKU)9I M!#2,=T]&JA3VF:\[#&>Q#)EF$.BG^4V-C_)NQ>?U;%N1FB*,"!ZA_L&P;W9^ MZDYB?H[)I\2,?[1TQ*GH1/AV62F"#-6'PJDL;J`NPW9Y.<`T\B;J7D9T;CZ?<8< M95G7W4.RU,G:&>?MP*!%B1G7KK`>>",!M`;00`W@=VXU+&7'%F$N@'3[*O_* M*TIE[KB.T$6\J%#;(+H9C*E/8_`-3+F/HC`2!RCYO\RYYQ-A]+7R">CP:JSBHVJV*F^$ M?@JW)5BK)FO\1-U#`>(6JS?1:GT;47NG3C"1< MXL"YPXS*CI)6(!=%R0)(-TU"]4/$P>*_B#.D+GAO#=OJM)L_?9SP9)HK;.SF M+F-VJS[D$84C;CB;TL<@3JMP/O*"LR4.TZ=:^Z<7GFK)]ZQ7OG?L^8[]7NM, MX*1].`TX+WT?+GU]1&>G\=ZYK*]SE/E>EE`R"9,D7*PD@H#IE+>E\M_%\X6? MA+%C[Y,DDS/P,%(R![O^]MZ;@5'W%@&N(K(SNZIV=%R=`WZ(?O:D'VL7`4D' M($.%P4-DAG+L7X/,7>2TS0G[T>R^WZ7+*T(V.I)B;`R@$)&1D"(A14+JA(34 M>KQT=^;B*9M7J[&DZA!Y6+EU"+)[N5P[)"'V>/!X*^Z.!,GA-/4;[.+92N+6 M.Q/$W_B9H3CE(WHC>CLTO?V*9<]$;J?JJ)#"?T.%O[?52QQ!`I@4/M';.=#; M*Q0^.?6DXW],QZM4LJ\ZE8RBEF1,'D"XL<205[P2@55/8/:[)["?T%GY%N*U MGD1G),A(D)TG@9$@(T%&@HQ,?R*TBR$TTIBD,4ECGCV=D2`C04:"[$0%V8N[ M<7Z3AF;SR_J>&`@.MKVWI)=-R):TK-\=8683P-_?ZL* M<3NI;1L"#X`G3J@5(LHR6W;[X,@Z`L6\41U^E:3TCG4I"2\27B]'E&-V6PT2 M7B2\3EAX58JX4^&[PS/=.HD<#CT'2^WYZ22)Z%UP'WJ*9#>\!FN7;C18MFDU M;+(:R&HX1;EU",2=`U>>JDEQ!F*?[(W3X5LR.2A44?J:;;8;%&+;-=[Y#P(N%UPL+K$N.LC>9I.D6G(;[)VWEKGB.#@0R&(TN60R51DI?GI]Z@6FH_1<0U=Y9T3_,9UN9;DU.91$JX@?BAS/G!\?L$#\0/Y"QI(PEBK$2,Y!RD,:2 M8UJD'8@A2#LH[4#,L+).ZIY4^EK/]XW?$OCS2ZX_V;^=U\'R1H[MC#>K.]/> MB)1+835*PSJ"A78IK-4T+:>ZJ[Z(M8BUWAYQ)V($'J$F@OB*^&J_L_E+T5=6 MRW0ZA^^)0HQ%C$4*B_CJ),CCPOCJW?E8MEFW'&(M8BUBKJUKMFQ#M^BB%B+6.O]J2P*#.Z+@)?E8[Q9QM)! M,R_")S>8,F,>1L:_`H##9],$[VC-7=<:W_P>A8]>[(4!?RYBA\F6Z538SXQ, M(Y*/)!])/EZ.?+0:9KM575`G0!1\)7-/]6& M=MVR_G#^\VU8,[S9I]K8G297HY'5'/4 M&M1[MIJ]UVK`[%=7EGWE6&+^31-EH`S#:;K0C_P.FQ?.QO!;O!N6<;_?:EKU MP:#A]$;=]K!O#P8*EM;8'M8^_^$(,#9.L@D.!'5/*$9-JV5;(]OJ#`>='B!A M,.XI*+J`G=IG?*L,#CW).A0"Q+UWI6WUZJT.0%'O.DVKT;+:XZ:"H=[K-00, M5_7NE5,O0E*8:!V.;\_+/:;O-_L-QW9ZXVZ_,;9'0]MNZ.E;PU:K]MFJ7_U1 MG!A'SN8;!8F7/`_@]\CUOP0S]OT?['GWQ-VAW>V,ZHWZH#ML=!S+;G0;:N). MKV[5/H/XL1RKU6HTQ?2E$ZW!$2X68?!G`FSZY[T;L?BW-(D3-T"A5P#JBP!J M[:&:,6-3;P%\^*E6S]-*?=AN#JQZ?^@T`;"N/6JV-*VT6[V:D8*8X$/'?$S` M7+O>MCN-3@'\+?"MKF7L^2P:P.;>A=$>&&W;5G_4ZX[:O9'3;=4'G49]K"`< M6!;PU)^P+!C2^,J6(2@>P`B``_+\.0]A8=95D+ZR.R\&_`?)K^YB'YEC.8"> M9@/P!I*OV6@-AAU-W:TN[#*(N0A48&`,$!MA&DV9\??01WS$IO$EF%[G@2O. M+Z#SO>#A=AZ&21`F[)_PQ?C.?XI"U##W2;*\O;EY>GJZ_CZ)_.LPNKNQZW7G M!O]\@P_6Y/,)D/6G&BP'Y"Z;U8P;&/Z7&WS)N\7_X>O_`5!+`P04````"`#6 MBFX_&+Y[W"T*``#R?@``%0`<`&%N8VDM,C`Q,3`Y,S!?8V%L+GAM;%54"0`# MM)3!3K24P4YU>`L``00E#@``!#D!``#M7=]SHS@2?K^J^Q]\V6>/P=A@IF:N M*C^G4I6=I":SM_M&"=%*N,7()W#B[%]_+6QG;`<#,9(RI/9EDC`MJ?7UA]1J MM<2G)$[_#$D&O446?\SH/4S)%:@^SVJ0"20]1[C//[WN\07L38QEW6[R_E!4_@&[">_/G;M\NM!LD41$RQ18,CE8Y]):M'7@-L=_I5&OV6W. MZ9_W/(E`9.?_F\?YTVOZT*@B_=W(KMDIR>XO$O[X*MI45F!$[>L9B&)D.5CO MES4H5?P,,BKBF6S@FIW,LSB%+#M.D;U9C*W?8`G4HU"@K@<'5*6V*ZN1#)L\ M3W,DZ&7*N)@VT[U!6:7*GA.1RN'UBF?9#8C;>Y2I4[*JC%+EOG#^&"?)Y71& M8B%AJ=-L;P&E:EVF^"M\)PNH?9M*1)6J\@T>()UC4U3L`=>64*OD[$8A#O5*[%RAT$I4MJ/.;5HV#(L<;O5@U5SA:S*2A85G.,_Z M=X3,!K)G`TCR;/VDZ&O?LE=>ZR^KQ\%QEFTTG9`0DL]'V%2P+1`PXD7AA+G] MX7@R[MLV6/V06N.^%TZ&-K4\2L'?[D`B/6\NUM!I[L'I7(B-T6EO1U9R`9L0 M<*R(MNG/!AF.!>UQ@1[4YR/[J/<(\=U]7ORZK($(^H(CVXN$E<0@FT^7\B!G@+%@L4%#SRL%B?[&`C1RP+"#=GD1:^9J*\7FK<>$K3^E!0\./@@$+ M71JZ1(.S:7+.:,4&Y0B9X,/&A-:(!J7R`6..#XX'W9X;6EE?%3`FC'Z9YB2] MB]';?2;J^8(F\PC70E\XCV1LM((#38H'$%%F$U?#@##N"B4TX62"(0U8L-&# MR&%#:!5$*[>TVQ5+M\#"A#6O8A+&29S'(/>W]N^,EEBYKF@`$(W&?C3Y^4*H MK^IG2<\L*V03FXW4+X/-Q,_4FHYKP,M0N&3IEA4:UT562Z0#RW9@#$.KJSQH M:ZJ7,1$%$!D)L_/IE*>-[+XK&H`[I(R--.RDF%G=*C:Z`GR,!,NCJ-BJ)LD- MB:/+])3,XIQ4>3%[2@3@V"3R(PW1+C/K6<7V5P>3"1I\@YS$*43K!)1C2N=3 M:0F(<)$>T[AJA5M?.&!(_C%T=[FKF!Q:$#/L%]?'QE\*!^!9GC MHA*\JEGP,MU%/@G.YO"=WX)XB"G<"/X0RQZ56':_,/+5VA8SNAY9(1&?[,/E];\+D&A$SNEM^0)[F9BZS&)V(.T:M>]5?4$B!P8XLX M5/WJP/@8T(8I9J#;H-"GP4[6FOY4MHJD^.>\-DTI=:](;#>FROXD=4-9?N5I M/3?8#8XN*A5`,CB#Y<]79U.55Q,P*[0=)VH5UM:#AMR$QBZL1NCHY.FW#%#_ M53Y^>G=,\_BA>/\JL&A>"2(Q<2>$:@C[FIDB]9F=&\34Q*2*'5CFI\M$_FKR M_)##OA#FTJ&&_``S_-!EMI?L:`6:"0(4)S=.\#V(3OE4ID)MG3,IBZ:7%@B` ML)%-_XW_SB153/7E!<(@-)19'L:PO9F(G.&F*(,/1/<^"U%'RR) M_X+H"XE3J>@UTEN@QX985'JS-24#<'S+HJ-6>]>U.2K][M-%/8[F4MLVQKYK MMD[16YX>K*).?6'L-0`;$@WL,9/W8H@\6I`TLYGXWWF6+X,NZV.47^2_$%UP ML0J(5AXR;%2!?'L\+V(:MAJ]]\0C;6B:3+M^/N>].E)R`BFPRNW(FI+RP$$8 MN4R#QS-Y3^Q1#Z.91-WM.-1E^O+`6F6B;GWQ`,;$(;Z.S'W_73E!FL!\&QJM M#K:MWXK2`VZO(E:3"A$=ZOOA6$=(T'KG7-.$[]L.8E6;A`<-:U45RG=SR(94 M!_O>543:&+P')7?L:O>J9(]&A0/+M>WQ)!SUPXEEJ4W^>!=Q:JU0&MK0*L/G M,GV`K.U6:4DE$N2Q[X\UY`N:X=-;;Y6JP=3(:0/R5*1&R!7IZCJH"@J52`?6 MF(PH<352$]_Y,<6W1\#>8^,-J%)?27 M:0YHSRK/0V.K\NXL.HJL28?'A$.9\S+H\A.A;&1[?AV-:/2.ED@'S/;'/@TU M;,";8<]/8_/='7LE6!M)&Q/R:G'!J[=0-Z0"H%X(0]+9K.36MMG-!&N%C9'D M8W33L]5MY-77U>U(RB-JONWH2#,2V#=Q< M+3`'&>XXFL9IG.6B2.*\@-)W;H]D$/D`Q)+[.A[SE!K/T(Z&(N,I@>8@\YTF M))YFF^T7N?YK-FU\A&*?69O7$'C%+IX+DI*N4G,;BOPI,K=6R(PNNE8))(V6 M7&O9@,D#2!,=^3N&IEK5WK,*B(SXT%"L#K]`BOHF,G]C:]Q::5_E6C>J(&"> M3*,<=?9,<$M[[OK=ND#[^T26.4]!+24Z=?#J[Z.=ING1X1.<7WG*MV?7^EEE M;YF`61!Z%G0V8^IG#>VJ1-Q0[O`KS\OL.^!AV9;+J*OA-E]S63%*]YI40&1D M=_G@[[3JN`FI^8=7=;1>_T55':W6?"U51Y-[OX>JH[&Z3YWJ:+/R0Z9:&FST M=5(=+9=_@G2[I4_/WY/'/_X/4$L#!!0````(`-:*;C^COPV#GAL``%X?`0`5 M`!P`86YC:2TR,#$Q,#DS,%]D968N>&UL550)``.TE,%.M)3!3G5X"P`!!"4. M```$.0$``-Q=6W/;.+)^/U7['W*RSQ[C?IF:;!6N4Z[*3E))YNR^L1B)CGE6 M%KV4E#C[Z[;`]"@"AO_[0Z`8:P&^S'&]*']= M3"Z*R_QU-_5/6G4X(0/;VK]62)]'\G MM\5.TD3XN7?_O(_+U[\]K\G M)_^T[UZ_\-5D=5G,ER]<7>3+8OKB2[F\>/&/XF,LX3L^+4Y.-N7K:E:\*\Y? MI-]_OCN[]X7Y95&7$V@\KXM%M:HGQ2^3ZO(T%3UUU7Q1S.WP]_,IV&^!*V>S<^K M^G+]C=NZW*;NHYW-Z\EM?V_^_+[+=U:QG"]/I^7EZ4V9TWSV8``^87=O36DR MUWS=T^]J]MDA^+N8+T#:DVEQGJ]FRX[=>[*=@3I;7>;E?/^^WFNFUZZN6SZY M+"X_%G77?C[61I^=O("VZLGJ8W%R!TG'KC:T]&B'@23EO$RC[#64N2F9^M3? MI+SYWN)Z6$1HVE M(%(PJ0-6E+FH[@LU2VYA5=^B.;Q4'_*/27G;)5H7S`1Q6&!I&,*<>1J%">%6 M&A(TVR;--W:8>O*BJF'"?O42W]:Z8>].QO:\KB[[4T+5H_306?A@/9Q^G#8@P5I^4@,Y^F7VDUZW,^2\LM9NGRNOY: MSC_]7SY;-3GMK>IG7!LL/(\2G""B">#I",@=B.7*Q+`U,CD$!3KKKAH>H5$& M_V12K:"G[XI)`;T&)_:/8GD#2I,-:*B6!1A,2AGL'9:>11A9&#!4##,BN=.^ M$P_(\^!!C\",H?ZW=7&5E]-P?06.3P$$?K.\*.I[D#2PH$7M#"&&M0T\>NDY M!P?ZPV5T7["M#Y@%0Y`0-GA.K90B4&9$DD,0 MF.QLQY4;_CSTNP\2XUCXZJJHEU_?SO+-WA5X)U-IKVIZME000B-"., M1.R5EY%'!5+*:&S$DA[E!+^WK]\C(F/H_;NIYH]J/FD=W376RTBTG'`@M$*& MB1`IYXG?&E/BB$'=-#_P;+ZWYON$Y%`3^+>.[SB'?ZN8$84PHP&,I'>$BDBI MEDE2H+CWF'5SY0:+[WK26HOIO#-$![,#NX[_C%`DHS!6\8&JXGL]6TG'_ZO:JF7\IOFYV/$*!- M]0RD2UXJ)K2@P%WO=63<29@: MG5$&HE2/A4Z]UY8X#(@=5^`VC)H[@C%>M+8U3,NBE(9A\'T\V"H2`]4V>:=. M,,<%X4<9?_>T-K^C[&-H[769?RQG`&>Q@##BQTS3%DYZVR8RS34*(2+'`Y?< M8PX!29+>1H^#HMTV5@>;MWO<=1L(H9'YT7Y3[NE*F>5>@(W2T1AF>.2<$)4XR02@1%B%).T`LF4Y]Y)K]V1V?H>>3$\6(VT3:`^O?&9)1,C.KRLERN3[ND=(%J MOH1HL0##5C3Y\0VU(,+T%B8_ZR@.P2ME'/%`;8@P.?)1=;@A<<1=MZ.;KC6$$AB%#;TB-E(NQ65M> M]WI;2M8CI<%R$A&EDT12R9"V@JL4ZT9DA)-NM,,4K:.]_97S8\+%GJ",-0=4 M\U9:?E@T2RM87F))E7("G!A/4\J`1AS@J\O5+)TY]*"%2=DTHV^OG!$J:.2,"1LE(0QS MF]8Q-9;,6\1,M^3:P=9P!Z!"[Q@=QK_;R:_+A',(&6,I`Q.',:6:ZB2182RJ MR+KE6PR6636`UO?&Y!A6]/=8R<^L"HI9#EA1@$Q9Y1V$L!H`=-P$T\VC'VS< MC[EZVP=>W['CM]/[)\T'/WW><$O*,SF*S@6BEFDAI!*!&NX19>!<&Q^HLDAN MS0H96*H=CZ)3H!VEWED0A=$T=6A[(PU%EL>1HJ==CZ*W5D+S4?3=I/_)CZ(C M!+$#_"=0RM&@.L+O6S`$5MW2G<8]BMY:GZV.HN\&R/,[@(P0^(LP700JE5'! M*2S-K7PV:/?$`0>R"(1H7$+MQ*Y*(QS\#2=]?2P[74ON#Y&11_O(;]D/H^AB6S_;9$ M#:=>I;S?Z&+@D3(D%$AH+7?4HW#\%X]T#_!ZPF3\S<^W>?VF7D,Q76_RO"WJ M]Q=YW7X_]*D&,FPM0LIIARP3GGN"?)HB':+!!L3'BNSV7U!MK<+&+=*>M>+LQJ>5'5Y7^*:6MF/*R86>FT%<$XX[A&F`1"TPYQ6BT$8%6WC95#[*CV MPX@]\3D4$\X6B]7.+-A4RISP!":^P*T6S,@HS7HZ=18[Y7CLEC9QB%W6/AG0 M"9M#:?_-:IFN>T\GKW:DP' M=`=HY%2:#CY#B]I9,#:$*'TDU&#F?2`6/&;AL;%8')`?+<,28<[79Z4CYGQ7<"YB!*;^<8-%7+C(@V6N\%9=@: MA)QW(DDI@^6*X6[K!^HYJ[\[.B.G6^SPH,LSR;A@-@JV17R?6K]3Z1.<2AIJVJ M?[Q"AK"6T?F(*,2>2G)F%+Z5C&O7;8]ML!V6?G7>"R1C*/ML/JF+?%'X8O/[ M;/YCT/RNFLUB57_)ZZ:5M!U;RC0"5!573EAF@@+Y?=I="EJRH)`\NG/+O46$ MPP+U7%?<)%(8486Y%<9J3DE$2"GB`_'*"'QD[X@,IL-=EN%V@^PYG'S40="` M.,(D4A],B(IPD,@98<$Y0MU6W0=S$\8BP=Y`C:'Z/XHEX%%=%J^K1=,*T+UR M&95@/:'+5CB":40JT*BH$-H1$9#MIO#!?(2Q%+X/1N/$"/^_6FRNV_E0/>'> MKLW51P!IFGPJ"*S7;V:_*P"D1;DL;B]S*^JRFKXK)M6GC1JWW8TQ]%=GC'EL MH^'1(\.#L%PB#FC+&(DB6'6+3P?+!QF+D4<&^VASV6;3TZ]JF&\W/=],P^N? M]J&LVR:[W5K+F$!411X`K<7L*1$5I&98FS:GO"]G'M@4>'O0YZ?4F9 ML9YZ2<.---9JVRVM;/@]\-9*:-X#WTWZX]\#W^O6`PY]U-7ZT/ MG7=#Z.=CPO'N>Q^8``=9W4K^T\W=\U/[]4^8A\[F;\!HYNFN83-9EI\W%U1M M/[>Z>V.9<^MD6TK3>Q@H(,*E$UKA2(FRW(UU35'WS9*NKL/@6!WOVJ@C7CL8 M4A)""L.LH8YJD(-@;AC"'>^F&$SG0RJJ<7ET-YA&7QY-*UWS2;E^$OQ;KS]4 M_9F3(;XNDUARH;Q)J8S,HB"U"0E5B1Q3@G>[A':PG9@1R7<$:(_BZ>R\!O7X M\HB,WC,)'H+&4F'!P?Z#NPRGWH'_6!Z!A<\<55#0[967]=J;;/:>'J^046V]\$(:K338>(,$"$C3,T`,*8V. M[-72HV).+XB.P94_YW61S]*AU-\!Y-3)-T#UNOP,B'QN?&1G2\W,>48C5B!6 MLK?!@:$%Z#22,F@$#N=Q;0DOW.++XYOWWZV\%D_*F12=LK M9PJ<3>H`3PUB,C"Q6G.0F%#OI1&DVZ;;8!NZ1T6FWM$=-Q!\<_Z/O*YS@/+W M]+.8QJJ^28AH?,JW50,91"W,64.,T!9)HCS(#I(;ZJV(6AS99NY1\6H0A,=Q MNC?LWX#V(;\.URE&*&PQ!VTVK1=LJ9E.=^-HA#%,X'2%K'8NR6J-Y]IYU6W* M&^SJ@Z-B4[_0'B;__PZ7F[2N%BM0[1O)!"<,>V^<)RIRA:AV,*8`!PACC5L7$(%.;\WKC54U\^G&+5PLBF63&]6MP0S, M,Y:6>1B8P40)D8E-`0JXDPI@M]W6+D<\C3`"GP;`\;#6J.D9Z4[VJ:G!C$<6QF6'IP?LT;I"E:LV;]!/W# MGCWZ)/TC#&E?.2.!NF@90Q+L+G,,*98L<8Q>>XQ"MY7*$8\>],:&P3`[KE21 M7E)$,LMH``\R!`*BVY1RY[W0!J6<=RK\D;W^/&Z:P#`8'I!%9_//Q:*OA*.& MQF#.#B@"[AH0(=I2[IA+B"C%":8='\,:\(+LH1..^L-J#/;`9+D.6M,25G6^ M_++E%OT?2V>:V2"5IC#PF#`4AH8&NVI@!`KC->YF5<9./NI%:0^O2]X;K#$) M\*$RDW^ORCK-F&#WEE_?SO+Y$IRH=&;F:I,FOY47VQO)I.)HT5E M>!>UUA(AREP:H,_"N>E%C3^\!=$;:L=E67JQ*!G1`<)/I<">:HYB9)R!U^<< M14P%Y;IM7HWMY0S!F\$P'(-%J>?@B*5?R1G[G,^2P[8Y^?UP$:J!1[LTDQE$ MHD"6Q4#`LS,D.)%F:2$4#\;1;I[.@*_.]#8G#8C2X;AB@/UU_16(ONWZFE;U M,QIAS,480TQWH#A*,<4@=R!4I17N<%QY8H.S8S]X1CDML;JZVAP_SV>W]RR< MS<^K^G*=J];F+%.??:M MH1_W!O=`9ZS9(4G]1S6?P)_?PO/Y]!%7R)>+=)_%JOYO=]>VV\B-1/]HEV3Q M"NP+R2*#Q089(`D0[%-#\?0XPFK4@"0/,G^?HFSOV!ZUW&)?;.7%L.7J%NN< MXJ7(JF([8'P8^^I&F&!Y](D+64H.AX2LH&Z29TDBU!TNSGBCS:1SRH+(+9Q@ M^G.[*85^?NVH7_RV/OQ12B*10F5W^M(,OA%O;:@O1P3R"5VPRD!&JX$PBB'Y MS/-B!6T&6M=R)M&?/#HSQ$_,<.E"4P\'K/3?YTVZDDI3$@!0$]"H`!(&U)YI M"0KZV2E.#^1I<:*@.H;^?)2QO`565II8W@#<@?K5I:7'X MI=W>E423R0:,!,28HE-:D*G16%1Q M%3>K]>?]T^\^UJ)Y-!LDS39=7V#BA6]H),M.958F<^N],E)%0_I@RA)UT'4> MSVR1/Q-R.QM&RTV6`ZHC/!=L`GH+*)5,@/1#**Y*1?:<>$*-N6X/,B2*C+0%@R;*]V MM5,/PB+^2;NA=][^T&[;W6I3TO&>S2,/&:#GW)9!+VB2M!"=-L:P)++.D)T@ MS2%&DZ2J3+Y=,D*FVIN9`Y]%NOA$!=M0<225T%DA@P%:AUAA9?(^$HBILF#; MDM$OU1U_"CR68'J)@H_2F(0,+%,2E0HHG91DW])#/)ZV55G!;#6-)K2"&=!9 MPB;^GU;Y,$"=+97V4K;!&(*B]6=@+(-@B#2.D3Y:&)KF%-1==;5D6%,MVV.A M6)3:047,3T@W"IC(S!D6HPO,%]^R3%;6"\S956:V+QE\,IK>:C`6B:/OMMWS MAKZ^C.M]IG&:A6"25Y"]AY!CYH;T0])3@;5UJ:/N"LB>"I+E@A*+/99OM:O?UB%2)GZ$G">[-4>5#NVOWKQ0* MF^M;&TC62!Z2!Y=`N^2=*ZY2UB8&GB)4F1UG5V!W[P?51<-I!Q<\[*O&9X/) M23.NC$5MF2\7.,](+*R#9*BT<(!B.(4*7*/ MK+(T8KVO\]3Q]+S"=PTH;T$VKC=WA_9W9!O#9":^#90G*?VO7MW]0T_P76FS>MC_=%:0^?+J_COO#W6%_6&U+ M8/MK_?ZB]S3HLF992Y1`=H\9,82"@[.T6F&A+A.;7\/QP)PXO:&]/!CX=VI< M;C%];VHXQ"QX9%9I`=H&`287+*($PR16+O>OX6!A7J062#7![N:N0%'J)9%W M>_CZ)*_P>6,N2C+9MS?_N.V^4*/7]P9,O[RT6_JH^>X[?SR36G+^@2:2%PV( MCNML.?<\>T1K%7(E:$G.7G5-)M-GW>[[#>-\C-GD0SE^,?V=K6YAZ4G6^2$5-D`P.B,RR"4%89K M2U/%@ZHZYLI-M(MY'I0C,H*H;BH$AL^8EXTUO;'^+T4:#S0'>!?],0F:Y7Q< M%-ZW%Q/X]Y?D,0KUEYUT'`SOG[[E:>O)S'@3UI9AZ^?V]AA>LSW\1(N0LZP] M%VVT]((K:[("!!U$8/X(0':T0$-65XUC\FV)N2;(<6C,Q6:DN72WVOR;5H%_ M_J?]>I;.%[)-IN6TD>7N,'0"6&!&%WM,4@):4NM][#K,QN[M/V(Y!7U<-HGWC@ML@3F.<,(P(SSUA<]G`Z077@G=45GH'4B M1.;JJGF]:7>1VG/;[233`"4Q(^H24P0">1([4^,QIW0LIUWLCDFS^S M==,Q8$Q/Y:-O_BN]OX?#IR(-*4DK!HZ!9YY0>"YX*.W5.0:,HBX\9/)=F!G( M&X'"?*S=5]X[/ZZ>E&T,)I3(! MY(83^T2^"<&'70W?QOR+G5L`<;D()SL$RJD@&(6(K&UL550)``.TE,%.M)3!3G5X"P`!!"4.```$.0$` M`-2=:W/;.GJ`OW>F_X'-=B9G9^)C7'C#Z9Z=P;7KJ7N2QCGM[ISI:&B)3C@K MBZY$GR3]]06HBV7+D@`0E-C]L,EZ%;PO'A./7H``^:=I-?O[3^:_;HM%&7U; M5#\MQE_*^^*Z'A=-5<]^?O.E:1Y^NKS\^O7KC]]NY],?Z_GG2P0`OMS\J[V? M,/_K8OVQ"_.C"X@N,/SQVV+R)OIV/YTMVM@60=8?_[;S^:^X_30DA%RV_^_F MHXOJM0_J9N'E7__]^J;MYT4U6S3%;%R^^?,__D,4_>F?+B[^RCY>1Z(>/]Z7 MLR;B\[)HRDGTM6J^1/]5WJI*Q_B\N+A8?K[E-Z^GYFG$W*R5*VS]J.JLG/;_3?1EK&U6BM7SK3UT!3-=^O9G?U_+[] M2J*WBV9>C)M1GG"1*P@HSVF,\C1!"<_S1(`<(25S,&H;'I6SBU]OUGFT/PH= MZ(T+E%W>\W)1/\['R^\XG>'LLR;5)OWGS==0,9M$RP2CK0RCW]8Y_O>?+I_Z M=QJZDU4K[3\;&.5GN9V4=CU^-CQ-]_7P@Q`0#-K!9PWD).E3W M==TM4>F.O8II,\(F935J@U7EXE-Q.RU'/$=3K_B"G\P9W9"A\3KKM>$PQB_UD74 M=&D5^JU:C'*6"4XRHC!*Q[G;3KK+\/?3$8N0]T9 MTO'!WB^UEVI#&!\^^7]\DO=K^,.(WMKDG!=S"7H9PAU>,&.\!N2@/SH1'(Q- MNO5BQRT!H#B8YF/YN3*K$+/FE^*^'*4Q13#),Y5@@5.&&*!MK:)(@K$`L9MC M'!L_C5V>DHI,5LY2<25FJY,>87F)Q)I3,'\\)W#0')ZP!N,,W_QW;-$)A(,G M>#G34:97LTGY[=_*[R,%TCB+8Q9301`&#&2I*7UD'&.1Z^ANHG!M_32F6&45 MM6E%.B]G5SA3LY5%G\"\;.'`*I@O7D`X*`Q?8(,QAG<'=I31#865,_CC?*ZC MJ&HQ+J9_*XNYG$U$T90CDB(58T`A$!QCD!&:4Q.+I`PKPJSK"^\`/9MCE5>T M3"PRF44ZMI0=JHWJS%[QS)+8!)*" M`:H2Y^'MUOJIQODR*Y_9@R=K#@5A`?[P`<<0@OM@&Y!#O+KQBD6XX/#RRU-8R&&.4Y9)R M:79N2@H!PL0$HP3(!''@9Q*7""=VR>KKM9M-G`BZ^J0O>-V,8LX+SBU8F]9O%'8N46JB--VFC3XO.(RAA"G@"1B1S%*B&92$T`D6NIY=CZ M7JI;JST[9)-,9+)QL(8CF^.FZ`^+FQULB03PP;,N[W&`'Y8!C'O/Q.NN5X3[ MGHGZ_KZ>W33U^.\W7PI]9;Q_;,Q1_TDU^SS",8(0YR!.,D:@$`H0IJ/".-6% M3,*DXP:*+J%.M)NB33%J?"[971UPOV,X_!?OI4]WB=^H['Y4E2G&.S MF9,SB6F,&U(MR\H1T6%9^0KHRZGNP,X M9]^![X[$AN81Q^SW&<,'@KL;;L;EK)A7=7OD%``9<_V?%+`,,TR4_G,=+(4Y M\5*$4X13F4(7O:NTW(Z&=^3G:([>T'D*Q(%:OR;9!F,C%"^00_.*7R?VZ:4# M$GO+K&+\.EL\E./JKBHGJR.P`"`4YRJ7.,MI+GD.,[H.J$L>[F0:[RA]VV:5 MV+MH*S77P^D!6%I:YR08'.. MT+'TZ96>FX0+,A.8HO@50` M,"#2#'*YCL05M7K^3H?F3VP;OZ+'!YN=:'HFULTPYZEO=I$ MU,$N)M\:YGKSC(\D!9C%)$VS/)68)@+@>!4I9R#S6[2Q;_YT:[O7SH_TZ4+- ML5[I!YCW0J\5JWXKE>L#S_()@&\@%NG2@WU%B2\,!XMH47VIIYK-0O[/HWGB MX/I>%$VPR),X3Q57,E$X!FFN(S*6<"R`=)P*>8?IVRKFGO@JL[=1V>;VD[-4 M_"':RN4D_%PE\Y34VVB95D2;9E[=/C;FED74U-&'HCV8?\;;W/O('9119]R# MD5+WGNS(*1`<:TE]T-=#.9^7DS:TOJ+>SUM#3OZSF#Z6'\IY.XA'D#$`_FPP=#1:*L)W-S@#7 MS6Q/7%?[XG2.>JQ&RRRC-DVS-W^Y7^[$1K.C=\!N@?$/Q'2A>U7W>LUV,N!R M'Q]];+[4\^I_R\F(99RP5%).>4(`1!+AQ$1-J-0>SJU.)@8*=6KC+98[5HM- MAIW,YT[6QWB]0NUHNM4.8&K!\P1V>TG*VFK>B`=I,__>'+181TB=['6U6#SJ MB#P5*,V@3!A)8YJIC+:+[)Q!GO-$63W.+4"8,UFK:K,+8"Q;FOZVZ@%D&%-= M'6%X,DLM$W$TE"/6`=O)M2<69O*"T\E*VVT0\4ZDY]JY\-5P>#ZFZHOKF%TU?5H55AG'3YI%9KR@.WEU1T+A?EC MLM]0\'3`:^^T5%(FIW2R[T-P7'Y.&YGTIJCF!*9 MIRA/,2),2"7,_@J!A19L1IWJM"YQ3NJTKLM>G8`Z.ZU7EEU<=N[5K@.,[+SE M379XOO+ORGY/=<3C[Z?UU#4F4B+.)(]SFE&FG6@6U$3"XSCEV.KQXEUCG,-+ M7@M;WA`]?=0#O^XN>G>>!:T]<%PDY(ASJ`)R[<8Q^7AA\1?/]H23IHHI)D2* M8\@H`%QP\UPBD4F6Y#%TVL'5*=`Y%.2_=M6-J:>,^L(9PDCG6[-R?#104+I# M%9177XY9RA^0M:KH8E$VB\U>,1X#G,($8R4)CP7+0!^$?JN5E;O*BO:Y%SWFGM"<]%% MG[Q\K/$N6B,[LSY>@#EJ$5^0@Y*)=R=>=4HW)/;3HF+QASJQZ0&9?48W']:,.][$NM4V%T++O6 M!#]N$=29;0JQ4U=?!S`=*L)"T!V(M,+TY65)%@Z0RZ[+AZ*:R&\/Y6Q1:E.^ M;[Z4\V?%X0B`&!(F$R4RD<0\`SP1)G2*62QY[O0\E!#Q^M]]:5*,RF6.B[:8 MJ$V:T?C97-%]#V9WU'8B.S5E-Y^M`:_2:_FV"48O)IBGWY%YC-KA79G!F`_$ M)U;[03\6W9;QMS2J69IQA/>TE!*$X@5CID"FD^L.Q5!-W]MX.FT-LHZ8SUV@-(!7X5@ M.Q!/!>E*'?[2Z[(`/Y(4@31E4B2895DJ<4Q3$R1%>J;*&!LU=5-,/1;>C[;L MY)Y-$M;#YY/Y)]U**4=2'JOM02%U6F4_Y]*Z[9*Z-:V!",,S^4-+Z(X('"9H M]4,Y;[Y_T-=(H\LDLXKU8)Y%I7TTDJE$*8E1C!04N1)4#&J=2X20Q;B00 M(XXHFYR>K_\\I7:^/08'21W04QC"`_%3 MH,[4?5R$`59]GJ*/4`Y@C*6,B>`(IPICDIFHVHI"P-AID;MCJ/^G:S\N,/V7 M?WKB&&H%Z"F]`2P"/27CN`[D`7D@P@K5&XO5(&](W8JJ$<(@4REE69(1&A-= MLQ&S*DZA2B0!Q.FYFGX13E)$S>K91:=%(D]Z'>JHH.#"U$]#*)I6%=KKHS+K1GI6USL-14O9,[$34"PXWV1PGT8M)+&SA#&<@1G#/N^YX57C= M-Q^I+*,QQ"D4NE1"2F+"S,HV3V.>I"A![C?,CS9YDCOEU/\.^7$F+K?&@^+P MN2=^EEOA1^^!6V,9R'AVS?K5N]Z.G;8>R]=5<5M-JZ8J%W0V.?!N$Y(0(*4" M/)%)E@B8*,I,?*8$E#E.7+[%@P7M^5O^^HJRJ^NK3U?R)J*_B.CF+_2C_,O[ M:R$_WKR-Y'_\>O7I;XZ>",?;SB1G0>WFFJT4-_?(F^_GNQ%EB^R`J()3'XC* MPO>K[OER]=?ARZ.Z+!&I+IR(HC2FB4H2A+B)*&,)4PRAIP!=P_2LO/51\^E3 MAJ[WU;LP=)9:G_B\-3:`$_O[$=EIRY?K\$3EW9/]:NH&YZB,BMFX&HG'\E-] M4\Y_K\;EAWG]>V4D.,(D`1+F4/_2$26)GM?!-"7:@"Q+!016=\T[--_WG?+' M]IV)BV5:T<,Z+TL!=>%V6#PG0N9X4US3^E1'JXRB#R>D-:G'CV:#6]%4]>S< MU)XETR.]%YXVO6OM"P@&K7OW]_<5YP:`Q*\7Q4P(?BNSGXJXM- M_9/Y8SG9U?P(BUZO),CR&PH'AH#:^'W\5` MBLY>NK;GF07A\768(X^H-)O<.4LQ4`3G!";(/"Q!L"S&B434Y5:`1_,GN2TP MWIT9=YX8'P?G.R$.RJS[1/CLLU^G6:\UO(&(ITL/CLYR'6$X/;J[:N[;QT/- M)KR>-=7LVNV-T\XRIR+IIIN7$+D=Q-Z>U[V'T`$!A>`Z$!,%ZKOAF[66KG?9AM0F=ZV\DK:`[HJ0O( M@6BI4Q<.ON;2!X?/VTV6<'.C9^@ M&'IZB\F.?>(]]M%>RMZ!#+7?_3!]1Q!Z_A:FY>/DGM[O$%6SR(R+]N?Z+^!= MI#_\4(Z;ZO=R^MW_92F6OR+[6JNWWXY[@?7T4I1S>NLEE",UE1>_@1C+/__] MKSKQ`6&_H#Z95.8&3#']4%23JQDO'JJFF(Y((JA,<,P0H81F(,'F=#&!*(?, MO`K*:?'<,T;?"^6;M"+SB+T++9CQ,C/7I7%?AI;+X"?`Y[CD_43.I&34S(^1 MZV=M^W4TA]:Q.\(<`4,IPK"LW"#$FF)A(-(Y5KF+AVG$$Y5`HZ6K, MW!=\?V?>-Z6F]=>GEW9J8298*I$H"3A("`)4I"13F62")=;/ENT4H\\28)56 M5-\M7[S69G:^\R:'.!VL`0+@'O*]CK?9@3]CW7Q?E MY&KV_J&<%^;>.S6W2I;#??.*7)[33)M4HV*3J^LINCY^"7;*.S-_-Q&:!QNU^-?I1K??HQ], MQE$U^V.T23IZROI\DG0G>T"=/?Z:!B+4/GM8G^R:=Y?O5?N,*_: M27Y/3BR9=MYNZ^'^[<'@Z4FDQJ#)6?D2,>0O:A^WY%@H?Y]&=N<5/?W*%$#C M=$0G!/Q;/0FFP&/+_7^?U]W!R*_-E]HZN&A[6!Y,?VU\98T4!)=45D@H@'BN M"*N4Q4IR@6B)/??KKP`P^6;_WB<[$5<[KVS)RM>*9O^W_3<'SN3$OFD?;LK0K-4"TE(A@I5A!:%%BF2MMK$&DN58"")^O M4Z")Q-^7-GWZX7<+*[L]PK5KC^R[)1K(HV-V-#V%GGE1"VC+WC&DL;.A9WGI MRX,.(W(B:C?4B]/<9PQ2//K5/)E@;M':,#\_U/8'>[_ZL5EM%O_L;&.F4%$R MJ*2"A`'!4<6-;0USBF"!O!IK13&86(V.,7;U'X[`>?>PB4&PFS"-SJV?3!W# MN\GV`+N*#TX,)^II\SYK/2(6E?2)2%I7Z:M0-TDQT@91;3E2J_OR:F1Y8&,CD1(1KJQ84:\8-(<1:;_UZNZOF# MO:[WTWRQM)8^&<%;+5[F]M+=>B8D@KJ@QH(-ZI0PT9QM]9X3HEA>J&JVK+_9 MD[=?W<5GJ$FGB<2ZB?0&G?.D.J#,OAF8F8D!OL]7*]LN^&X/UE.7!I/M)E"C M$!RD5$>D6FB[5)WA]@C?R*KU#EL]\A6+YXGH6#1WFC2O8U#+P*-X[=/]KG>A M:(.*]8Q"`*$@!6'&'#+A&V/86`902E*5P.L"4@1SJ?='CL#9PVD/S?+;!_.< MQ^SV8='V%ORVJML334'M!8Z):%Q,C\YV*XQ(5L!N\Z?[7[L89?V3_;6^T\UJ6[?56"\T$KP"5?1>Q@Y4>>T:QJ%^XDH8FRO+NYL M1B3-N]-]MXWZ=?ZGZN8]KY?U_6(SJTI=Z*JL*E063.><"6'-\DIB)B0-:G4? M:BOY?D&\7O?!=+IN$8S'I._NP);$[5$3V_1^"R[[VQ;>V!?/WV&K=U<@#L\3 M4;)H[ESH>!^')H^&U+=FW;RN9=W]?G388UNZ8W_2H\0`%5)60@*J,Q1Q<3C,5$)#*%9V\:6R];H/6 M:GG7)2J[WL4F6"T(1Y+D0E6:L)QPN_$,14TIWH[);:MM!V>ZV7*,;>ABM7DH;=9PFJ[UQO7Q7 MC1.0&B$H[>L7-<,Z+P4E"FO%2YGG"$-NT*@"\()`[G6J.1&$U+O6:7K=I1J/ MH1'M:$,1-\9]IS'>U07:A=Z@4#C*>$U6H.-ZZ1PN1R35K:7S*93S#4^!@D)S MA')B`G4D4$Z1#=VUEDP6N7(Z@1W17.H-HP@MGR/QVB^J5Z)TN(!.B&&/MM'C M,QW61CH.XVZMI9TX.?-]24#H%%I/1_:H2?;V)2N_-N,(*E8II8`QS3G@7,J2 M53DJ+SJ_$M]\'):"\VF1K MJO5$W@G&8B+1=@K/@FNG>9(W5#$_+E_J]86R%9RI7-.*,(,$,`ZQ0,(BH12# M`E(6H6#E$/.I#S6<%*Q<[*#&+U@Y:!`&*>E8_$=5U#WH250,\F?67V1C#-.T MQ3:*AVZB&X],]UZY\[_:DD+VH&USO_D^7]4SAK@BE$%2<516T`@^,Y%Q!34K M*\F*(F##+\3,.+MY'>?M8?3%,EMOP65W]4O]T#QU]\N;M?>F7A"O;H*9C,NP MUKA;--VQ_2V>L3OBOF6D1\F&\#<1J1KDPFE'W,%T>(O-UZ:Z_;_GQH!:\QO4D M;ZABZL72;A.=KX[-D6+S4V?S[?'7GG64<1++C"GXL?CW7[*^HW0++]LC&7J#W MD-2W)(_![414+HXOI\ON>`0E"!MG@"F5`TI-L,IPKC7"B!KM%#!'5%%115AH MAY@=:Z']=!2KG(L5DX6*[Q,?.T2,RGGRT'"R\6"4.-!Y+":BC"D\"X[[/,ES M5DUKOEK>V=]L*O1E_F#3I9_KU:*Y.SV0.:MRH,N<(ZT`HZ@"2I1VP5^6%*M* M0*\$953#(RCGW1:+S5"V*FHW%MH?Z@-\3^6,2[Z;=EZ-=S_U%#N*VQ^.D-YD M'=;LS"'PD?73A\H>!4TR(A/1T#2^-2.\TE%TM#+ROEK]993\?^8/S_4,:K-" MUUHKC2DL!80%+(QQ!2"U=Y[4[*D%_O\%..4W<891%GK%("%1("`DEC&'` M,)6Y,:X)MA`8V\Y8M;R+.5_?L^H_7W<`X\S6VI;.^)>>IZXC\$/-4V>G@N:I M'V7N32F?GYX>VMKU\P>+0#\TWS\N[YO58WMI<)\0IU+ELL)8%KS*J68YPO:: M0RF)+@H&D%>7RD@V$^>ICV%V\]3N`IH5RAZI[[9?-++=%B/7X-EO'?**XE83 M+<;L".3U]O,O1PMC\3T0-H[MUVB,S"6T^!6>Z:K7U^O-\<3E"8^8 MR#4O2Z8AL<)+(!"($:D\*\EX/7N,HPUM@2A[3CVDL+4W66[*E9(G/X4ZU*NN M;;&6Q=CQV`D3/6H3RME$5"48_MOB*`-H\%K?6&'ZV7AG?CPGT"]NPAK(,+UXO?AI+^SB)WE/&< MB#:/Y^^9I?&(1`://YJ'.X/*7AP[W^O=A*M"0BHK MQBDF4$M:0@-)<%7I0O,\K)M4?!R)-?_COIM*]OT`=VU;6IJW\L4\<-L'[O10 M6'B?J01CY:;_4QDF/^D_0IU].;3[LJU;CI!W5UPM]@^_6_#9,?JK=:KRYKE' M[<<8O8D(_2BN7FQTE9I>]Z3HQL#H6F_]LFEN_V%Q&$%2K1(=B@]@#;"H,.<< MRH(`5!6:0ERA"FB"CI'&,)\)G):!#V3,04Q'H*77).`P4NA,ZTNG:.*1<]&\3PU'1L MF#.7]"L"1&(?31JS`+B77J=#9E MOW6X?-4ID#XW54K/G)\:!9"61(/.\M*C/<-XG(CF#'2BB?EJ^6Y(-(^/S;*- MR?ZK?OR]7LTXXDSH$FC`E9"H*#0F6T,8$B2\=AB\GYYZZ[(%U*U'LM\Z3+ZZ M$D"98[X_*5N>"7P_HM*DXD_YZ,NM!W,W$0T9X,!I]GL@%1[I[*ZFUOS!;IE^ M7&[[36Z-VL0Y8XH*5L&*Y@!+@O9&,?>J*SO,4F)-.8!K=_H_+):'OJQA"C.0 M6-?L\EB<^N:/!]"9*#_^U!L34=5W:KZR MEQO66VMYP8@64N=0"UMP#%6TV%G#3'@54@@TD5BI=JBR':Q0@0IET$V91B#/ M3Y)">$NB1.>9Z9&@@51.1'N&>M%$?;\&=R)\FP'_TCP\Z&9ERY;,6&[6>!13 M47)4*6I,2T$%5HP@17/B>HH[MMFD9R7/];H[OV=D(6=;S-=O=M]+:?^ARR2# M,Y'YFLR]=SO:Q:0Q)(?2;CBO/SUOUIOYTFY"STA.BQS2`O.RX@Q#H/.<4B`5 MD+0J"QIPNW2(.9]I''RIE,_-'V_KFVS=XKM>VN`-/VX9A'!:)S(!X_AR.:\P ME""/K=O3^3QCJH0JQWD!-)2J4IH";"R)JN02%3GPGU`!1L:<1J/O(IZRT;MU M&$S=1*;*$`_>;!(.),.GK%9W$/(_F_5Z!@E#R#R/EP(44.=404UA63(!2I5S M,'NI5[\W'J56/9[M,Q&.83A/`EOFY<$@&;\,TX&%G@D0QM9$WOU`\&_K)053 M$')T^FMS(6O4?I5^/SWM]\6>!%XO-O6N:V4KQU_JV^;;LGW*]J(TD@77%=8R MK[`J.2:YK6Q`M`84%-1KV^OJ8).?)#)"MSVW>WN$/JO_M#_W?+$F.K:N&?,? M:%A]D^Z'0]NV<KVCW4F&K#?[/Y&W M92(?F^GPE&#&)"920B8D MS"6E,->":Z(1\#OL&M]^X@^716N75/9,^FUWPF'=GG!X?GIS@<@\9K-:W-KK M*]M_8\9T?9,MZ_9(^^D-I/>3'>,-HMOG[-KCY_>%ZDZB='"S#N_V\[+])*W[ M/DT_=X.FF]5]O=@\CY^4"B#[O65WHJ&;R.C\PX>X)F/2!(CE0A!`&45$!1>V&DY)P`@T!Y MUZ\<8LQ_*\.[;.6_WGZ@*ZD3F8)Q?/'9#_0C:,A^(`2(@*I$%..<0Y@S2$IC M"4F"$2&"^TZF`!/C3:$?;"_0E;B)3),A'KR_%^A'QKM3PI:QF?W<;&KZ4]/< M?5\\/'Q\?)HO5C:1M;]172$,&::`"TB`E(HJ+ADN;+L*,S'5>X?)HMA(%T9: M9!G]]VP'+CN@;@SEA0H-O]?IK_>>&&W__,9,%PZB2`!"L MS*^,2FDL@@*0$I&B]$I!#[65.-W-%N`V6\68M9B]+X;-)1>Q[W.$9GU MW*H<1FJ:;<9^MOIV"2/Q/)$(*IH[IWMT46ERBZUDO;Y=+9[L%_/3/7]>+Y;U M>ETM[_A\O5A_NO]LWM'=%_507+I0A'`-->.Y6?,88:6BM#EBDN?***Q+O)7" M;KKI>(369N5V>-LBGRUB^[?'F`,CLR2CX1&M77M4PB*X-*/C%M<%,'8IUDM) M_A3BOZ3^-2.]Q9YQXL[Z$:3S0`XJKX&F94FHP(Q`C3$1E%DD&@,)8(E]0L<$ MYA-'D_O)>SRI>R9R>(R98FC/30_.7?8MXO:SO%YNCLOH'Z8)$<*$1A2:2U(0R"HO"`,`:E(P#Z17` MQ;.:.&Y[#33;(7W5[2(\5HM(OEN(=AW>_00^&N5)HC%G!GN"L/BC,)'8*X%C M3>H7V+>NZ[;NR.>Z*U"_UV<3RD'!.;'[,IA4F$ID+"G*)*>*%ZX5DX.?GVY" M[@OG&$S=T;[KE7^_1$_/;!O,Z$0FUW`_3FN5QB$F>.H/M='5_[V"JBT0"5!C$$.*<]511@OF60,FR48!JYS M:("%=)-H"^KX8N_UON>7&>J91!%HG<@LBN')FP)YD8MQC(G(** M"LJ)4$P*3.R\180#+G+E5)1SL)'$7_6SL\G_LSZ<2X=D[E@T1M"C:S#HD=D= MB\FP[&XXHVXIWA[O+Z5Y8Q`VA51O%#^:R&^2CU[_.E^MYK;WS>ZC0"0O"@ER M#)B0>:Y``1F%P/;PPI00)V'Q?F@Z-=E!"=P6\J?'0S62TA0F%5YTN:G#J9>7 M)"&8C2GH0#CX)L8+X;G2.>1'/]V_KH'2-M\4S7IS=%7^\_ROKJ#*7HB`J@"0 M!22\@*5$$&L@#"PN&-"$^+792XTE<;QWM`O1W+^ZW+QOF-NZ\/H2],Z-(1F? MY(/HMJ:=TOCY?1I&&;HDJ^2!G/`!AE*'.,=7OU(YWR&L>H6EXU&:*C^3N0`3Q]//8%2%'HG$@7% M\>5M/X]8!#D>>V[N-]]-R"3KE_JA>6JO%MHX:B^1N<055Y5@&&`-!42YDB53 M`AF-Q`2YG7\>:B3=S-I!RXZP=0N8T"/1@PGU.1L])K&!AZ2'$>QX7/H='BX% M1]'XFT*D%,^9)L4KYGVN8%V;?_S'D=UJV18N>S;!R![5&9EDN5(5!85F2HJJ ME(H!2$5I_D.50LBK[6HZ%,EW5#O@-\?S[J:]F[5#GQVF9I3X+.&(N1X4F<)@ M^>[;IARG1*=-`FGN/8R2>N@F$C6.X.B;HRSC4.NY.O[%Q!'UJVH\B%()*=&8 M%@SA$A14LA)!S!C/&2_\EG#^CT^^>MM#NMY!L0O%19 M7F\^W6_M'`K;T1P40J-"Y82SHBPEM/6=2XX95CGR.FH09B&Q2EA072W[(*4( M9,U-+](3YJ<:.ZYV!QJO%GV<):9'2881.1$]&>C$FXK3PREQ2PQ_7C4O"\/- M;AM]5E:<2U[)G%8S\YL9;L\&1/6T`^Z5Y_FASR MY4D9\A.//3F?1R''(_>=E*2P7/=_U/.'S1^W-E7CP9M;BOO4W4LI[6!:II#" M#@??Q'@S?/2QNGM<+!=6@#>+EUK7M6W\BJ"40@F&"X`YY=*>)B@K2E1>LKQT M5LB`9R?6R->(LOO:.>0*)LM!)Q/SY*>45Z#(0RT34Q6FEVJE[%MIE[@MDBS^2NH[;;0TRZRN#N@]1&:F+P[:/25*/=< M(O\0;'O(_958#_L,Q&+?[7O@3LVE[T0"&_PF57ZH4_^#![9V.[JE1-;U;:RRB=H9E(*8P"W9W]]VL3DB;M-/$QF#`W M596JG/>\AL?'CK'[HZJ;A9"<41DGL:+2_"`)3NP!>%IA)5.IT:*MV^4&,DOJ M?&E0[W%0X?Q$_67_Y7TAY3=)ZNX69'8TB%%^TZ)[*5>9#-T'OS@+"C9L5M.? M8H0IQU(*CA%/XYAPA.W&H3D$#I#K M!B9#45?M=OWTVG6Q+\OM:ET!L0`RR8T)H?R!`:%3$>UD3`R#(P/.D,#'IIE@ MP$MZ/?PN@:ZS*#?FKZN[LBJWRXTI3D['PNJG?>>P7*B8T2)/LRQ#BNC4'@Q! M3'3:'1J6"-CRBW%"!AZ.]BIOH]5.9U>=+T^G;\J=5/"JC9$\=T/-%>R&4>C@ M]-V1T^\FRGJ54R\!<;+NW,J0<;V?"=K&SNK].I(0ICD#\?%':>-4JSY.LY"% M$(D9E`F$-"5(2A/"!$I)9L";4`*IB^!7GV3<5.]E^2+-PS4W>H4U#`:J@Y8] MCJ8>07TPXPQZ_(V;"64&)%"/=0_YLF.W6/;!5&^+A"*B49ZAHNC.TDH$LYAB MG$BM%SVCB;8V^_EMG]0@$`9X)P;5J8Q#0:78TT'OO2RID;,I_Z<`"FQ$2J<>^W;Q>6;-PTR8].X>ZKEY-\)Y^==6(\KG>ED=[S*B?9H1FO%U7 MR^U_]VWYTAC57^WL:]T-Z.XKPX"R:1=4L2S&0G&:*[LQ*<]S.Y6ETZP06!44 M4A)=4V?@TNK^N*"*GKHT]E56:Q/QVDWF2DWJ1M7?I35A7#XI]2*+B^@MM>@M MMWT;'V^A=1N=)!AU&=Y&ISE&^R2O\G)ED.8ZTTW,X2:924'_F2W]*@Q M#>2[2QG4/4B?$-8X+Y[;O$X$1RR5#*=Q@@B66E`.^H8!=N7`):Q]M=UQ7C#,*/38 MC',C3R_39O(H>(I_/\(<8,'P4S"YUBK1BFD52QZG*DXTL_%8BA$U,8>SB%KA_1F7HH,H:_U%746)U__L9G8KI:.Y-'9G@>KF=BPHSQ?I#$LEE_ M-<%H@;!41!592G)*B?U:*R%(LH297FS(4^06(?`CU(D8>.*EHU5NQ6EXEV"E MZ<>3+F^C"Z9-PI9.`P`L,!]G2A5@$A>0XF.)-T_D>O/:EM\6/+9G]Y(DX4E< M8*H0Z^H`0@E3+,:#^F77&(&9TLL82!5GP_RX$L*KX62Y:-TD;.E5`.@"=7.F M?`&G<8$P?K8X,^;OAF\?7MFF7U3>C9PL4Z326,364DUI*(:R(G)G1-Q(<0IYQ(T]1XT3_]I*CY4[SR4BAB>HWT4!P MC=P*;CB[7@/`(+?7&?5"HYW2[J6IG?%'8J]368&L/,/$,$TR$U(&2JZ>XJX> MAZH]RS]H66!::((+Q)*4T)0)0C-M910QS5`L0=]IC!U[FDIOIWZ$F@GG+&#&V;>E!V>GAMG1[+QB+3'-]J#^<_ M^'B?'7_]]E"28^M"@B`(070> M)(6>&79__4U/]TQC\,NLG/_S)&^*-S=-^7,S.2\N\O?5)%^4U?S7M^>+Q>7/ M!P?7U]<_W9S4LY^J^NR`($0/OO9ZMD7ZOW?WS=ZEC]YA\H[BGVZ:Z=LW-Q>S M>=-B_+N6/]^D#[YK?TV7K;'6^F#YKU^;-N53#6%8?/"/O[__N%3Q73EO%OE\ M4KS]W__^KS=O?OF?=^_^83^\?^.KR=5%,5^\<761+XKIF^MR%X737553XJ?)M7%06IZX*IY M4\W*:1K;YK,DPG'137YYWDUFQ9U M$_YU52Z^;*)#JX%VKT9S=.KRYCS.JNN-:+-R@$'$/KHLZJ5GZ2SWXQ%Z%=P7 MS:0N+],7')W:JZ:<%TUCYL#>IH1O/X8>(,=2@'4:=!BJ7U7N/!E\99@O@*"' M\].JOF@G>XN^O0H;\GJ>W.O[JFF.B_KC.;19)^2J/KT*]UM579>SV>'%95[6 M"99UDCW;H5>Q#N?P9_$IORG6SJ8GFO8JRH?BMF'8\SUZ%>PC M?$V=UAT'[#A;2ZEGFOO5R'_S&O`8;U0 M#]MM+,2W49^^_>YY<9:\_OO\I'@083S5;U;7WW5+D:9.D2862PF?&JU'*7\O M%OT*^G#`'F4%)UE6X-![AO;I87N7&Z*`NF>LGQNX1]D_07Q8]"OUXR'[E+=: MY+.>Y7TT9#_R=B##XK&(+2Q_^4VH]AY:W;5-8_:7]]U^W($BV2?=,,NNE)-%0@Q!G&'ND!9-: M!:2P$/)[Q6=IRZ&J[S'?O>:?\I-9T4;'9<-,$(<%EH8AS)FG49@0DC8!*TJ" M9NNT^99#IIZ\J6K('']]B]^^@7\Y+>KZ;HE:L26RY-'BT>3/Z\DC)G[?\:[% MP>4RZWXW.2]GT_O>IW5UL4OC5CVB"GH,QX^/DV*>P_)@;LJF#4V^;9\1JXT( M)B`>$4>$:-!2.6F)8\PH:[NS9<'_,F\MB4IZ6Q=17 M%WDY7V7HY_ID1F/&N>2:,JMPX,9X>ZN?-]@P/EIC=[/20YOWA,N@DQM6\>(0 M_FPUL[\VS@S%'+``G0RA46,IB+R?%\Q%U='29,2+0$\.H2N&0[#"-`W$82W" MGN\;9HXA*C"G-`;MF+=2^;0&6N\YHHR(/0P).IBQZA'#X=C@KNH$3&M2/&B? M82.%#DQ3!'X5<>F#3A/&"TJ-YL;M#S>Z&O1)7FP'XQ#T2.[5[=`=Q.I-)=062?B@F!4@-2^[OQ>(.E%6^9T6W+,!$5,I@[[#T+,*L MQ("A8I@1R9WV^Q.L],NA'D$=@CK'=7&9E]-PB5 MA6B%=)8":EH3PCB&!((I@0U\K!SIR!^V[_SI#]/!X^:V\7(6#$%"V.`YM5** M0)D120]!8(&VG3?*^,;<>'1&,6YN;(/B,*M2=5G4BR_'L_RVB@2BL>61-7!X MY7+T?+M6=,GG"\5L/PE^(8QRU\= M,Z(09C2`<_:.4!$IU3)I"M/#>\RZAKTCS,%[LGB+\*4SO"_F?S;U.QFA2$9A MK.12&Z;!D^H4T1L<>=!(Z_U9I79#FSY0'8(MAV"C^5EY,BN^LCO<3&97TW)^ M]EM535,!Z`KRM.F>@78IHJ>$N6!ML,:I%.5;Y"VWDG:-CD>X=NV&2SL`>0AJ MM:#/5^EU9-Q)6,Z=449#"H"%3M)K2QP&Q/8GN=X-13H".5Q&O3:5SJ*4AF&( M]3SX2!(#U39%\DXPQP7AP^VO#)1#]W36M"%N0UC\?9F?E+-R41;I09''CQBU M2(;:#I%IKE$($3D>N.0>AP4[5JU,L(XI=R4AS7U>Y0J]V&J MJF<\ASR@/LZ_I!-1F`?P27T%=GD$2(OSZA:C9-@1Y3B)1&"$&,4D[6PSY;EW MTFNW1^M3CYS:/=`OLU1MM$1E)J2M;6<%15%3R`$X28?T$"`RR@,9[L!ZYP'Q M#JBS-9Z#5&%5%Q?E8OE(>"KWJ>8+R.@+<*C%JGQI1:\,1V]AP;:.XA"\4L81 M#]/"(L@E?%1=G^\8M[O933C3'\S#U(1WR+)6H(8HI2JPM'U$%0M2AN5V4N"* MNVA#U[AXA'MV.R=2;R@/5(=U:YVEU.O*0)]H#1Z;B"B=)))*AK057*7]B(B, M<-+MUR-FVQOV<;'5EH`.M6Y5\U8,>=@T2[N;7F))E7("@C9/4\F/1AS@8@*=9TNGS&,I\=Y^7T<.[RRW*1KSH$>*8'^%MO`J<,HC^C MC42_XODPL MO%$,G`GG$#+&4@:N%6-*-=5)(\-85)%UK;4:837G#ABS-9YC.*':XF0JLRHH M9CE@10$R995W`;0%`!TWP73-G$9XCCGDB4(?6'_#K%\.'MZ&,L`=*2NNB]RC M"U,4DY%ZF.L1QR`D=]012%B,UQ;9%E>,[%CS#2],H4!/2KVS@1I&T]*F[5*; M0"FR/.Y3-MNG<5=?F+(9JJ_GPA2$(.V"_P1*)5=41_A]KY?`JFO5Y)C9LJ%! M6UVULAF,K^^J%80@4(;U*E"IC`I.86GN]8-9M$>/U6]IW]:7M&R&Z*`.Q,6ZT[EH?.YQ7A_52RBFR\.DAY?/KSWO?6Z`#%N+D'+: M(I4';FW_E$7!/&`_/KJ64C;E:G%=U^>]BVII5#SMF M5CIM13#..*X1)H'0=`*>=O@`6+57UQ7NF$U;8OM2+#ILFJN-&73;*7/"$PCA M`K=:,".C-,O`T%GLE..Q:SG**&.?0=C3"=>78L[1U2*]'RL]*;DA?;[IF7'+ M""4<_"N5%%PNX6+I:X.%&$%[]$,<(??)H>[@#ES>U"%&:M$["\:&$*6/A!K, MO`_$0LXI/#862XZ[GBIL?L+\&@G5/\`#DVJ#T&A%KTP19G10@BA!B;8^1)_V M*3SU,(6DZ>J5Q(]&HBV!?1'RK(V(GNF1.:9#(,X&EZJ]C(79D0(^SQUCPM&N M3UG+'Y,TG4!]$<*T"X16=D3G=D M7Z",98,WA@Y?R=)Q'[1%_\SR2+@SZ?)!ZK&$=0%'1;EAAD3)T-JMAW'5LBA@ MF6,N$&-E\#Y*Y\A2&XK7NZF*6S6`=]+SH5F'P/9?5?/D@6\OS MYZ?Z94I&BQ!HY4W4`B-%L;K5$Q-)8M>RV#'39T,#/\>3'N`<@C8/Q%Q[%/UD M^TP;[HCS1&L'>99CO[5OVC.G"(^??BXJ2HV\65MVTSRZQV M49!((&KV#./(Y9T^G$JV1R506]KS^3BR$Y(O^`C86I:L[)<%BH*&M-QI0XU" MA'O)ONK)[1[=2-DO8_I$]26>!UM+FZ<[9`AK&9V/B$*JIB1G1N%[S;AV78\- M1WCPTR]?>H'S-51%,1L%3M6AC`']"0T6W6E$X)]LUT!EA`ZE[WBV*X9#L.)P M/JF+O"E\M46ZH8C91K!7%-<.6&9"0IFA4]'H4%+ M%A226UQ\,%@55&MS/KJA=I=0O=8-4XD41E1A;H6QFE,2$5**^$"\,@(/]OJS MRV?>#]\WH7;&@DWV4C<#_34\CJR#H`%QA$FD/I@0%>&@D3/"0KB/NA[9;+Q. M[1N-MH9Z"/+\7BP`C^JB>%\UJ^*;[]IE5(('!Y&M<`33B%2@45$AM",B(-N5 M,AO'OI^+^J3:<7`S%%VV07B8K/O_KYK;^\H^5<\D?4MW>0(@35.V4,R;I84_ M%`!24RZ*^QL\EQ/]0S&ISN;+4=9=\K/KK\X8\]A&PZ-'A@=AN40 M2^\IY.44>:4HBLY&&5E7MSS"LJ]!U_"=6N$%F;F<2'T1<\5@F2%6>^D%HX3" M#\-P(#!7=23>X$"[)BH;5Y+M4[BPQE!KK>*]7A"A]#UFRH4%;7:*T&8RO[Q*E@#Q7D0A' MTZV4-D`P@^_U8T9V#0'&3)-N]FU]B=)FB+Z&(W[(IBQF&GD4N$*8$([,G4;. MJOUZ=+Q?5](5PX'.1-*B>O>BJ:G]\@=DTH?S(PC&\_22#C-9E)]O;PU='WYM M/ECFW/(I'TK32_=00(1+)[3"D1)EN=O'.R$[T.'Q\A#,#4.X\^5M(^3++HV\\CAN,X@'/XY+IR/S23DKOI/Z4]6?&]O% MUV422RZ4-ZE6C%D4I#8AH2J18TKPKF]@&.'R.2!Q1V"I04*WC<\MGMX4E]%[ M)B'6U5@J+#BL.Q#F*LJBC<&1/1+R"*9)77X&1#ZO?(/HFIZ9\XQ& MK$"MY.>#`P=,08Q-'>"I04T&'EYK#AH3ZKTT@G3=QAMAW=2HB-B[ M98;-NX]._\SK.@<]80([1%DB@/NH/FAGHK MHA:#U4S]8)S"#WOU%1D.G-[M@Q%K2;0W\R]#MN"X@[Y_>>_<[ MIV[FT]MHN&F*Q:KHL=N`&:P.6%KF86X'$R4DF>%F?>)Q_21,K[8E.)O45&/FO-Z9V\I*K!LQX1,(I&7@,5GB$&*<6D`F8 M6"RI[>HW1[@A^:(.LT<;K&9G>L?GDG-(4[1D7/KDD63^JOA4W3_L=QN_U$^Q MJWWGC`3JHF4,27#[S#&D6%H(8O3:8Q2Z;FV_BNV/2SO`>5PU7+[5;F64T M0/P<`@'5;:J"\UYH@]+#@%3XKF_EWMQW[?RMW,/6X.P&_Q=DX.'\<]'T546X M8C"(,P**@+L&1(BVE#OF$B)*<8)IYW<%C_!0>?=5A/WA/`3S8(%?;A6D#W[M,35I0:_T@F52<"P@8E.0`JHK, M@^[:P&?N/]U=6V\;MQ+^1Z>\7X#S0G+(HCA%$J0%BO-$J/;:$2IK`TG.2?[] M&-:1CM9/LL& MB''*,%2)$6@*BH$O"`2JA3'P_@5P?#.P-_S=D8)K.RPZIFT!NQV!9!XR2 M4?K`O*)$)"EBR0RR7((@KOHZR`@_B_0?R'6'\R"+\**]:)K+94*D[@^CX_=F M<3%=[O1VN[IE*E5PA%!CDJ+E^"A;K:E]<*XW_`O[)<0<'CQDF.\*2(EZDR#"2=2P&52(+I8R,+O#:R.[X MC\*]L[##=;1'A-^.9PXM9['X@4:RK_+D0?TS3VBO*:682@G"P#GE%.6.C)MR MCE);W;MH#O!+IPZ=F?:&!AU*)G]6Q0^"U*C-[GMN#_?3JM@6J,WBU1/R=TV'V-UWID80R" MKG'#1JV0BE$#5@DNK?7$>BKW&45/\75E95'+@"%MD4H&S48E%$$7:9S!Y1M, M;:6:$9KXR?K<753T."`'K0%X4E%1#9H3"EJ'&&54TOGT*!?^Z'P(4JO0@XJ* M'@?C(/3HM*BHCMX'(I4FLA2X%H)K^R`?C?X<2_O5Z??@HJ+'(3JH0_F]\MU0 MSCDH#%A`=84BGW/B)!`'^=;2+E,@' ME-?:Y_*F-@T(1"3:6ZH4\/+`B_+2RDC.J718A^3H`LJJJT\/-V8>,C)?4?>K M[;)RWH-W0(SS4@$H9M`U(J6#U#Y4/S8^0A]PHF[:[E"LTK"[O)G.IV76I9A2 M:EY-H=G2,G,M.$"(P4K*I#<>&%56.:,C49;4%O(=H3%WJ.63<:S2$,B]X;>[(""\R=!@9U@,X MR!ZRF>&8U[\V\V8QF94+_$_6OOMZ$[NVE@<-D*,P/%BEM2:1)95XL@PEYR'H M*&1UM9`17I_O,TQ[C+,B.A<0!!C=3WA$5;1 M[-+A=('E$"P9H@ZZT#H"X89(`5)Z$%8(M`WA>%@?%`^5[OBN&-0#LD/PZ6<1 MAWO'N+.$[_.V&8+W$F-U3TCBC`"@_T1Y%-.X-$M>^]+Y\=F+[RFX.17&06EQ MT#M(K[3.DA.6B-4D!.N)*_O_LL`:QR`E6UW[Y_@\L7=)C6H@![FWUL[;IQ/= M'_)N[9.M(M[KZ"1/SG&?0J(:Y0.44W)C:L_9[%FO-EW!.5S.<^%RN9<9VCE. M^A;G_9ACY9NK=M%LY.7&[QBNHR*G\\GBQQJIDNJ&/1'MV5IDU%:SW)\0UIZ@( ME=J`,D0E%DF1S=N@C3/5=6Q'>.K4.=M.17.@:^`5KTUJ1\&!!>8L*_=(2WN;M<-T_`<`@NQ,EBCGZMW.Q=IU$?D)"PK4MV*97ZH29% M`4ZH*&0R13JC*.$H82U#1GA>U2%#.H+S+[A2`^A;$`6FL]M5L^OVX98>V0GP)C(IG12! M\DC,VF,RSDPT@M;ZE!&F1O1.ECI(AZ#+7\WT^@M.S7W#P/RZ^7![\W>S^'BU MGO7RX^UJN9K,RUV???[FJ'$RV*1(4@($1YN!!.!]P<$:C,Z(KZU.0\_[N*M/ MC-^0:_?&\4*,X]FV;:1,>4B,!F*D8EP9S[A.!8L@N"8"JK=5YWU0UB_*`]WZ M@V9YL9A^O7OKSM\N$97ETLTOBY$L/UY]VO@53^>W]_K?EC2U(W[ACHB_=JAL M:-3:ES/N\@$YN?,.W`6AC*0;07M^MKE_/+.%]-5S\V MZD]TY!%V_(:]+N"`OMG(`"91XH)Q@ADEF0S&2""&,8Q>]V[K=MG\LKGXUW7[ M[9?+9GIG[OB7YU:./\KKV4V;Y;9;OB_:Y&"8(D:#H^7Y@.@XL[3,FN**(;6M M_JHU-IOL5(-M-V@>'NX=JO_?F^O)[$[`+;=Y7VE5OM!"L-HFSJ1AFBJ#\>G] MK%5(U:VW?367KK=SG3;+C&'(Z&]RZ[`Y):;WWO9LO1%Z] MX1N7GJNU]-RJZV#K2\T;#NOW'?=K=W?(@2O+`2Q5R5#J:'(`][(DSTFMNQ_1 MYZ1N3+TS"/NBP^?F>IUB.U]]P+AJ)Q&>-LU*.$9EJ6C!@2O/,.!H`L%ON##24CVQ82`2"PFL]\P*/[^G^;'3BH\:YL34:5T@!<.+./$ M$ZV*:XM"<(R$9.W*/T9WT#473H.R>S*$VT7!(4V7%Y/9?YO)(LXO8;+:YAJV M-<]6L20X<91`X)QHZXPK1IK-F$7`^U^UBMX-X MTC)[S2!&YB(8!(.KR%+9$"6"_L['5!LMC.B`H#?W<`J0W=/@8?O[)XZ_1?^; M33(*B0$S!4\3C<`<9=27^:H4/`16FR(ZHB_U/2C^!`3[T_BGAPK6.]:"5]MF M#1$$4`8B0GD1*VHIB@01,,Y)LI8#([J4TB,'3H&R/S(\KD\)?[)M^[BE=>:> M)&U!&V$U*U6F)$G&*,*I#Y15OZ`SHLK9/1+B-##[IL0=70\GQ4;[[+WSY07W M6';3$2,=QFV1Q%D2<8==F\XTHOK$O=.B'L[NB>%P6I?KJ3N4C0J%#E!6/Q)3<7?C/?&C:&;!(L/[:HQ+\LZ[,NM MV-,M.U'489@/7#.`B)H`*VEYT6]=.N1M;,\ME\WJ<;8!U7[=+`^QP#T],U`K MA0/&M(SXIS4`*"JC3"NAJ3J7A(S.U/[\P81.X1W((CPR^KV=H2$@GMT=>3>$85?;M07=L+J@/9W1]-N;,POVCN5N%NEK9G@^Y;WK8T MS]9C-![0[46M2E5#HX.U0A-E8E1.[JV6TX^+^-0N5\W-UUF[+MQ\?X-^>=QZ M=_`8F>O@0Q*&EU,(;:SAE"(&,N&NQ[.S6?Q.IL#S1^][`G@HJVRO5O\KUR$? M"P&7*K`=19[;1M]KIWOZ90+2^>@"!NLR\<`%B8`>+@B,5Z06;V2PGU$?J+4HA"UI6]'9]"= M<:5]&^0'LO2_)HN2J]B193^,ML^2G[?+Y0E/"HQ(9@,0$AGEZ`D9!ZJET?J- M=I./6OQXM?ELXOTSBVM"/3ZL^/"4PB'V>^+(F47'&%"N/>[00'!<+@+BY8-E M2>M4?4]V9%9'-D550)``.TE,%.M)3! M3G5X"P`!!"4.```$.0$``.U:37/;-A"]=Z;_`>6E[8&F%"=IK+$R$W]E/./& M'LN=Y):!R)6%"04P`&C)_SX+D*`HB:9$2DW<*B=1X.[#VWWX6I+',Q7U5#B& M"254:\F&J88+(2=G,*)IK/M>RK^F-&8C!I%'((8)<+U@4+JMJ;P'_8%.0"4T MA+XWUCKI!<%T.CW`1LE"RD,J08E4AG`0BDGPHM/M=HX..QZ936*N>FC`VOC% MC']9\)L-97P@Y#U:=@X#DP^PO""(?2]\OW,WJC,)HF0FO`5=494#6U7J?+O M*4UL;OU.US_L>B0;&U54"_EX@?\WHQ9+N8!R/@_$0 MA"+E6CYNO+95^;D_K1:U1=142N!A"SIEQ^+?]H0B8(VY.!]SL3T#F(7CQA0* M)WNU/0G&'T#IQC1*;OGU]E0X9>'F6_&J5W:Y/0_%PL8LG(^YV`$#G:)(R/1-Z$C68/[[F-_!9&Q)YO>_DN6G\*#A(I$I":X>&J M=%BW`&,)H[YG*@/?'?L_AS0^P'.S,UGI8/&(8?1T#0>=%%8IK4;>P;A#BT( MPP+Q5'`E8A:9X]\)CE[%(#D8RM.-@&6(9/5407?.W]GHY4[EW;E+GN32]-W=H`==CT"A(O$.Y%G'7:?>JB79D`7N?E2P2=CT::!%^&8LX`JG. MOZ9,/VXG9CWT&CT/U\S%^0TQ(F7XWTG6P4]1,1YU/3JE:GP1B^F6"VDUY!H1 M7VXJHC(J&EAB<7]JER7Z&K=ORVZ'XI4PUZC7;:3>''??U#L#%4J6&+SKT4FJ M&`>EWG'R=^+F;R(PY>=2_$E,7Q MY22A3)KAVER358AZ0;IO*@3)0<@<9=^4N.284;BC,VAQGB@[K\G^847V,W=B M_?*[)_^N*_#O?_W&VCX/E%TQYR^*+*/L:*O\FS0IB'M1_ M?A=-L%NE39G]`!=@=G'S_JSO5=[!LPX=FD?X6J;FLY5TJ+!"2$TG[Z5(D[YG M/_KJ,2SB/9(]JL]:)H*#IO+Q$N\8\A[)VH?9,]2^%\&0:=>*=3\3T9WUCU*9 M5T9!32"G,643528M.%9$-U(\L`AD:?JY`!MY/+O`Z=!P#K5C5"2B07'_+L=P M&6GGVCXU"('5S')B=I""FHIX)>;-;']8D/.@4K@3`Y`/+`0W1HO)^M3-?W'8 MAA*BZG&;?26GFVE6*@66):J^]>,505X2J,)S0OY;I]"FQO^=A>:#T/`&"^!H ML8Q>5F^]V8]7T@EP0Q_MLV?'O:+]V>E3!+%:S=W!3)_$(OSBXJDW:1-:]FUX M3SN8W2_F2Z71\O!Z^O;SVY>>*BQ68EIO]_R"PDG'W@A7^_ M`5!+`0(>`Q0````(`-:*;C\>_>Q'CE<``&=?!``1`!@```````$```"D@0`` M``!A;F-I+3(P,3$P.3,P+GAM;%54!0`#M)3!3G5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`-:*;C\8OGO<+0H``/)^```5`!@```````$```"D@=E7``!A M;F-I+3(P,3$P.3,P7V-A;"YX;6Q55`4``[24P4YU>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#6BFX_H[\-@YX;``!>'P$`%0`8```````!````I(%58@`` M86YC:2TR,#$Q,#DS,%]D968N>&UL550%``.TE,%.=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`UHIN/S;/?%Q@-````Q0````(`-:*;C]ZS7^5L"```#YE`0`5`!@```````$```"D@?&R M``!A;F-I+3(P,3$P.3,P7W!R92YX;6Q55`4``[24P4YU>`L``00E#@``!#D! M``!02P$"'@,4````"`#6BFX__6;$JA@&``#",0``$0`8```````!````I('P MTP``86YC:2TR,#$Q,#DS,"YX`L``00E#@``!#D!``!0 52P4&``````8`!@`:`@``4]H````` ` end XML 20 R13.htm IDEA: XBRL DOCUMENT v2.3.0.15
Severance Charge
9 Months Ended
Sep. 30, 2011
Severance Charge [Abstract] 
Postemployment Benefits Disclosure [Text Block]
Severance Charge

On July 25, 2011, the Board of Directors accepted the resignation of David S. Boone from his positions with the Company, including his positions as President, Chief Executive Officer and director.

In connection with his resignation, Mr. Boone entered into a severance agreement and general release with the Company, effective July 25, 2011. Under the agreement, Mr. Boone will receive, in addition to any base compensation owed and earned but unused vacation pay, severance payments over a six month period that in the aggregate equal six months' worth of his annual base compensation, and has the right to continue participation in the Company-sponsored group health insurance plan in accordance with COBRA. In addition, the terms of his vested but unexercised stock options were extended to, and expire on, October 10, 2011. During the three months ended September 30, 2011, the company recorded a severance charge of approximately $263,000 in connection with the severance agreement. The charge is included in selling, general and administrative expenses on the condensed consolidated statement of operations. In addition, in September 2011, Mr. Boone executed a cashless exercise of 209,000 options, which resulted in 84,000 shares of common stock being issued to Mr. Boone.

XML 21 R6.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements of Cash Flows (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flows from operating activities:  
Net income (loss)$ (7,390)$ 344
Adjustments to reconcile net income (loss) to net cash used by operations:  
Stock-based compensation expense632606
Depreciation and amortization585571
Goodwill impairment charge4,3610
Unrealized gain on warrant derivative0(18)
Amortization of long-term client agreement187187
Client administration fee expense related to warrants67150
Deferred income taxes615193
Changes in operating assets and liabilities:  
Accounts receivable1,7301,072
Prepaid expenses and other assets(81)22
Accounts payable and accrued liabilities76(287)
Due to service providers(3,662)(2,313)
Net cash used by operating activities(2,880)527
Cash flows from investing activities:  
Investment in software development costs(513)(283)
Additions to property and equipment(58)(282)
Net cash used in investing activities(571)(565)
Cash flows from financing activities:  
Proceeds from exercise of equity incentive awards0157
Net cash provided by financing activities0157
Net decrease in cash and cash equivalents(3,451)119
Cash and cash equivalents at beginning of period14,51211,868
Cash and cash equivalents at end of period11,06111,987
Supplemental cash flow information:  
Cash paid for taxes65134
Supplemental non-cash financing activity:  
Income tax withholdings on conversion of equity incentives $ 19
XML 22 R9.htm IDEA: XBRL DOCUMENT v2.3.0.15
Earnings (Loss) Per Share
9 Months Ended
Sep. 30, 2011
Earnings Per Share [Abstract] 
Earnings Per Share [Text Block]
Earnings (Loss) Per Share

The following table details the reconciliation of basic earnings (loss) per share to diluted earnings (loss) per share (amounts in thousands except per share amounts):
 
Three months ended
September 30,
 
Nine months ended September 30,
 
2011
 
2010
 
2011
 
2010
Numerator:
 
 
 
 
 
 
 
Net income (loss) for basic earnings per share
$
(6,523
)
 
$
44

 
$
(7,390
)
 
$
344

Less:
 
 
 
 
 
 
 
Change in fair value of warrant derivative liability

 
2

 

 
18

Net loss for diluted earnings per share
$
(6,523
)
 
$
42

 
$
(7,390
)
 
$
326

 
 
 
 
 
 
 
 
Denominator:
 

 
 

 
 
 
 
Weighted-average basic and diluted common shares outstanding
17,011

 
16,631

 
16,978

 
16,413

Assumed conversion of dilutive securities:
 

 
 

 
 
 
 
  Stock options

 
239

 

 
282

  Stock warrants

 
254

 

 
474

  Restricted stock units

 

 

 

Potentially dilutive common shares

 
493

 

 
756

 
 
 
 
 
 
 
 
Denominator for diluted earnings per share -- Adjusted weighted average shares
17,011

 
17,124

 
16,978

 
17,169

 
 
 
 
 
 
 
 
Earnings (loss) per common share:
 
 
 
 
 
 
 
Basic
$
(0.38
)
 
$
0.00

 
$
(0.44
)
 
$
0.02

Diluted
$
(0.38
)
 
$
0.00

 
$
(0.44
)
 
$
0.02


For purposes of this calculation, outstanding stock options, stock warrants, and unvested restricted stock units are considered common stock equivalents using the treasury stock method, and are the only such equivalents outstanding.  For the nine months ended September 30, 2011, options to purchase approximately 2.4 million shares of common stock, warrants to purchase 475,000 shares of common stock and approximately 41,000 unvested restricted stock units were excluded from the calculation as their impact would be anti-dilutive.

XML 23 R10.htm IDEA: XBRL DOCUMENT v2.3.0.15
Software Development Costs
9 Months Ended
Sep. 30, 2011
Software Development Costs [Abstract] 
Research, Development, and Computer Software Disclosure [Text Block]
Software Development Costs

The Company capitalizes costs associated with internally developed software, developed for internal use only, during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. Costs of significant upgrades and enhancements that result in additional functionality also are capitalized, whereas costs incurred for maintenance and minor upgrades and enhancements are expensed as incurred. Capitalized costs include external direct costs of materials and services utilized in developing or obtaining internal-use software and payroll and payroll-related expenses for employees who are directly associated with and devote time to the internal-use software projects. Capitalization of such costs begins when the preliminary project stage is complete and ceases no later than the point at which the project is substantially complete and ready for its intended purpose. Capitalized costs are amortized using the straight-line method over the useful life of the software, which is typically five years.
During the three and nine months ended September 30, 2011, the Company capitalized $160,000 and $513,000, respectively. During the three and nine months ended September 30, 2010, the Company capitalized approximately $101,000 and $283,000, respectively.
XML 24 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 25 R11.htm IDEA: XBRL DOCUMENT v2.3.0.15
Income Taxes
9 Months Ended
Sep. 30, 2011
Income Taxes [Abstract] 
Income Tax Disclosure [Text Block]
Income Taxes

Income tax provision (benefit) for the nine months ended September 30 differed from the U.S. federal income tax rate of 34% approximately in the amounts indicated as a result of the following:
 
 
2011
 
2010
Computed “expected” tax provision (benefit) at statutory rates
 
$
(2,293
)
 
$
192

Change in valuation allowance
 
2,906

 

Permanent differences
 
(19
)
 
(507
)
Shortfall from restricted stock units conversion
 
42

 

Warrant deduction
 

 
511

State taxes
 
14

 
37

Other
 
(3
)
 
(13
)
Total income tax provision
 
$
647

 
$
220


At September 30, 2011 the Company determined a valuation allowance against its federal deferred tax assets was necessary. A valuation allowance of approximately $2.9 million was recorded in the third quarter of 2011, which is included in the income tax provision for the three and nine months ended September 30, 2011. Due to the nature and timing of the deferred tax liabilities, the valuation allowance was established against the net deferred tax assets except for the Texas margin tax carryforward of approximately $232,000.
Differences between financial accounting principles and tax laws cause differences between the bases of certain assets and liabilities for financial reporting purposes and tax purposes. The tax effects of these differences, to the extent they are temporary, are recorded as deferred tax assets and liabilities and consisted of the following components:
 
 
2011
 
2010
Deferred tax assets:
 
 
 
 
Operating loss carryforward
 
$
1,038

 
$
101

Accounts receivable allowance
 
56

 
69

Warrants
 
202

 
179

Texas tax credit carryforward
 
232

 
238

Stock option compensation
 
1,251

 
1,140

Goodwill
 
873

 

Accrued expenses
 
246

 
203

Alternative Minimum Tax credit carryforwards
 
16

 
16

Total deferred tax assets
 
3,914

 
1,946

Deferred tax liabilities:
 
 
 
 
Goodwill
 

 
(563
)
Property and equipment
 
(713
)
 
(496
)
Prepaid expense
 
(63
)
 
(41
)
Total deferred tax liabilities
 
(776
)
 
(1,100
)
Valuation allowance
 
(2,906
)
 

Net Deferred Tax Assets
 
$
232

 
$
846


The Company was notified during the nine months ended September 30, 2011 of an examination by tax authorities for its U.S. federal return for the year ended 2009. The examination began in April 2011 and is currently in process
XML 26 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statement of Stockholders' Equity (USD $)
In Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Balance at Dec. 31, 2010$ 20,786$ 169$ 21,602$ (985)
Balance, shares at Dec. 31, 201016,92216,922  
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Net loss(7,390)00(7,390)
Stock-based compensation expense63206320
Issuance of common stock upon conversion of restricted stock units, net of tax withholdings, shares 150  
Issuance of common stock upon conversion of restricted stock units, net of tax withholdings(49)2(51)0
Balance at Sep. 30, 2011$ 13,979$ 171$ 22,183$ (8,375)
Balance, shares at Sep. 30, 201117,07217,072  
XML 27 R7.htm IDEA: XBRL DOCUMENT v2.3.0.15
Description of Business and Basis of Presentation
9 Months Ended
Sep. 30, 2011
Description of Business and Basis of Presentation [Abstract] 
Business Description and Basis of Presentation [Text Block]
Description of Business and Basis of Presentation

American CareSource Holdings, Inc. (“ACS,” “Company,”  the “Registrant,” “we,” “us,” or “our”) is an ancillary services company that offers cost effective access to a comprehensive national network of ancillary healthcare service providers.  The Company sells its services to a number of healthcare companies including preferred provider organizations ("PPOs"), third party administrators (“TPAs”), insurance companies, large self-funded organizations, various employee groups and other middle-market organizations.  The Company offers payors this solution by:
 
lowering its payors’ ancillary care costs throughout our network of high quality, cost effective providers that the Company has under contract at more favorable terms than they could generally obtain on their own;

providing payors with a comprehensive network of ancillary healthcare services providers that is tailored to each payor’s specific needs and is available to each payor’s covered persons for covered services;

providing payors with claims management, reporting and processing and payment services;

performing network/needs analysis to assess the benefits to payors of adding additional/different service providers to the payor -specific provider networks; and

credentialing network service providers for inclusion in the payor -specific provider networks.  

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), interim reporting requirements of Form 10-Q and Rule 8-03 of Regulation S-X of the rules and regulations of the Securities and Exchange Commission (“SEC”).  Consequently, financial information and disclosures normally included in financial statements prepared annually in accordance with GAAP have been condensed or omitted.  Balance sheet amounts are as of September 30, 2011 and December 31, 2010 and operating results are for the three and nine months ended September 30, 2011 and 2010, and include all normal and recurring adjustments we consider necessary for the fair, summarized presentation of our financial position and operating results.  As these are condensed financial statements, readers of this report should, therefore, refer to the consolidated financial statements and the notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010, filed with the SEC on March 18, 2011.

The Company uses the “management approach” for reporting information about segments in annual and interim financial statements.  The management approach is based on the way the chief operating decision-maker organizes segments within a company for making operating decisions and assessing performance.  Reportable segments are based on products and services, geography, legal structure, management structure and any other manner in which management disaggregates a company.  Based on the “management approach” model, the Company has determined that its business is comprised of a single operating segment.
 
Our interim results of operations are not necessarily indicative of results of operations that will be realized for the full fiscal year.

Certain prior year amounts have been reclassified within the condensed consolidated financial statements to conform to the current year presentation.
XML 28 R2.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Net revenues$ 11,496$ 14,763$ 35,881$ 45,092
Cost of revenues    
Provider payments9,09111,06927,71533,171
Administrative fees6167991,7912,552
Claims administration and provider development1,0081,1893,2613,597
Total cost of revenues10,71513,05732,76739,320
Contribution margin7811,7063,1145,772
Selling, general and administrative expenses1,7781,4464,9434,722
Goodwill impairment charge4,36104,3610
Depreciation and amortization204197585571
Total operating expenses6,3431,6439,8895,293
Operating income (loss)(5,562)63(6,775)479
Other Income8243285
Income (loss) before income taxes(5,554)87(6,743)564
Income tax provision96943647220
Net income (loss)$ (6,523)$ 44$ (7,390)$ 344
Earnings (loss) per common share:    
Basic$ (0.38)$ 0.00$ (0.44)$ 0.02
Diluted$ (0.38)$ 0.00$ (0.44)$ 0.02
Basic weighted average common shares outstanding17,01116,63116,97816,413
Diluted weighted average common shares outstanding17,01117,12416,97817,169
XML 29 FilingSummary.xml IDEA: XBRL DOCUMENT 2.3.0.15 Html 18 87 1 false 3 0 false 3 true false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.americancaresource.com/role/DocumentAndEntityInformation Document and Entity Information false false R2.htm 1001000 - Statement - Consolidated Statements of Operations Sheet http://www.americancaresource.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations false false R3.htm 1002000 - Statement - Consolidated Balance Sheets Sheet http://www.americancaresource.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R4.htm 1002500 - Statement - Consolidated Balance Sheets Parenthetical Sheet http://www.americancaresource.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets Parenthetical false false R5.htm 1003000 - Statement - Consolidated Statement of Stockholders' Equity Sheet http://www.americancaresource.com/role/ConsolidatedStatementOfStockholdersEquity Consolidated Statement of Stockholders' Equity false false R6.htm 1004000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.americancaresource.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R7.htm 2101100 - Disclosure - Description of Business and Basis of Presentation Sheet http://www.americancaresource.com/role/DescriptionOfBusinessAndBasisOfPresentation Description of Business and Basis of Presentation false false R8.htm 2104100 - Disclosure - Revenue Recognition Sheet http://www.americancaresource.com/role/RevenueRecognition Revenue Recognition false false R9.htm 2107100 - Disclosure - Earnings (Loss) Per Share Sheet http://www.americancaresource.com/role/EarningsLossPerShare Earnings (Loss) Per Share false false R10.htm 2110100 - Disclosure - Software Development Costs Sheet http://www.americancaresource.com/role/SoftwareDevelopmentCosts Software Development Costs false false R11.htm 2113100 - Disclosure - Income Taxes Sheet http://www.americancaresource.com/role/IncomeTaxes Income Taxes false false R12.htm 2116100 - Disclosure - Warrants Sheet http://www.americancaresource.com/role/Warrants Warrants false false R13.htm 2117100 - Disclosure - Severance Charge Sheet http://www.americancaresource.com/role/SeveranceCharge Severance Charge false false R14.htm 2118100 - Disclosure - Goowill Impairment Sheet http://www.americancaresource.com/role/GoowillImpairment Goowill Impairment false false All Reports Book All Reports Process Flow-Through: 1001000 - Statement - Consolidated Statements of Operations Process Flow-Through: 1002000 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 1002500 - Statement - Consolidated Balance Sheets Parenthetical Process Flow-Through: 1004000 - Statement - Consolidated Statements of Cash Flows anci-20110930.xml anci-20110930.xsd anci-20110930_cal.xml anci-20110930_def.xml anci-20110930_lab.xml anci-20110930_pre.xml true true EXCEL 30 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C,#=F.&)C95]D9&$P7S0V,C=?8C`U,U\Q,C5D M-3%D93)E9#`B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5A#I%>&-E;%=O#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E=F5R86YC95]#:&%R9V4\+W@Z3F%M93X-"B`@("`\>#I7;W)K M#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R M:W-H965T&-E;"!8 M4"!O3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]C,#=F.&)C95]D9&$P7S0V,C=?8C`U,U\Q,C5D-3%D93)E M9#`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S`W9CAB8V5?9&1A M,%\T-C(W7V(P-3-?,3(U9#4Q9&4R960P+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$"!+97D\+W1D/@T* M("`@("`@("`\=&0@8VQA2!&:6QE3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^4VUA;&QE3QS<&%N/CPO'0^,3`M43QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'1087)T7V,P-V8X8F-E7V1D83!?-#8R M-U]B,#4S7S$R-60U,61E,F5D,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO M+R]#.B]C,#=F.&)C95]D9&$P7S0V,C=?8C`U,U\Q,C5D-3%D93)E9#`O5V]R M:W-H965T'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA&-E<'0@ M4&5R(%-H87)E(&1A=&$\+W-T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XR,#0\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,C8\3H\+W-T MF5D.R`Q-RPP-S(@86YD M(#$V+#DR,B!S:&%R97,@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!I;B`R,#$Q M(&%N9"`R,#$P+"!R97-P96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ M,"PP,#`\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!W:71H:&]L9&EN9W,L('-H87)E M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O<&5R871I;VYS.CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$F5D(&=A:6X@;VX@=V%R'!E;G-E(')E;&%T960@=&\@=V%R'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!O<&5R871I;F<@86-T:79I M=&EE2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M/B@U."D\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!I M;F-E;G1I=F4@87=A3H\+W-T"!W:71H:&]L9&EN9W,@;VX@8V]N=F5R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0@0FQO8VM=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MT97AT M+6EN9&5N=#HT.'!X.V9O;G0M2PF(S@R,C$[)B,Q-C`[)B,Q-C`[=&AE("8C.#(R,#M2 M96=I2!S97)V:6-E2!S96QL2!A9&UI;FES=')A=&]RF%T M:6]NF%T:6]N2!O9F9E'0M86QI9VXZ:G5S M=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#MP861D:6YG+6QE M9G0Z,C1P>#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE2P@8V]S="!E9F9E8W1I=F4@<')O=FED97)S('1H870@=&AE($-O M;7!A;GD@:&%S('5N9&5R(&-O;G1R86-T(&%T(&UO2!C;W5L9"!G96YE#MP861D:6YG M+6QE9G0Z-#AP>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I M>F4Z,3!P=#MP861D:6YG+6QE9G0Z,C1P>#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;&EN92UH96EG M:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6QE9G0Z-#AP>#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#MP861D:6YG+6QE9G0Z,C1P>#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ=&]P.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+6QE9G0Z M-#AP>#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P M=#MP861D:6YG+6QE9G0Z,C1P>#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P M)3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6QE9G0Z-'!X.W!A9&1I;F6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE'0M:6YD96YT.C0X<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&AE(&%C M8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N9&5N&-H86YG92!#;VUM:7-S:6]N("@F(S@R,C`[4T5#)B,X,C(Q.RDN)B,Q-C`[ M)B,Q-C`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`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0@0FQO M8VM=/"]T9#X-"B`@("`@("`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`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`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`@8V5L;'-P86-I;F<] M,T0P('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CL@9F]N M="US:7IE.C$P<'0[('=I9'1H.C$P,"4[)SX\='(^/'1D('-T>6QE/3-$=VED M=&@Z-#AP>#L@6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C(V.SPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E&5D(&%M;W5N="!P97(@=')A;G-A M8W1I;VX@;F]R(&1O97,@:70@6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT M97AT+6%L:6=N.FIU6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MT97AT M+6EN9&5N=#HT.'!X.V9O;G0M2!T M:&4@86YC:6QL87)Y(&AE86QT:&-A2!I;F1I8V%T;W)S('1H M870@#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE2!W97)E('1O(')E<&]R="!I=',@ M6UE;G1S(')A=&AE3II;FAE M3II;FAE&EM871E;'D@/"]F;VYT/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO M'0M9&5C;W)A=&EO;CIN;VYE.SXF;F)S<#LD,BXT(&UI M;&QI;VX\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^+"!R97-P96-T:79E;'DN("!&;W(@=&AE(#PO9F]N=#X\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[ M8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^=&AR964@86YD M(&YI;F4\+V9O;G0^/&9O;G0@3II;FAE3II M;FAE&EM871E;'D@/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXF;F)S<#LD,RXW(&UI;&QI M;VX\+V9O;G0^/&9O;G0@3II;FAE6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN M9&5N=#HT.'!X.V9O;G0MF4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M M6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SYT:')E92!A;F0@;FEN93PO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$P<'0[/B!M;VYT:',@96YD960@(#PO9F]N=#X\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P M,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^4V5P=&5M8F5R)B,Q-C`[,S`L M(#(P,3$\+V9O;G0^/&9O;G0@3II;FAE&EM871E(&%M;W5N=',@;V8@=&AE($-O;7!A;GDF(S@R M,3<[6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.F-E;G1EF4Z M,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I;F3I4:6UE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#L^4&5R:6]D#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD M:78@F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#L^06-C;W5N=',@4F5C96EV86)L93PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z.'!T.SX\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^ M06-C;W5N=',@4F5C96EV86)L93PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)FYB#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HR<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXQ+#8R-SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF;F)S M<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MB;W)D97(M=&]P.C)P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF;F)S<#LD/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MB;W)D97(M=&]P.C)P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ3II;FAE6QE/3-$)W9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXT-3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.CAP=#L^)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)FYB#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HR<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXR,BPR-C4\+V9O;G0^/"]D M:78^/"]T9#X\=&0@"!S;VQI9"`C M,#`P,#`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M M86QI9VXZ3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#L@ M'0M86QI9VXZ6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T M.SXR.3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#L^06QL($]T:&5R#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#L^,2PU-38\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.CAP=#L^-2PQ,S`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CAP=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CAP=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M M86QI9VXZ3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R M=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#L^)FYB#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXS+#6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#L^)FYB#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXQ,2PT.38\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z.'!T.SXQ,#`\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z.'!T.SXF(S$V,#LE/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z.'!T.SXF;F)S<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D M9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CAP=#L^-BPS-#4\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CAP=#L^,30L-S8S/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[<&%D9&EN9RUL969T.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.CAP=#L^,3`P/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ M3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@3II;FAE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]C,#=F.&)C95]D9&$P7S0V,C=?8C`U,U\Q,C5D-3%D93)E9#`-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S`W9CAB8V5?9&1A,%\T-C(W7V(P M-3-?,3(U9#4Q9&4R960P+U=O'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0@0FQO8VM=/"]T9#X-"B`@("`@("`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CAP=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.CAP=#L^3F5T(&EN8V]M92`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXH-RPS.3`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE M/3-$;W9EF4Z,3!P=#L^)B,Q-C`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`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`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)FYB#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXT,CPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HS<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#L^)FYB#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^*3PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXS,C8\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZ'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q M-C`[)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXR,SD\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,X M,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI M9VXZ3II;FAE"!S;VQI M9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^,38L M.36QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`P,#`P,#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXH,"XS.#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC M;VQO#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.'!T.SXI/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`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`P,#`[8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[)R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF;F)S<#LD/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXH,"XT-#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXI M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`[8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^1&EL=71E9#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUL969T.C)P M>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#L^)FYB#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXH M,"XS.#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#L^)FYB#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXP+C`P/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`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`P,#`[ M)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIU M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M2!S=&]C:R!M971H;V0L(&%N9"!A3II;FAE3II;FAE'1087)T7V,P-V8X8F-E7V1D83!?-#8R-U]B,#4S7S$R-60U,61E,F5D M,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]C,#=F.&)C95]D9&$P M7S0V,C=?8C`U,U\Q,C5D-3%D93)E9#`O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`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`Q,3PO9F]N=#X\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BP@ M=&AE($-O;7!A;GD@8V%P:71A;&EZ960@/"]F;VYT/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXF;F)S<#LD,38P+#`P,#PO9F]N M=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.C$P<'0[/B!A;F0@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C M;W)A=&EO;CIN;VYE.SXF;F)S<#LD-3$S+#`P,#PO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BP@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^(&UO;G1H3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^+"!T:&4@0V]M<&%N>2!C87!I=&%L:7IE9"!A<'!R;WAI M;6%T96QY("9N8G-P.R0Q,#$L,#`P("!A;F0@/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXF;F)S<#LD,C@S+#`P,#PO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$P<'0[/BP@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C,#=F M.&)C95]D9&$P7S0V,C=?8C`U,U\Q,C5D-3%D93)E9#`-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO8S`W9CAB8V5?9&1A,%\T-C(W7V(P-3-?,3(U M9#4Q9&4R960P+U=O'0O:'1M;#L@8VAAF4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY);F-O;64@5&%X97,\+V9O M;G0^/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[9F]N="US M:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CQD:78@'0M86QI9VXZ:G5S M=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(@,S`\+V9O;G0^ M/&9O;G0@3II;FAE2!I;B!T:&4@86UO=6YT'0M:6YD M96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^ M/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL'0M86QI M9VXZ;&5F=#LG/CQT#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C)P>"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI M9VXZ3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.'!T.SXH-3`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#L^)FYB#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)FYB#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#MB;W)D97(M=&]P.C)P>"!S;VQI9"`C,#`P,#`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`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`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`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`R/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXR,S(\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#L^,C,X/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#L^4W1O8VL@;W!T:6]N(&-O;7!E;G-A=&EO M;CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZ6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`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`C,#`P,#`P.V)A8VMG6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP M861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O M;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF M;F)S<#LD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ3II;FAE6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)A8VMG"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)FYB M#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXX-#8\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N M.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE2!W87,@;F]T:69I960@9'5R:6YG('1H92`\+V9O;G0^ M/&9O;G0@3II;FAE3II;FAE'1087)T7V,P-V8X8F-E7V1D83!?-#8R-U]B,#4S7S$R-60U,61E,F5D,`T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]C,#=F.&)C95]D9&$P7S0V M,C=?8C`U,U\Q,C5D-3%D93)E9#`O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ M:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M'0M M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M2!N97<@ M8VQI96YT6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M M3II;FAE&EM871E;'D@)FYB7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$;&EN M92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M:6YD96YT.C0X<'@[9F]N M="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SX\+V9O;G0^/&9O M;G0@3II;FAE2P@:6YC;'5D:6YG(&AI M&5C=71I=F4@3V9F M:6-E6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD M:78@'0M86QI9VXZ:G5S=&EF M>3MT97AT+6EN9&5N=#HT.'!X.V9O;G0M2P@969F96-T:79E($IU;'D@,C4L(#(P M,3$N(%5N9&5R('1H92!A9W)E96UE;G0L($UR+B!";V]N92!W:6QL(')E8V5I M=F4L(&EN(&%D9&ET:6]N('1O(&%N>2!B87-E(&-O;7!E;G-A=&EO;B!O=V5D M(&%N9"!E87)N960@8G5T('5N=7-E9"!V86-A=&EO;B!P87DL('-E=F5R86YC M92!P87EM96YT2US<&]N'!I&EM871E;'D@)FYB&5C=71E9"!A(&-A3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]C,#=F.&)C95]D9&$P7S0V,C=?8C`U,U\Q M,C5D-3%D93)E9#`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S`W M9CAB8V5?9&1A,%\T-C(W7V(P-3-?,3(U9#4Q9&4R960P+U=O'0O:'1M;#L@8VAAF4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY';V]D=VEL;"!);7!A M:7)M96YT/"]F;VYT/CPO9&EV/CQD:78@6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D M:6YG+71O<#HU<'@[=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C0X M<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^07,@;V8@4V5P=&5M8F5R)B,Q-C`[ M,S`L(#(P,3$@86YD('!R:6]R('1O(&]U2!C;VYC;'5D960@=&AA="!I M;7!A:7)M96YT(&EN9&EC871O2=S('1W M;R!M;W-T('-I9VYI9FEC86YT(&-L:65N="!A8V-O=6YT2`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` ` end